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Introduction: Patients with coexisting Diabetes Mellitus and End-Stage Renal Disease (DM-
ESRD) represent the fastest growing and most frail segment of the ESRD population. 
Multimorbidity can lead to psychological distress, intensify illness perception, impair 
nutritional Quality of Life (QOL), health literacy and adherence to treatment, but evidence is 
largely lacking. The study aimed to document prevalence and factors associated with 
psychological distress outcomes in DM-ESRD. 
Methods: This was a mixed-methods study involving N=31 interviews and a cross-sectional 
questionnaire survey with N=171 DM-ESRD patients using: the Hospital Anxiety and 
Depression Scale, UCLA Loneliness Scale, Beck Hopelessness Inventory, and measures of 
Health Literacy, Illness/Treatment Perception, Nutritional Quality-of-Life, and Adherence. 
Results: Interpersonal tension and challenges related to diet/appetite dominated patients’ 
narratives. Survey data indicated considerable range of distress (46% ; 53%; 79%; 53% for 
depression, anxiety, loneliness & hopelessness). Multivariate modelling predominantly 
revealed that Health Literacy dimensions and Nutrional QOL were associated with distress 
indicators. 
Conclusion: DM-ESRD patients find diet and health care communication/navigation 
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The present study addresses the following research aims. 
1. Produce a rich description of patient perspectives on DM-ESRD comorbidity, 
challenges in managing treatment aspects and available health services. 
2a. Document rates of: 
i. Psychological Distress (Depression, Anxiety, Loneliness and Hopelessness), 
and 
ii. Four psychosocial variables identified to be of significance (Health Literacy, 
Illness Perception, Nutritional QOL and Adherence) to the DM-ESRD population. 
2b. Assess the effect of Psychological Distress (e.g. depressed vs non-depressed) on 
Health Literacy, Illness Perceptions, Nutritional QOL and Adherence. 
3. Identify determinants of Psychological Distress. 
 
Significance of the Present Study 
The coexisting conditions of Diabetes Mellitus (DM) and End Stage Renal Disease 
(ESRD) present a myriad of treatment challenges to DM-ESRD patients. To compound the 
problem further, this segment of the ESRD population is the fastest growing and is the most 
frail. Multimorbidity can lead to significant psychological distress and additionally, the 
presence of coexisting conditions may intensify illness perception, impair nutritional Quality 
of Life (QOL), health literacy and adherence to treatment regimen. However, evidence for 
these phenomena in the DM-ESRD population remains largely lacking. The present study 
will be a significant pioneering endeavor for understanding patient perspectives, 




Importantly, understanding the needs of the DM-ESRD population and identifying 




End Stage Renal Disease 
Chronic Kidney Disease (CKD) is a debilitating chronic condition characterized by a 
loss of kidney function over time and ESRD represents the last stage of CKD. The function 
of the kidneys primarily involve removing waste products of metabolism as well as excess 
water, maintaining appropriate levels of electrolytes (e.g. potassium, sodium, calcium and 
magnesium) and reabsorbing blood proteins (e.g. albumin). ESRD patients have kidneys that 
can no longer support this myriad of critical bodily needs.  
Clinical diagnosis of ESRD is made based on tests of Glomerular Filtration Rate (GFR). 
GFR is a test of the function of the kidneys; specifically, it measures the amount of blood 
passing through the glomeruli per minute. Clinically, ESRD is marked by a GFR below 
15mL/min/1.73m
2
. Normal adults GFR results fall between 90 to 120mL/min/1.73m
2
 (Jones 
& Lim, 2003).  
ESRD is a rapidly escalating global health problem, with the expected number of 
ESRD patients projected to increase by 40% from 2010 to 2030 (United States Renal Data 
System, 2010). Prevalence rates of ESRD range from 13 patients per million population in 
Bangladesh and 350 patients per million population in the United States (USRDS, 2014) to 
961 patients per million population in Singapore (Singapore Renal Registry, 2014). The 
common symptoms of ESRD include fatigue, constipation, pruritus (itchiness), chronic pain, 




2011). The options to restore kidney function and sustain life include kidney transplant and 
dialysis (Hemodialysis [HD] and Peritoneal Dialysis [PD]). 
 
Transplant 
A kidney transplant is considered to be the ideal form of treatment for ESRD patients. 
Briefly, the process of kidney transplant is classified to be either deceased-donor or living-
donor (further classified into genetically-related or genetically-unrelated). The new healthy 
kidney(s) subsequently assimilates the work of the old dysfunctional kidney(s). Post-
transplant patients are required to continually consume immunosuppressants (e.g. Calcineurin 
Inhibitors, Antiproliferative Agents, mTOR inhibitors and Steroids) to control a natural 
bodily rejection of the foreign kidney. Other than a strict adherence to the 
immunosuppressant medication regimen, transplant patients live a relatively normal life 
compared to dialysis patients (Johnson, McCauley & Copley, 1982). 
However, the ratio of prevalence rates for kidney transplant vis-à-vis the number of 
ESRD patients is critically low. In 2014, less than 1% of the Singapore ESRD population 
were able to receive a kidney transplant (SRR, 2014). Many patients qualify for being placed 
on the transplant waitlist. Of the 123,193 patients waiting for a lifesaving organ in the United 
States, 101,662 of them await kidney transplants, with 3000 new patients added to the waitlist 
every month (USRDS, 2014). Reasons for the low rates of transplantation include a 
ubiquitous global shortage of available kidneys (Rosen et al., 2011) and strict medical pre-
requisites such as good general health and low comorbidity. Elderly patients may also be 
precluded because of these pre-requisites, posing a paradox for public health policy 
considering that the elderly are amongst the fastest rising segment of the renal population 
(SRR, 2014). In addition, ESRD patients over the age of 60 are ineligible for kidney 




median wait time for a kidney in Singapore is 9.4 years (Vathsala & Chow, 2009), compared 
to 3.6 years in the United States (USRDS, 2014). 
Given the low rates of kidney transplantation, dialysis thus becomes the primary mode 
of treatment for ESRD patients. 
 
Dialysis 
Compared to transplantation, dialysis (also known as Renal Replacement Therapy) is a 
necessary but less-than-ideal form of treatment for ESRD patients. The 5-year survival rate 
for Hemodialysis patients in Singapore is 58.9%, much lower in comparison to the 91.5% 5-
year survival rate for transplant patients (SRR, 2014). A study comparing the mortality of 
ESRD patients in different treatment modalities projected dialysis patients to live 17 years 
shorter compared to transplant patients (Wolfe et al., 1999). Overall, dialysis patients face 
poorer survival rates, higher hospitalization rates and poorer psychological outcomes (i.e. 
depression) (Ogutmen et al., 2006; Basok et al., 2009; Griva et al., 2014). However, these 
results should be interpreted with some discretion, with the caveat being that transplant 
patients are usually younger (hence healthier). 
Peritoneal Dialysis (PD). The present study examines the hemodialysis population, but 
for the purposes of providing a rich description of the dialysis population, the PD modality 
will be briefly discussed.  
About 12% of the Singaporean dialysis patients are on PD (SRR, 2013). Amongst 
developed nations, global prevalence of PD ranges from 2.5 patients per million in Cyprus, 
68 patients per million in Greece to 489 patients per million in Hong Kong SAR (Jain et al., 
2011). Prevalence rate of PD in Singapore was 177 patients per million in 2013 (SRR, 2014). 
Within the field of Nephrology, there is an increasing emphasis on increasing the use of PD 




become more widespread since the introduction of continuous ambulatory PD (CAPD) in the 
1980s and is presented as an alternative to Hemodialysis with comparable survival but 
improved quality of life and lower cost (Chaudhary et al., 2011).  
Briefly, the process and mechanisms underlying PD is such that the peritoneum in the 
abdomen is used as a membrane for which fluids and dissolved substances (e.g. albumin and 
glucose) are exchanged from the blood. Dialysate is infused into the body through a 
permanent catheter tube inserted into the abdomen of the PD patient (resulting in peritonitis 
susceptibility), and is drained out either at night whilst the patient is asleep (known as 
Continuous Cycling Peritoneal Dialysis, usually occurring for 10 hours) or via manual 
regular exchanges performed by the patients throughout the day (known as Continuous 
Ambulatory Peritoneal Dialysis, occurring 4 to 6 times daily for 3 to 4 hours each time). The 
drained dialysate comprises of wastes, toxins and excess water. PD is a continuous treatment 
modality that is performed every day. 
Hemodialysis (HD). The present study examines the HD population. 88% of the 
Singaporean dialysis patients are on HD (SRR, 2014). In developed nations, global 
prevalence of HD ranges from 322 per million population in the United States (USRDS, 2013) 
to 785 per million population in Singapore (SRR, 2013). The 1 and 5 year survival rates for 
HD patients were 90% and 58.9% respectively (SRR, 2013). While PD has seen increased 
utilization, HD remains the predominant dialysis modality worldwide, even in developing 
nations (USRDS, 2014). Some reasons for HD being more predominant include higher 
perceived susceptibility to technique failure in PD, with peritonitis being an important cause 
of infection complications (Aslam et al., 2006). Additionally, PD requires greater patient 
autonomy that may preclude elderly patients (Sinnakirouchenan & Holley, 2011). Another 




compared to the more expensive use of imported dialysate solution might also result in the 
lower uptake of PD (Anand et al., 2014). 
The following figure presents a select few countries in illustrating the global prevalence 
of HD. 
 
Figure 1. International Epidemiology of Hemodialysis vis-à-vis Peritoneal Dialysis 
(USRDS, 2014) 
 
The mechanism of HD is similar to PD, in that it involves the diffusion of solutes 
across a membrane. Unlike PD, HD is performed thrice weekly, usually in hospitals or 




HD, a dialysis machine and a special filter (called a dialyzer) are used to clean blood. Access 
to the blood is done through an intravenous catheter, an arteriovenous fistula or a synthetic 
graft, which is in turn influenced by factors such as prognosis and condition of vasculature. 
 
Figure 2. Illustrating the Hemodialysis procedure 
 
Comparing PD with HD. Studies comparing clinical outcomes (e.g. mortality, 
morbidity and hospitalization rates) between PD and HD see mixed findings. Some studies 
suggest general comparability (e.g. Harris et al., 2002; Griva et al., 2014); another 
documented that PD patients seem to have lower mortality rates (Fenton et al., 1997), while 
others suggest that HD patients have lower mortality rates (Bloembergen et al., 1995).  
A study examining modality selection found that the choice of dialysis modality is 




reasons for choosing HD is primarily the desire for having a set schedule and leaving the 
management of the dialysis procedure to Health Care Professionals (HCP) and nurses. Cited 
reasons for choosing PD is primarily due to the desire for flexibility of schedule and a 
convenience for performing dialysis at home (Wuerth et al., 2002). Demographically, HD 
patients tend to be older and less educated (Little et al., 2001). 
 
Diabetes Mellitus 
Diabetes Mellitus (DM), or commonly known as Diabetes, is a global epidemic 
projected to be the 7
th
 leading cause of death by 2030 (Mathers & Loncar, 2006). The World 
Health Organization (WHO) reports the global prevalence of DM to be 9% in 2014, and an 
estimated 1.5 million deaths in 2012 were directly caused by DM (WHO, 2015). In Singapore, 
the prevalence of DM rose from 9% in 1998 to 11.3% in 2010, and constituted 10% of the 
cause of death within the Singapore population in 2010 (Ministry of Health Singapore, 2015). 
Additionally, DM is also associated with a 3-fold increase in mortality in Singapore (MOH, 
2015). 
Clinically, DM is a group of metabolic diseases characterized by hyperglycemia 
(excess of glucose in the bloodstream) resulting from defects in insulin secretion, insulin 
action, or both. Clinical diagnosis of DM is made when fasting blood glucose is above 
7mmol/I or if a 2-hour plasma glucose during an oral glucose intolerance test is above 
11.1mmol/I. Long-term hyperglycemia is associated with both short and long-term damage 
and dysfunction of several organs in the body, including the eyes, heart and kidneys 
(American Diabetes Association, 2015). If untreated, these complications could be fatal. The 
plethora of DM complications include: 
- Polyuria (abnormally large volumes of diluted urine), 




- Susceptibility to infections,  
- Retinopathy (disease of the retina resulting in impaired vision),  
- Peripheral neuropathy (damage to peripheral nerves),  
- Cardiovascular dysfunction. A study found that 50% of diabetic patients died of 
cardiovascular complications (Morrish et al., 2002), and 
- Nephropathy leading to renal failure. WHO reports that DM is amongst the leading 
causes of renal failure (WHO, 2015).  
Majority of the DM cases fall into two broad etiopathogenetic (cause and development) 
categories: Type 1 and Type 2 DM. Type 1 DM is essentially a deficiency of insulin 
production in the pancreas. It is most common in children and young adults, and this group of 
DM patients requires injections of insulin to control levels of glucose in their blood. Type 1 
DM accounts for 5-10% of all DM patients worldwide (WHO, 2015). The more prevalent  
(90-95% of all DM patients) Type 2 DM involves patients’ resistance to insulin action and 
inadequate compensatory insulin secretory response (or Insulin Resistance). Type 2 DM is 
common in the elderly and the overweight. Usually, they can control their diabetic condition 
if food intake is controlled, coupled with weight loss and regular exercise. Therefore, patients 
with Type 2 DM produce insulin but do not use it as well as they should. Both Type 1 and 
Type 2 DM patients are required to adhere to a treatment regimen that involves strict diet, 










Coexisting Conditions: Diabetes Mellitus and End Stage Renal Disease 
Multimorbidity 
Multimorbidity refers to the coexistence of multiple chronic conditions. Previous 
studies indicate that as much as 45% of the general population and 88% of the population 
aged 65 years and older have at least 2 chronic conditions (Wolff et al., 2002). With 
increased life expectancy, the prevalence of chronic conditions is expected to increase. By 
2020, it is projected that at least half of the US population would have at least 1 chronic 
condition, with suggested reasons including advanced healthcare that prolongs life (Wu & 
Green, 2000). Singapore faces the problem of an ageing population, with the number of 
persons aged 65 years and above projected to increase from 9% of the population in 2010 to 
19% of the population by 2030. Individuals with at least 1 chronic condition are also more 
likely to have other comorbid conditions (Guralnik et al., 1989). The presence of multiple 
chronic conditions presents greater disease burden and compounds the effect of the diseases, 
making it difficult to address the patients’ clinical needs (Tong & Stevenson, 2007). Public 
health research has endeavored to identify patient outcomes, factors, needs and challenges of 
patients to devise disease management programs and patient education efforts to prevent and 
control the rising rates of chronic conditions (Bodenheimer, 1999). However, despite 
accumulating evidence of the tendency of chronic conditions to co-occur, most of these 
research efforts focus on handling a single chronic condition, leading to a dearth of similar 
research for multiple chronic conditions (Wolff et al., 2002; Mishra et al., 2011). 
 
Coexisting Conditions of Diabetes Mellitus and ESRD  
In addition to DM and ESRD being global epidemics in their own right, DM is amongst 
the leading causes of ESRD (Reutens et al., 2008). It is the primary cause of ESRD for 20% 




disease occurs in about one third of people with either Type 1 or Type 2 DM (International 
Diabetic Foundation, 2014). Diabetic Nephropathy (as nomenclature for etiology leading to 
DM-ESRD) affects approximated 60 million people worldwide (IDF, 2014). In financial 
terms, 30% of the predicted 1.1 trillion dollar (USD) medical costs of dialysis worldwide 
would stem from Diabetic Nephropathy (Lysaght, 2002). DM- ESRD patients do not fare 
well in clinical outcomes – disconcerting evidence demonstrates that more than 50% of DM-
ESRD dialysis patients die within 2 years of commencing dialysis (USRDS, 2014). In 
response to these critical findings, policy advocacy discussions have shifted towards finding 
ways to increase awareness of the severity of DM and kidney disease (Atkins & Zimmet, 
2010). 
 Briefly, the mechanisms behind Diabetic Nephropathy are such that high blood glucose 
levels could damage vessels in the kidney, which in turn affects the filtering function of the 
kidney. Wastes then build up in in blood, and when kidney damage reaches the final stage of 
ESRD, built up waste in the blood can build to toxic levels and cause death. 
Overall, the comorbid conditions of DM and ESRD lead to an adverse compounded 
effect on patients, with higher mortality rates and poorer quality of life presenting a mounting 
challenge to public healthcare. However, the lack of research on patient outcomes for 






Figure 3. Diabetes versus other Etiologies of ESRD in the United States (USRDS, 2015) 
 
Psychological Distress 
Psychological distress is amongst the most common comorbid conditions in chronic 
disease patients, and is associated with diminished health status and significantly lower 
health-related quality of life (Chapman, Perry & Strine., 2005). Furthermore, a study also 
reported that psychological distress increases with multimorbidity (Fortin et al., 2006). 
Psychological distress can be key indicator of an individual’s overall health status and can be 
thought of to refer primarily to a subjective experience that describes an individual’s 
functional (or dysfunctional) adaptation to their environment (McDowell & Newell., 1996). 
In relation to patients with chronic diseases (e.g. DM and ESRD), psychological distress can 
intensify the effect of these diseases and lead to poorer health outcomes and increased risks 
of treatment complications (Anderson et al., 2002; Kruse, Schmitz & Thefeld., 2003). 




multimorbidity despite epidemiological prevalence of multimorbid conditions (Huntley et al., 
2006). 
Considering that ESRD is a chronic and life-threatening condition, psychological 
distress is documented to be highly prevalent (Kimmel et al., 2003; Cukor, Cohen, Peterson 
& Kimmel, 2007; Ramirez & Macedo, 2012; Griva et al., 2014). A broad spectrum of 
challenges is associated with a diagnosis of ESRD, which may in turn increase psychological 
distress of a patient (Martin et al., 2004). Some evidence has suggested that psychological 
distress contributes to greater morbidity and even earlier mortality (Gilbar et al., 2005). A 
dialysis patient must cope with the constant threat of death and reduced life expectancy. Thus, 
a maladaptive form of coping can contribute to psychological distress as well (Wright et al., 
1999). 
Despite DM being one of the leading causes of ESRD, the documentation of 
psychological distress in DM-ESRD patients is largely lacking (William et al., 2008). 
Existing studies mostly focus on either DM or ESRD singly and evidence on how these 
patients manage multiple conditions with psychological distress is largely unknown. In 
comparison to other chronic medical conditions, including other etiopathologies of ESRD 
(e.g. Hypertension & Glomerulonephritis), DM-ESRD patients face a wider spectrum of 
demands from their treatment regimen (e.g. very strict diet, more medication, glucose 
monitoring and exercise requirements). Managing just a single dimension of the treatment 
regimen would be ineffective – for example, medication without dietary modification would 
not result in optimal treatment outcomes such as good glycemic, potassium and phosphate 
control in DM. Thus, it is expected that these additional demands impact the psychological 
well-being of DM-ESRD patients. 
There is no question that DM-ESRD is a complex condition driven by many factors. 




status, understanding psychological distress in DM-ESRD patients promotes policy advocacy 
discussions to find ways of improving mortality rates and overall quality of life. In fact, some 
research has emphasized that subjective psychological distress may have a more direct impact 
on patients’ lives than medical outcomes since the experience of negative emotions are more 
visceral and immediate (Petrie et al., 1996).  Hence, the lack of studies examining 
psychological distress in DM-ESRD patients thus drives the goal for a deeper understanding 
of this high-risk population. 
 
Depression 
As one of the more common manifestations of psychological distress (Sartorius et al., 
1996; Ibrahim & El Salamony., 2008), depression is a state of low mood and aversion to 
activity that can affect a person’s thoughts, behavior, feelings and sense of well-being 
(Diagnostic and Statistical Manual of Mental Disorders Fifth Edition, 2014). Typical 
depressive symptoms include “depressed mood, anhedonia, appetite or weight change, sleep 
disturbance, fatigue, psychomotor disturbances, feelings of worthlessness or guilt, impaired 
concentration and suicidal thoughts” (Koenig et al., 1997).  
Several studies documenting prevalence rates of depression in HD patients estimates 
the figure to be between 28% to 40% (Fukunishi et al., 2002; Drayer et al., 2006; Park et al., 
2010). A Singaporean study examining depression levels between HD and PD patients 
reported 16% and 32% prevalence rates respectively (Griva et al., 2014). To further 
compound the problem of high depression rates, many studies indicate that depression is 
related to higher morbidity and mortality rates in HD patients (Israel, 1986; Craven et al., 
1988; Cukor et al., 2007; Hedayati et al., 2009; Park et al., 2010). Depression is projected to 
be a leading future cause of mortality, surpassed only by cardiovascular disease in terms of 




Previous studies examining the association between depression and survival rates suggest that 
ESRD patients who live longer report more depressive symptoms (Kimmel et al., 2000). A 
concrete link between depression and mortality in ESRD patients has yet to be established, 
but suggested reasons include impaired nutrition status, self-care activities and immune 
functioning (Kimmel, Weihs & Peterson, 1993). 
Studies examining the effects of depression in ESRD patients found that depression 
increases the likelihood of nonadherence with medical treatment, resulting in unfavorable 
treatment outcomes (Griva et al., 2014). Another study also found that depression may be 
associated with ESRD patients’ ideation about withdrawing from dialysis treatment, a 
concept linked with hopelessness (to be discussed subsequently) (Christensen & Ehlers, 
2002). Studies examining the effects of depression in diabetic patients found associations 
with poor self-management in diabetic self-care (e.g. blood glucose monitoring, dietary 
adherence and medication adherence) (Katon, 2008). Conversely, both DM and ESRD, as 
chronic diseases, have been reported to worsen symptoms of depression primarily through a 
heavy disease burden (Katon, 2008). Despite evidence of adverse effects of depression, the 
construct is still largely under-recognized, misdiagnosed and undertreated in the ESRD 
population (Young et al., 2010). Of clinical relevance, symptoms of depression such as loss 
of appetite and lack of concentration may also be a manifestation of ESRD. Thus, Healthcare 
Providers (HCP) may not notice the presence of depressive symptoms in patients. 
Past studies identifying predictors of depression in ESRD patients suggest that an older 
age, being female, having a high number of comorbidities and poor nutrition status as 
indicated by serum albumin to be useful in predicting depression (Carton & Schweitzer, 1996; 
Friend et al., 1997; Kimmel, 2002).  
In the context of DM and ESRD as comorbid conditions, research on depression in 




literature, one study documented a 20% prevalence rate of depression in DM-ESRD patients, 
and also reported that depression was associated with a 2.95-fold greater risk of death, a 
number significantly greater than those found for the general DM population but equivocal to 
the general ESRD population (Young et al., 2010). More research is necessary for exploring 




Anxiety is an emotion characterized by an unpleasant state of inner turmoil and dread 
over anticipated events, and includes a feeling of imminent death. Feelings of uncertainty, 
tension, inadequacy, difficulty in concentration, feeling flushed, helplessness, irregular 
breathing and quick heartbeat are common symptoms of anxiety. Several studies have 
identified anxiety to be associated with poorer quality of life (Vazquez et al., 2005; Vasilieva, 
2006).  
Similar to depression, anxiety has been cited as a common manifestation of 
psychological distress (e.g. Segrin et al., 2007). In comparison to depression, the attention 
given by research to anxiety in ESRD patients is in stark contrast and is largely lacking. Of 
the limited evidence available, one study documented the prevalence rates of anxiety in 
ESRD patients to be 24.7% (Patridge & Robertson, 2011), while another documented 57% 
prevalence rates of anxiety in HD patients (Martin, Tweed & Metcalfe, 2004). The authors 
further reported that anxiety adversely affects adherence to dialysis regimes. A Singaporean 
study examining anxiety levels between HD and PD patients reported 22% and 14% 
prevalence rates respectively (Griva et al., 2014). The mechanisms in which anxiety affects 
treatment outcomes in the ESRD population is suggested to be that symptom severity, 




compliance may lead to a situation where the patient feels uncertainty about the future in 
terms of disease management and treatment outcomes (Martin & Thompson, 2000). Little is 
known about the relationship between DM and anxiety (Li et al., 2008). Some available 
evidence suggests that complications from DM are associated with higher levels of anxiety 
(Peyrot & Rubin, 1997). A study by Li and colleagues (2008) found that older age was 
associated with lower prevalence of anxiety diagnosis, although the authors have stated that 
underlying mechanisms between age and anxiety remain unclear. 
There is a paucity of research examining anxiety in DM-ESRD patients. It is thus 
necessary to further strengthen literature examining prevalence rates and associated factors in 
the DM-ESRD population.  
 
Loneliness 
There is no current consensus on the proper definition of loneliness (Karnick, 2005). 
Individuals may experience and describe loneliness in subjective ways. An early study into 
the construct suggested for the definition to be “the extent that a person’s network of social 
relationships is smaller or less satisfying than the person desires” (Peplau & Perlman, 1979). 
A more recent operationalization of the term describes loneliness as “a continual, painful 
companion that causes people to regard their affliction as a personal defect or deficiency” 
(Thesen, 2001). Loneliness is considered to be a multidimensional psychological construct, 
and represents a personal and subjective experience related to the individual’s gender, age, 
marital status and social relations amidst a cultural context (Nilsson et al., 2006). Overall, 
sufferers of loneliness describe the experience to be emotionally and socially excluding, and 
is a significant portion in the experience of psychological distress (Lindgren et al., 2014).  
It is suggested that poor physical and psychological states resultant from the experience 




2012). Chronic conditions such as ESRD are postulated to have a significant effect on other 
healthy members of the family, especially for the spouse of the ill person (Asti et al., 2006). 
This in turn may promote a sense of helplessness in dealing with the illnesses and elicit 
psychological responses including loneliness. Furthermore, it has been suggested that the 
complex treatment regime that ESRD patients face may restrict patients’ social activities and 
lead to feelings of isolation (Asti et al., 2006). Additionally, a cognitive bias may cause 
persons suffering from chronic debilitating illnesses to see themselves differently from 
healthy persons, resulting in attitudes facilitating social withdrawal (Weillitz & Sciver, 1996). 
Miller (1983) suggests that friends of patients with chronic diseases may withdraw from the 
patient because of their reaction to unpleasant symptoms or a discomfort over being healthy 
in the presence of somebody ill, although there is insufficient evidence to support this claim. 
Overall, loneliness is assessed to be an important theme in patients’ experience with ESRD 
(Herlin & Wann-Hanson, 2010). 
In terms of research on loneliness in diabetic patients, reports have been mixed. A 
longitudinal study examining social relationships in young adults with Type 1 DM reported 
that diabetic patients experienced less trust and a sense of intimate friendship compared to 
controls, but did not differ in the experience of loneliness (Jacobson et al., 1997). Another 
cross-sectional study on the differences in loneliness between healthy subjects and different 
chronic conditions reported that diabetic patients scored poorer on loneliness scores, but 
receive better instrumental support (e.g. given help with chores, meals and transportation) 
compared to other chronic conditions (Penninx et al., 1999).  
In the last few decades, the prevalence of loneliness has been studied in different 
clinical populations, and generally, the findings usually document that loneliness is a 
condition that is widely distributed and severely distressing (Weiss, 1973; Prince, Harwood & 




studied in the diabetic and ESRD population. Overall, epidemiological studies point out the 
importance of social networks and social inclusion for morbidity and mortality (Berkman & 
Syme, 1979; Penninx et al., 1999). 
Overall, research into loneliness has been disparate in the sense that it is studied 
exclusively in either the ESRD or the diabetic population. Loneliness as a construct in DM-
ESRD patients is relatively unexplored, despite the collective evidence for documented 
loneliness in chronic diseases.  
 
Hopelessness  
Hopelessness is defined by Aaron T. Beck as pessimism or “a system of negative 
expectancies” concerning oneself and one’s future life (Beck et al., 1974). Hopelessness is 
identified as one of the core characteristics of depression (Beck, 1967), and is also reported as 
an aggravating factor for depression (Abramson & Metalsky, 1989). Additionally, 
hopelessness is also associated with a wide spectrum of other psychological disorders.  Of 
note, longitudinal studies have identified hopelessness to be predictive of suicide ideation 
even after controlling for history of attempts (e.g. Klonsky et al., 2012). 
It is necessary to distinguish hopelessness as a distinct construct from depression. 
While hopelessness is reported to be a symptom of depression and thus it may be challenging 
to disentangle these two psychological constructs, hopelessness is found to have both somatic 
and psychological effects that are distinct from depression. For example, a longitudinal study 
examining the relationship between hopelessness and heart disease found that the effect of 
hopelessness was stronger than the effect of depression on incidence of fatal ischemic heart 
disease and hypertension in general (Everson et al., 2000). In addition, hopelessness has been 
found to correlate weakly with standard depression measurement scales (Everson et al., 1996). 




that is, depression refers to a loss of pleasure (a form of mood) while hopelessness refers to a 
loss of meaning (a form of cognition). Hopelessness is suggested to be primarily linked to a 
“Demoralization Syndrome”, where a sense of pessimism, helplessness, loss of hope for 
improvement or recovery along with associated alienation and lack of social support would 
pose as a significant barrier to effective care (Kissane, 2009). Therefore, hopelessness may 
deserve studying in its own right. 
Hopelessness has been associated with discontinuation of life-prolonging treatments 
(e.g. Dialysis) (Jones et al., 2003). A study also reported that hopelessness predicts a wish for 
hastened death (Breitbart et al., 2000), which has significant implications for dialysis as a 
life-sustaining treatment. A study examining hopelessness (using the Beck Hopelessness 
Scale) in an ESRD population found that reported hopelessness rates were greater than 
population norms by more than 2 standard deviations, and these rates may also be related to 
treatment withdrawal ideation (Kim et al., 2002). The authors suggested that the primary 
reasons for hopelessness in the study population were due to treatment and disease burden. 
Several other studies of ESRD patients also document the presence of hopelessness (White & 
Grenyer., 1999; Lew & Piraino, 2005). 
Studies of hopelessness in the diabetic population have been limited, although a recent 
first-of-its-kind study documented the prevalence of hopelessness in a diabetic population to 
be around 40%. However, the reported mean hopelessness score in the study were below the 
clinical cut-off score (Pompili et al., 2009), signaling the need for greater examination of 
hopelessness in the DM population. 
 Considering that studies of hopelessness in combined DM-ESRD patients have been 
very limited, the urgent impetus to examine hopelessness in DM-ESRD patients is clear. 
Implications for the documentation of hopelessness are especially important in shaping the 




the accompanying construct of suicide ideation. Studies examining hopelessness usually do 
so in the context of examining it as a symptom of depression, but the reasons for 
distinguishing these two psychological dimensions and examining them separately have been 
discussed. Overall, the study of hopelessness as a separate construct in this study would set 
precedence for future research in distinguishing these two psychological dimensions. 
 
 
Figure 4. Psychological Distress Dimensions Explored in the Current Study 
 
Psychosocial Dimensions of Importance to Psychological Distress 
Four important psychosocial dimensions have been identified in the present study. The 
overarching theme to these constructs is that some evidence exists suggesting their 
relationship with some (or all) of the dimensions of psychological distress (in the present 
study) that in turn affects treatment outcomes, but these four constructs are relatively 
unexplored in the context of the DM-ESRD patient population. The four psychosocial 
constructs include: 
i. Health Literacy, 
ii. Nutritional Quality of Life, 
iii. Illness Perception, and 
iv. Adherence. 
Psychological Distress (Current Study) 




Health Literacy  
The WHO describes health literacy as “the cognitive and social skills which determine 
the motivation and ability of individuals to gain access to, understand and use information in 
ways which promote and maintain good health” (WHO, 1998). Broadly, health literacy refers 
to a set of skills that individuals need to function effectively in the health care environment 
(Berkman et al., 2011). Some of these skills include the individual ability to read and 
interpret health-related information, use quantitative information for tasks (e.g. interpreting 
caloric and other nutrition information on a food label or measuring and understanding blood 
glucose levels in a meaningful way), adhering to treatment regimens and the ability to 
establish good communication with Health Care Providers (Berkman et al., 2011). Poor 
health literacy has been linked with poor treatment outcomes, increased mortality, lower 
physical functioning, lower use of preventive healthcare services and elevated risks for 
medication errors (Osborne et al., 2013). It is important to examine health literacy in patient 
populations as poor health literacy may lead to difficulties in understanding basic medication 
instructions, health documents, education information or even provide informed consent with 
regard to their treatment. These patients may subsequently become disadvantaged in the 
proper management of their conditions (Kalichman & Rompa, 2000). Health literacy has 
been described as a key factor of a patient’s ability to better manage their conditions and of a 
particular health system’s ability to ensure equitable access to health services (Nielson-
Bohlman et al., 2004). 
In the United States, a report suggests that 80 million U.S. adults have limited health 
literacy, and further projects poor health literacy to increase national annual healthcare 
expenditure by US$73 billion, thus presenting a major public health problem (USA National 
Academy on an Aging Society, 2013). In response, policy and advocacy organizations have 




(IOM) published a comprehensive report “Health Literacy: A Prescription to End Confusion” 
(IOM, 2004) to rally nationwide efforts to improve health literacy in both general and clinical 
populations.  
Poor health literacy is reported to be most pronounced amongst patients with chronic 
medical conditions (Osborne et al., 2013). As 2 chronic conditions, co-existing DM and 
ESRD have complex treatment requirements and therefore health literacy research should be 
extended to examining health literacy needs in the DM-ESRD population, as managing DM 
together with ESRD may present a significantly higher requirement for good health literacy 
as compared to unidimensional illnesses. In addition to the competing needs and demands of 
DM-ESRD, the added complexity of treatment regimens require DM-ESRD patients to make 
complex decisions and even reconcile contradictory treatment guidelines (Lai et al., 2013). 
For example, dietary recommendations for the management of DM include the consumption 
of fruits high in potassium (e.g. avocadoes and bananas), but dietary recommendations for 
ESRD paradoxically recommends against the consumption of such foods as it may cause 
hyperkalaemia and side effects such as nausea, weakness and slow pulse (Kopple, 2001). A 
study suggested that the complexity of DM and ESRD treatment increases the chance for 
misinformation about medication, which in turn reduces confidence and increases the chance 
of non-adherence to the medication regimen (Williams, Manias & Walker, 2009). In addition 
and of interest to the present study, several studies report that ESRD patients may be 
predisposed to choose HD as a dialysis modality when certain deficiency in health literacy is 
documented and patients are not given adequate information regarding both modalities (Little 
et al., 2001; Marron et al., 2005). Furthermore, it has been reported that when patients have 
access to information about the differences between PD and HD as treatment modalities, as 
much as 50% of pre-dialysis patients who were suitable for both modalities chose PD 




dialysis modality worldwide. Thus, there is some evidence to suggest that between the PD 
and HD modalities, health literacy in HD patients may be less-than-ideal. This provides an 
additional impetus for examining health literacy in a HD population.  
However, considering that health literacy is a relatively new concept in public health, 
there is a shortage of studies examining health literacy across various populations in 
Singapore. One such study examining the relationship between health literacy and self-care 
management with regard to behaviours such as dietary adherence and blood glucose testing 
indicated that some aspects of health literacy were associated with better diabetic self-care 
management in ESRD patients, but found no relationships between functional health literacy 
(defined as basic literacy skills of reading and writing) and self-care management (Lai et al., 
2013).  
Overall, there is a need for greater effort to identify and address health literacy needs in 
the DM-ESRD population to improve disease self-management. 
 
Nutritional Quality of Life 
Nutritional QOL in HD 
Proper nutrition is essential for chronic disease patients to maintain general well-being 
and optimal treatment outcomes. Malnutrition is defined as “a condition that results from 
eating a diet in which nutrient are either not enough or are too much such that the diet 
causes health problems” (Chung et al., 2003). It is important to note that malnutrition refers 
to both “over-nutrition” and “under-nutrition”, as opposed to a common misunderstanding of 
malnutrition to be limited to “under-nutrition” (National Institute of Health, 2014). 
Malnutrition has serious consequences for any individual and sub-optimal nutritional may not 
be clinically identified until a later time. With increased malnutrition, altered biological 




cases, death. Even malnutrition of a less severe degree may have a substantial negative 
impact. For example, protein nutritional deficiency may result in an impaired immune 
response, which in turn increases the risk of infections, while excess of protein is related to 
metabolic changes (Grundy et al., 2005). 
For HD patients, the documented sensory, hedonic, physical and psychosocial problems 
are found to decrease nutritional status (Han et al., 2012). The prevalence of malnutrition is 
frequently documented in HD patients (e.g. Wolfson et al., 1984; Han et al., 2012; Sedhain et 
al., 2015). Signs of malnutrition in dialysis in HD patients include low concentrations of 
albumin and low soluble protein in the muscles. A more convenient method of examining 
nutrition is Body Mass Index (BMI). A recent study indicated a significantly lower BMI 
difference between HD patients and controls (Montazerifar, Karajibani, Gorgij & Akbari, 
2014). Multiple medications (which may lead to certain side effects) and socioeconomic 
constraints (e.g. stemming from the perception that healthy food costs more) may also further 
contribute to decreased dietary intake (Diaz-Buxo et al., 2000).  
Mounting evidence suggests that Type 2 DM is strongly related to malnutrition 
(Rosenbloom, Joe, Young & Winter, 1999; Pastors et al., 2002). Type 2 DM usually occurs 
in the context of obesity, which is found to be related to malnutrition in the sense that an 
overabundance of calories results in impaired biochemical processes that confuses 
metabolism (Prentice, 2006). The collective evidence for malnutrition in DM-ESRD warrants 
a closer examination into the subject matter for DM-ESRD patients, but few studies have 
directly examined nutrition in DM-ESRD patients. 
Nutritional status is related to health-related Quality of Life (QOL). QOL can be 
broadly defined as “a state of complete physical, mental and social wellbeing” (WHO, 1995). 
Measurements of QOL typically target physical and mental components, such as general 




Zadeh et al., 2001). Many studies have identified poor nutritional status in HD patients to be 
associated with poorer QOL in both physical and mental components (Diaz-Buxo et al., 2000; 
Laws, Tapsell & Kelly., 2000; Kalantar-Zadeh et al., 2001). Poor QOL is also thought to 
precede declines in nutrition status (Han et al., 2012). Overall, poor nutrition is found to be 
closely associated with poor QOL in HD patients and decreased QOL is generally found to be 
associated with increased morbidity and mortality rates (Dwyer et al., 2005). Thus, it may be 
worthwhile to study nutritional status and QOL collectively. In fact, a recent pioneering study 
developed an instrument to assess nutritional QOL (an instrument used in the present study) 
and the authors report the instrument to have strong correlation with health-related QOL (Han 
et al., 2012). 
It is important to examine nutritional QOL in DM-ESRD patients, considering the 
scarcity of research examining nutritional status in this segment of the patient population. 
 
Illness Perception 
Theoretical developments of illness perceptions are based on the Common-Sense 
Model (CSM) (Leventhal et al., 1997). The CSM describes a parallel response model in 
which individuals process emotional responses to illness and make cognitive representations 
of the illnesses independently. These cognitive representations subsequently motivate certain 
behaviors to regulate their emotions as well as seek ways to improve the outcome of their 
illness. These behaviors then further lead to an appraisal of the effects on the illness and 
result in a feedback loop. As research into the concept developed, illness perception became 
associated with reference to mental representations and personal ideas about an illness.  
Self-regulatory theory is also used to illustrate the concept of illness perception. 
Broadly, the theory suggests that illness outcomes are influenced by how patients perceive 




control and may be prone to acting on immediate desires, leading to situations such as 
treatment nonadherence (Leventhal et al., 1984). Petrie and Weinman (2012) suggests that 
patients’ mental representations and ideas tend to fall along at least five dimensions: identity 
of the illness (name and symptoms), cause of the illness, consequences (impact on quality of 
life and different life domains), timeline (course of illness) and lastly, control (how the illness 
can be controlled). Illness perception is found to have a direct relationship with illness 
outcomes in several studies (Hagger & Orbell, 2003; Petrie et al., 2007). In a meta-analysis of 
illness perceptions and treatment outcomes, it was demonstrated that negative illness 
perceptions were associated with poorer overall well-being (Hagger & Orbell, 2003).  
In the HD population, studies have examined the impact of illness perceptions on 
clinical and psychological outcomes such as treatment adherence, self-management behavior 
and psychological distress (Chilcot, Wellsted & Farrington, 2011). Illness perceptions 
involve cognitions surrounding illness identity, treatment control, illness comprehensibility, 
treatment burden and consequences (Broadbent et al., 2006). In multimorbidity studies, 
illness perception is also thought to involve the degree to which patients may face conflicting 
requirements in prioritizing one condition over another (Gibbons et al., 2013). Importantly, 
illness perception has been found to predict survival rates in the ESRD population (van Dijk 
et al., 2009). 
In diabetic populations, illness perception has been mainly used to study adherence to 
treatment (e.g. Broadbent, Donkin & Stroh, 2011). Adherence is mostly associated with 
lower perceived consequences of DM, higher personal control and specific beliefs about the 
usefulness of treatment. 
Multimorbidity presents a significant challenge to patients that may significantly affect 
illness perception but overall, there is a scarcity of studies examining illness perception in 




conditions in general indicate that the presence of multimorbidity impacts patient illness 
representations in relation to dimensions of identity, perceived cause and consequences 
(Bower et al., 2012). In addition, illness perceptions may also be critical to the patient 
experience of multimorbidity, as illness perception is suggested to be an enabler of the ability 
to make sense of conditions appropriately (Kenning et al., 2015). 
 
Adherence 
A widely used definition of adherence in health research is “the extent to which a 
person’s behavior, such as taking medication, following a diet, and/or executing lifestyle 
changes…that corresponds with agreed recommendations from a Health Care Provider” 
(Sabate, 2003). Nonadherence to treatment recommendations (in terms of diet, medication 
and dialysis) is predictive of higher mortality rates in ESRD patients and is postulated to be in 
the same order of importance as clinical indicators (such as outcomes of patient care) (Bander 
& Walters, 1998). As previously mentioned, the treatment requirement for dialysis is 
complicated, demanding and time-consuming. Regular dialysis sessions at community HD 
centers, taking a plethora of medications and fluid/diet restrictions contribute to treatment 
complexity that is often cited as a cause of nonadherence in ESRD patients (Donovan, 1995). 
In the case of DM, Diabetic patients are instructed to perform insulin injections, 
conduct multiple urine or blood glucose tests, follow a diet low in saturated fat and other 
safety precautions relating to the body (such as foot care). Behavioral researchers have 
consistently given adherence in DM considerable attention (Glasgow et al., 1986; Ho et al., 
2006). A systematic review of adherence to medication for diabetic patients found the rates to 
be range from 36% to 93%, with higher adherence rates documented for patients who use 




diabetic patients mostly report a high degree of nonadherence to diet despite their diagnosis 
(Schafer et al., 1986; Lin et al., 2004).  
Adherence is not a one-dimensional concept as DM-ESRD patients may not give the 
same level of importance across all aspects of the treatment regimen (e.g. dialysis, medication 
and diet/fluid). Few studies have attempted to document adherence rates in the DM-ESRD 
patient population. In HD adherence research however, many studies demonstrate that 
dialysis sees reasonably high adherence rates (e.g. Block, Hulbert-Shearon, Levin & Port, 
1998; Taskapan et al., 2005), but the evidence for medication and diet/fluid adherence has 
been mixed (Lin & Liang, 1997; Curtin, Svarstad & Keller, 1999; Griva et al., 2014). A 
suggested reason for the disparity in adherence to different aspects is because somatic 
symptoms are relieved by dialysis, and skipping even a single dialysis session would have 
significant impact on the patient’s health (Khalil et al., 2011). Thus, it may be useful to direct 
focus towards an in-depth examination of medication and diet/fluid adherence in ESRD 
patients. Of note to the present study, adherence in the DM-ESRD population may be more 
problematic compared to other etiopathologies because these patients developed kidney 
disease due to nonadherence to diabetic treatment in the first place. 
 
Psychological Distress and Health Literacy, Illness Perception, Nutritional QOL and 
Adherence in DM-ESRD Patients 
 
There are limited studies on DM-ESRD patients in general and there are even fewer 
studies examining psychological distress and the four identified psychosocial dimensions 
(Health Literacy, Illness Perception, Nutritional QOL and Adherence) in DM-ESRD patients. 
This study is a pioneering effort in this research area. Nonetheless, it is necessary to review 




distress for ESRD patients in general. Overall, the literature review of this area affirms the 
need to compare the four dimensions of psychological distress with the four identified 
psychosocial dimensions. 
 
Health Literacy and the Four Dimensions of Psychological Distress 
The available evidence for the relationship between health literacy and depression in 
ESRD patients is very limited. One available study found that health literacy has no 
association with depression in patients on HD (Green et al., 2011). However, the sample size 
was relatively small (n = 41) and the study had excluded patients on transplant lists or those 
of whom who are considering a switch to PD, which may at the same time exclude subjects 
with higher health literacy.  
A literature search did not find any available studies examining anxiety and health 
literacy in ESRD. One study examining health literacy self-management in patients with 
Type 2 DM and stage 3 CKD found that feelings of anxiety may alter the ability to perceive 
and receive health information, and could also possibly compound information confusion 
(Sakraida & Robinson, 2009). It is likely that DM-ESRD patients may report similar 
tendencies. 
No existing studies have explored the relationship between health literacy, loneliness 
and hopelessness in DM-ESRD patients.  
 
Illness Perception and the Four Dimensions of Psychological Distress 
Studies examining the relationship between illness perception and depression in ESRD 
patients are also limited. An epidemiological survey of depression, perception of illness and 
mortality in ESRD patients report that illness perception is associated with depression and 




a greater perception of illness burden was associated with reporting more depressive 
symptoms (Devins et al., 1990). 
There is a general lack of studies examining the relationship between illness perception 
and anxiety in DM-ESRD patients. One study examining illness intrusiveness and quality of 
life in ESRD patients found that in both PD and HD patients, higher levels of perceived 
illness intrusiveness (treatment burden) was associated with greater negative affect, including 
anxiety (Devins et al., 1990). 
A search in the literature reveals that no current studies have explored the relationship 
between illness perceptions, loneliness and hopelessness in DM-ESRD patients.  
 
Nutritional QOL and the Four Dimensions of Psychological Distress 
As nutritional QOL is a relatively new concept on its own, the review of literature in 
this area will focus on reviewing the closely related construct of nutritional status (as 
discussed previously in this chapter) with psychological distress. 
Research has generally shown significant associations between depression and 
nutritional status (Koo et al., 2003; Bilgic et al., 2007). The severity of depression is 
predictive of the degree of malnutrition in HD patients, but it remains unclear as to whether 
depression may be the cause or the end result of poor nutrition (Bilgic et al., 2007). Some 
suggestions for the underlying mechanisms include a clinical explanation that 
proinflammatory cytokine-induced chronic inflammation that could cause both depression 
and malnutrition in HD patients, in addition to depression usually having accompanying 
symptoms of loss of appetite, in turn affecting nutrition (Bilgic et al., 2007).  
Research on nutritional status, anxiety and loneliness are limited and unclear, although 
it is likely that these psychological distress constructs would influence nutrition status in 




poor nutrition in general (Kalender et al., 2006; Lew et al., 2005), although these studies 
usually examine hopelessness as an extension and symptom of depression.  
 
Adherence and the Four Dimensions of Psychological Distress 
The relationship between nonadherence and depression is well documented. For 
example, Cukor and colleagues (2007) reported that depression was a significant predictor of 
nonadherence to treatment for HD patients and argue for routine screening of depression to 
promote adherence. The proposed mechanism underlying the relationship is still unclear, 
although some suggestions include poor health education and high dosage frequencies that 
increase depressive symptoms (e.g. rumination) (Stein-Shvachman, Karpas, Werner, 2013). 
Additionally, a study reported that depression affects adherence mainly through perceived 
side effects, general barriers and low self-efficacy (Chao et al., 2005).  
In the study of adherence in ESRD patients, depression, anxiety and hopelessness have 
usually been lumped together under the ambit of a broader term – Emotional Distress (e.g. 
Brownbridge & Fielding, 1994; DeOreo, 1997). However, the present study attempts to 
distinguish these three dimensions. 
Loneliness and social isolation have been shown to be associated with low adherence in 
ESRD patients, but evidence is also limited. One study found that social support is an 
important psychosocial factor related to fluid control adherence in patients on dialysis 
(Heaney & Israel, 2002; Yokoyama et al., 2009). The proposed mechanisms include the idea 
that social support can enhance an individual’s ability to access information and diminish 
negative effects of the complexity of treatment, thus improving motivations and beliefs for 






Limitations of Previous Studies  
The present paper has presented a case for the scarcity of studies examining the DM-
ESRD patient population in general. The four psychological dimensions (depression, anxiety, 
loneliness and hopelessness) are distinct constructs, but in general previous studies do not 
give accordance to the distinction and usually examines them collectively, especially in terms 
of depression and hopelessness. In addition, studies examining the four psychosocial 
dimensions (health literacy, illness perception, nutritional QOL and adherence) in the context 
of co-existing chronic conditions are limited as well.  
 
Study Hypotheses 
Hypothesis 1: The study population will report psychological distress. In addition, 
Health Literacy, Illness Perception, Nutritional QOL and Adherence is expected to differ 
between the respective distressed vs. non-distressed subgroups.  
Hypothesis 2: Health Literacy, Illness Perception, Nutritional QOL and Adherence are 
expected to make significant contributions to the prediction of each of the four psychological 
















This was a mixed methods study. By combining qualitative and quantitative 
methodologies, mixed methods research has been argued to increase the meaningfulness of 
research compared to either qualitative or quantitative methods on their own (Creswell & 
Clark, 2007). In addition, mixed methodology is suitable for addressing the research aims of 
this study. Firstly, the lack of studies examining psychosocial outcomes in DM-ESRD 
patients permit an explorative qualitative component (in-depth interviews with patients) to 
examine a unique population that faces unique and complex treatment challenges relative to 
other chronic disease populations (including other segments of ESRD population). A 
quantitative approach allows the identification of significant relationships between 
psychological distress and the other psychosocial variables (i.e. illness perception, health 
literacy, adherence and nutritional QOL), as well as identifying determinants of 
psychological distress using regression-based methods (i.e. hierarchical stepwise logistic 
regression). Hence, the use of mixed methods in this study allows for a critical exploration of 
new lines of enquiry of DM-ESRD population needs, as well as test for significant 
relationships between psychological distress and the 4 relevant psychosocial constructs 




As part of a broader study exploring multi-morbidity, (DM & ESRD) (Griva et al., 
2015), a total of thirty-one (31) DM-ESRD patients were recruited for the qualitative 




In consultation with NKF Health Care Professionals, the study identified eligible DM-
ESRD participants and these patients were approached at several participating National 
Kidney Foundation community Dialysis Centers in Singapore (NKF DCs).  Following 
informed consent, arrangements were made for a mutually agreeable date, time and venue for 
conducting a semi-structured interview. Participants were purposively sampled to ensure age, 
gender, and ethnic diversity.  
 
Inclusion Criteria 
Patients were recruited if they met the following criteria: 
1. Cause of renal failure was Diabetes Mellitus; 
2. Aged 21 years or over; 
3. Received dialysis for a minimum of 3 months; 
4. Able to provide informed consent; and 
5. Able to communicate with research assistants using English, Malay or Mandarin. 
 
Procedure 
The semi-structured interviews averaged 45 minutes each and were conducted by 
research assistants with experience in interviewing in either English, Mandarin or Malay. It 
may be useful to note that although English is the lingua franca in Singapore, there is a more 
predominant use of mother tongue (e.g. Mandarin or Malay) in older Singaporeans and as 
such a multilingual approach is necessary in this study as ESRD patients tended to be in the 
older population segment (Cavallero & Ng, 2014). The interviews were audio-recorded and 
transcribed verbatim to promote accuracy of data and allow for in-depth analysis.  
Interview questions (See Appendix A were informed by topic guides developed in light 




representatives. Through emerging findings following analyses of early interviews, a topic 
guide was devised and includes the following categories of questions: 
i. Patient perspectives on multimorbidity (e.g. “How do you feel about having to 
be on dialysis as well as managing diabetes? Have you ever felt that being on 
dialysis affects your diabetes? Or, conversely, that diabetes affects how well you 
do on dialysis? In what ways and why?”).  
ii. Challenges in managing aspects of treatment, including Diet, Fluid and 
Medication (e.g. “What are the main reasons for failing to achieve treatment 
goals (specifically, in relation to either your diabetes/kidney condition(s))? Any 
other reasons? What are the main challenges for people who have to follow diet 
for both diabetes and dialysis and why?).  
iii. Health services and interactions (e.g. Thinking of your health condition and all 
aspects of your treatment for both diabetes and kidney condition which do you 
think you could use the most help with? In what way could you use help?).  
 
Data Analysis 
An inductive thematic analytical approach was used in which transcripts were cross-
compared (e.g. De Chesnay, 2015) to examine potential issues and experiences that cut across 
different patients’ accounts and underlying reasons for similarities and differences in their 
experiences and views. The thirty-one interviews were evaluated, discussed, coded and 
compared between the Principal Investigator (also the thesis supervisor to the present study) 
and two research assistants, including the current author. Coding and constant comparative 
analysis continued until saturation occurred (reiteration of items in themes identified, with no 










Participants were recruited from various NKF community DCs across Singapore 
between October 2014 to February 2015 (upon completion of qualitative interviews). The 
DCs are geographically distributed across Singapore. They include centers in the East (Bedok 
DC), West (Clementi & Ghim Moh DCs), Central (Ang Mo Kio & Kim Keat DCs) and North 
(2 Woodlands DCs) districts of Singapore. There are no NKF community dialysis centers in 
southern Singapore due to it being primarily a business district. Patients who undergo dialysis 
in NKF community dialysis centers are supported by some degree of government funding. 
63% of all HD patients in Singapore are treated at these community dialysis centers, while 
the remaining patients are treated at privatized dialysis centers (SRR, 2014). 
 




Similar to the qualitative component requirements patients were recruited if they met 
the following criteria: 
1. Cause of renal failure was Diabetes Mellitus; 




3. Received dialysis for a minimum of 3 months; 
4. Able to provide informed consent; and 
5. Able to communicate with research assistants using English, Malay or Mandarin. 
 
Recruitment Process 
DC staff nurses identified patients whose etiology of ESRD was DM and research 
assistants subsequently approached these patients while they were undergoing hemodialysis. 
All approached patients were given a short introduction about the purpose and procedure of 
the study. Patients that expressed discomfort with participating in the questionnaire survey 
were immediately excused. Patients failing to meet the inclusion criteria were excluded from 
participation. Eligible participants were read a participant information sheet that lists out 
details of the study (Appendix B). Written consent was acquired prior to study administration 








(n = 175) 
Eligible and 
Agreeable 
(n = 173) 
Included in 
Final Sample 
(n = 171) 
Dropped Out 
(n = 2) 
Excluded/Declined 
(n = 2) 




One hundred and seventy-five patients were approached at the various community HD 
DCs while they were undergoing Hemodialysis. Considering that the process of initiating HD 
is complex and requires some setup time, research assistants did not administer the study 
instruments in early period when HD was being initiated. Of the 175 patients approached, 1 
patient was misidentified for having DM as cause of ESRD, and 1 patient declined to 
participate in the study. The low exclusion rate (1%) may be due to DC staff nurses selecting 
more cooperative and/or cognitively-able participants for the Research Assistants to 
approach. Of the 173 eligible patients who agreed to participate in the study, n = 2 patients 




Demographics (gender, age, language spoken, ethnicity, education level, income, 
employment, relationship status, housing conditions) were collected using a self-designed 
questionnaire (Appendix C).  
 
Medical Information 
Medical information (time on dialysis, comorbidities, medication prescription, 
potassium, creatinine, phosphate, hemoglobin, HbA1C, Kt/V) were extracted from medical 
records by research assistants in the community dialysis centers. HbA1C is a term commonly 
referred to in diabetes, and refers to glycated hemoglobin, which is use to obtain an overall 
picture of blood sugar levels. Kt/V is a number used to quantify hemodialysis and peritoneal 
dialysis treatment adequacy (K = dialyzer clearance of urea, t = dialysis time and V = volume 





Charlson Comorbidity Index (CCI) 
In addition to being an indicator of comorbidity severity, CCI is used to estimate the 
prognosis of ESRD patients, and is calculated using an empirically validated methodology by 
Di Lorio et al. (2004). Comorbid conditions included in the calculation of CCI, and their 
respective score weightages are: 
1 Point: Myocardial Infarction, Congestive Heart Failure, Peripheral Disease, Diabetes 
without end-organ damage, Dementia, Cerebrovascular Disease, Chronic Pulmonary Disease, 
Connective Tissue Disease, Peptic Ulcer Disease, Mild Liver Disease; 
2 Points: Hemiplegia, Moderate/Severe Renal Disease, Tumor without metastasis, Leukemia, 
Lymphoma, Diabetes with end-organ damage (retinopathy, neuropathy, nephropathy or 
brittle diabetes); 
3 Points: Moderate to Severe Liver Disease; and 
6 Points: Metastatic Solid Tumor and Acquired Immune Deficiency Syndrome (AIDS).  
An additional point was added to the total CCI score for each decade of ≥ 40 years of age. 
 
 
Psychological Distress Measures – Anxiety and Depression 
Hospital Anxiety and Depression Scale (HADS). Symptoms of depression and anxiety 
were assessed using HADS (Zigmond & Snaith, 1983). HADS is a popular instrument that 
consists of a Depression subscale (7 items) and an Anxiety Subscale (7 items). Participants 
rate their degree of depression and anxiety in the past 2 weeks on a 4-point Likert scale, 
ranging from zero (0; yes, definitely) to three (3; no, not at all). Aggregate scores for the 
subscales are calculated and the final score ranges from zero to twenty one (0 to 21). A higher 
score represents a higher level of depression or anxiety. Scores are classified into normal (0-




subscales demonstrated moderate to high levels of reliability, as determined by a Cronbach’s 
alpha of .58 for the anxiety subscale and .82 for the depression subscale. In addition, HADS 
is chosen over other depression and anxiety instruments because it precludes somatic 
symptoms such as fatigue and weight loss, which may be confounded with symptoms related 
to renal conditions and uremia (Mykletun, Stordal & Dahl, 2001). Furthermore, HADS is 
consistently applied and validated in measuring depression and anxiety amongst ESRD 
patients (Martin et al., 2004; Loosman et al., 2010; Johansson, Hickson & Brown., 2013; 
Turkistani et al., 2014; Griva et al., 2014). To facilitate between-group comparisons, patients 
with scores of 8 and above for each subscale (qualifying for “borderline” and “abnormal”) 
will be classified as either Depressed or Anxious (coded as “1”), while scores below 8 will be 
classified as either Non-depressed or Non-Anxious (coded as “0”). This classification process 
is illustrated in Figure 6. 
 
Figure 6: HADS Score Classification  
 
Psychological Distress Measures – Loneliness 
An alternative short-form of the widely used revised UCLA Loneliness Scale (ULS-20) 




the scale is found to be a short yet reliable and valid substitute for the ULS-20. The 8 items 
(Appendix C) are scored on a 4-point Likert scale. The aggregate score (range = 8 to 36) was 
calculated, with a higher score indicating a higher degree of loneliness. This scale had 
moderate reliability in this study, Cronbach’s alpha = .60. In the original ULS-20, aggregate 
score range was 20 to 80, and the combined score may be classified into low (20-34), 
moderate (35-49), moderately high (50-64) and high (65-80). There are currently no 
guidelines for the classification of the scores for the ULS-8. Thus, for the purposes of this 
study, the categorizations have been extrapolated from the ULS-20. Figure 7 illustrates the 
extrapolation process used in the current study. Goossens et al. (2014) recommend that scores 
above 15 (“moderate” level category) be used as a cutoff and to facilitate between-group 
comparisons, patients with scores of 15 and above (qualifying for “moderate” and above) will 
be classified as Lonely (coded as 1), while scores below 15 will be classified as non-Lonely 
(coded as 0).  
 
Figure 7: ULS-8 Scores Classification 
 
 
Psychological Distress Measures – Hopelessness 
The Beck Hopelessness Inventory (BHI) – Short Version was used to assess 




original 20-item Beck Hopelessness Scale (Beck et al., 1974), the 4-item BHI was chosen 
(Appendix C) as it was found to have good psychometric properties with internal consistency 
(Forintos et al., 2013). The 4-item BHI is used in the current study to also reduce the burden 
of completion for respondents. In addition, the creators of BHI report that the scale is a good 
predictor of suicidal thoughts and behavior. The items are rated on a 4-point Likert scale (0 to 
3) with higher scores indicating higher hopelessness. The BHI had high reliability in this 
study, Cronbach’s alpha = .82. The clinical cutoff score for suicidal risk in the BHI is 
proposed by the creators to be >5 (Forintos et al., 2013). To facilitate between-group 
comparisons, scores >5 will be classified as Hopeless (coded as 1), while scores ≤5 will be 
classified as non-Hopeless (coded as 0). This classification process is illustrated in Figure 8. 
 
Figure 8: BHI Score Classification 
 
 
Health Literacy  
The Health Literacy Questionnaire (HLQ). HLQ is a comprehensive measure of health 
literacy developed to assess nine different dimensions of health literacy needs and challenges 
(Osborne et al., 2013). Despite its youth, the HLQ has been validated on chronic diseases 




a range of 1 to 4 (“How strongly you disagree or agree with the following statements: 
strongly disagree/disagree/agree/strongly agree”), and these five dimensions are:  
- “Feeling Understood and Supported by Healthcare Providers”, 
- “Having Sufficient Information to Manage My Health”, 
- “Actively Managing my Health”,  
- “Social Support for Health”, and 
- “Appraisal of Health Information”.  
The rest of the four dimensions are scored on a range of 1 to 5 (“How easy or difficult 
are the following tasks for you to do now: cannot do/very difficult/quite difficult/quite 
easy/very easy”), and these remaining dimensions include:  
- “Ability to Actively Engage with Healthcare Providers”,  
- “Navigating the Healthcare System”,  
- “Ability to Find Good Health Information”, and  
- “Understanding Health Information Well Enough to Know What to Do”. 
The HLQ is appended in Appendix D. The nine dimensions and their reliability 
coefficients are displayed in Table 1. As observed from the table, all HLQ dimension 
subscales show a high level of reliability (all Cronbach’s alpha > .78, range = .78 to .93). 











Table 1mber of Items, Reliability Coefficients and Concepts Measured by  
Number of Items, Reliability Coefficients and Concepts Measured by HLQ 







and Supported by 
Healthcare 
Providers 
4 .78 This dimension examines the extent of 
relationship and trust with at least one 
healthcare provider as a source of information 
and provider of advice about health. 
Having Sufficient 
Information to 
Manage my Health 
4 .82 Examines the extent of confidence in having 
information necessary to live, manage their 




5 .88 Examines how patients may recognize the 
importance of, and the ability to take 
responsibility for their own heath. They 
proactively engage in their own care and make 
their own decision about their health. 
Social Support for 
Health  
5 .84 Examines the extent to which a person’s social 
system provides them with all the support they 
want or need. 
Appraisal of Health 
Information  
5 .83 Examines the extent of the ability to identify 
good information and reliable sources of health 
information, including ability to resolve 
conflicting information by themselves or with 
help from others. 




5 .89 Examines the extent to which patients are 
proactive about their health and feel in control 
in relationships with HCPs. Additionally, 
examines if patients are able to seek advice from 
additional HCPs when necessary. 
Navigating the 
Healthcare System 
6 .92 Examines the ability to find out about services 
and supports to meet individual needs. 
Additionally, examines ability to advocate on 
their own behalf at the system and service level.  
Ability to Find 
Good Health 
Information 
5 .93 Examines if patient is an “information 
explorer”, and if they use a diverse range of 
sources to find information and is up to date.  
Understanding 
Health Information 
Well Enough to 
Know What to Do 
5 .87 Examines if patient is able to understand all 
written information (including numerical 
information) in relation to their health and fill 
up medical forms where required.  
Note. HLQ = Health Literacy Questionnaire. 
1Cited from “The grounded psychometric 
development and initial validation of the Health Literacy Questionnaire,” by Osborne, R.H., 
Batterham, R.W., Elsworth, G.R., Hawkins, M. & Buchbinder, R, 2013, BMC Public Health, 









Brief Illness Perception Questionnaire (BIPQ). A subset of six items that were deemed 
relevant for the purposes of this study was chosen from the original 9-item BIPQ. The six 
items assess “Consequences”, “Personal Control”, “Treatment Control”, “Identity”, 
“Concern” and “Illness Comprehensibility” (Broadbent et al., 2006). These six items were 
also created separately for DM and kidney disease (Appendix C). This presents an 
opportunity to compare the overall scores on BIPQ between the two conditions. Each item is 
rated on an 11-point Likert scale and an overall score was calculated to examine the degree to 
which the illness was perceived as threatening or benign. Higher scores indicate a more 
threatening perception of the measured illness. Both BIPQ-Diabetes and BIPQ-Kidney 
Disease scales demonstrated satisfactory reliability. BIPQ-Diabetes scale Cronbach’s alpha = 
.72, BIPQ-Kidney Disease scale Cronbach’s alpha = .74. The original 9-item BIPQ has been 
validated and applied successfully in measuring illness perception among Diabetic HD 
patients (Petrie & Weinman, 2012; Pula, 2012). Relevant score items that were required to be 
reverse-coded were performed appropriately. 
Multimorbidity Illness Perceptions Scale (MULTIPleS).  The MULTIPleS scale is 
divided into five discrete domains, namely, “Treatment Burden”, “Prioritization”, “Causal 
Relationships”, “Emotional Representations” and “Activity restriction” (Gibbons et al., 
2013). To reduce the burden of study completion and to scrutinize the exact psychological 
parameters in the interest of the present study, only the Treatment Burden and Prioritization 
subscales are be employed (Appendix C). The MULTIPleS scale has been utilized in several 
studies examining the impact of multimorbidity on illness perceptions in chronic disease 
populations (Coventry et al., 2015; Kenning et al., 2015). Each item is rated on a 6-point 
Likert scale ranging from zero (Strongly Disagree) to five (Strongly Agree) and an overall 




multimorbidity. Both subscales displayed satisfactory reliability in this study. Treatment 
burden subscale Cronbach’s alpha = .69, Prioritization scale Cronbach’s alpha = .67. 
 
Adherence 
Adherence is commonly measured via self-report measures and is considered a more 
cost-effective approach compared to using biological/biochemical markers or monitoring of 
dialysis records. Although some studies have shown that self-reports may not be as accurate 
because of responder bias and an overestimation of compliance (Vlaminck et al., 2001), it has 
been suggested that the benefits of self-report in a larger sample size may offset responder 
bias (Domino & Domino, 2006). The following figure illustrates the various self-report 
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Appetite and Diet Assessment Tool (ADAT). The original 44-item ADAT (Burrowes et 
al., 1996) evaluates appetite and factors affecting dietary intake in hemodialysis patients. To 
reduce the burden of completion, this study employs only one of the key items in the ADAT 
– “Do you have difficulty following your diet?” (0 = no, 1 = yes). The subscale was found to 
have good reliability in this study (Cronbach’s alpha = .88). 
Dialysis Diet and Fluid Non-Adherence Questionnaire (DDFQ). A tool to measure 
nonadherence to diet and fluid guidelines, the DDFQ is widely used for the collection of 
nonadherence data (e.g. Vlamick et al., 2001; Kugler et al., 2011; Clark et al., 2014). The 4-
item instrument captures frequency of nonadherence behavior with diet and fluid restrictions 
by asking the participants “How many times in the last 14 days did you not follow your diet or 
fluid guidelines?” of which the responses range from zero to 14 days.  Degrees of deviation 
are examined by asking “To what degree did you deviate from your diet or fluid guidelines?” 
and deviation is rated on a five point Likert scale from zero (“no deviation”) to five (“very 
severe deviation”). The scale has good reliability in this study (Cronbach’s alpha = .85).  
Summary of Diabetes Self-Care Activities (SDSCA). The SDSCA-revised version is a 
well-validated measure of diabetes self-care (Toobert et al., 2000), and has been used by 
studies examining diabetic patients (e.g. Piette et al., 2003; Bains et al., 2011). It measures 
various domains of self-care behaviors and includes general diet and medication. The authors 
of the scale have recommended for each domain to be assessed separately rather than to 
combine scores across domains (Toobert et al., 2000). For the domain of general diet, the two 
questions are “How many of the last SEVEN days have you followed a healthful eating 
plan?” and “On average, over the past month, how many days per week have you followed 
your eating plan?” to which participants would be asked to respond from zero to seven days. 




For the domain of medication, participants are asked to tick all that apply in relation to the 
following medications for DM that are prescribed: 
a. “An Insulin shot 1 or 2 times a day”, 
b.  “An Insulin shot 3 or more times a day”,  
c. “Diabetes pills to control my blood sugar level”, 
d.  “Others (Specify)”, and 
e.  “I have not been prescribed either insulin or pills for my diabetes”.  
If the participants answered either (a), (b), (c) or (d), they would answer the follow-up 
question “On how many of the last SEVEN Days did you take your recommended diabetes 
medication?” to which participants would be asked to respond from zero to seven days. A 
score is calculated based on the total number of days from the follow-up question. The two 
subscales see moderate reliability in this study, general diet subscale Cronbach’s alpha = .61, 
medication subscale Cronbach’s alpha = .65. 
Morisky Medication Adherence Scale (MMAS-8). While the SDSCA is an indication of 
medication self-care (Toobert et al., 2000), the MMAS-8 (8 items) provides an indication to 
the severity of medication nonadherence and is a reliable measurement tool examining the 
circumstances surrounding adherence behavior (Appendix C). The MMAS-8’s questions are 
phrased to avoid a “yes-saying” bias by reversing the wording of the questions about the way 
patients might experience failure in adhering to their medication regimen, as there is evidence 
for a tendency for positive responder bias to health care providers (Morisky et al., 2008). 
Each item measures a specific medication-taking behavior rather than a determinant of 
adherence behavior. Response categories are yes or no for items one through seven and on a 
5-point Likert scale for item eight. The scores are then further categorized in high level of 




adherence (total score = >2). The MMAS-8 has good reliability in this study, Cronbach’s 
alpha = .87. 
 
Nutritional Quality of Life 
Nutrition-Specific Quality of Life (NSQOL). The NSQOL is a 15-item questionnaire 
providing specific information about hemodialysis-related food intake issues and is 
developed based on a combination of items from the Appetite and Diet Assessment Tool and 
Food Enjoyment in Dialysis tool (Appendix C) (Han et al., 2012). It is a rapid self-
administered tool that can be used to assess appetite-related quality of life in patients 
receiving hemodialysis and is well correlated with other Health-related Quality of Life 
(HRQOL) indices in hemodialysis patients (Han et al., 2012). A total combined score is used 
to indicate quality of nutritional status. The NSQOL had good reliability in this study, 
















Summary of Study Instruments Used in Present Study 
 The following table presents a summary of the instruments used in the present 
study.  
Table 2 





Psychological Distress   
Anxiety Hospital Anxiety and Depression Scale (HADS) .58 
Depression Hospital Anxiety and Depression Scale (HADS) .82 
Loneliness UCLA Loneliness Scale 8 (ULS-8) .60 
Hopelessness Beck Hopelessness Inventory (BHI) .82 
Health Literacy Health Literacy Questionnaire (HLQ) .78 to .93 
Illness Perception   
General Illness Perception Brief Illness Perception Questionnaire (BIPQ) – Diabetes .72 
 Brief Illness Perception Questionnaire (BIPQ) – Dialysis .74 
Prioritization 




Multimorbidity Illness Perception Scale (MULTIPleS)- 
Treatment Burden 
.67 
Adherence   
Dialysis Diet 
Appetite and Diet Assessment Tool (ADAT); Dialysis Diet 
and Fluid Non-Adherence Questionnaire (DDFQ) 
.88 




Summary of Diabetes Self Care Activities (SDSCA) .65 
Medication (Severity of Non-
Adherence) 
Morisky Medication Adherence Scale (MMAS-8) .87 




Table 3 shows the distributions of missing items. The number of missing items was 
minimal in nature and the distribution was random. Thus, mean imputations were used if at 










Distribution of Missing Values  
 Frequency % 
MMAS-8 1 0.01 
HLQ 1 0.01 
BIPQ-Diabetes 2 0.01 
HbA1C 5 0.03 
Urea 5 0.03 
Kt/V 3 0.02 
Creatinine, Hemoglobin, Potassium, 
Phosphate, Albumin 
3 0.01 
 Note. MMAS-8 = Morisky Medication Adherence Scale – 8. HLQ = Health Literacy 
Questionnaire.  
Statistical Analysis 
Descriptives. Descriptive statistics included medians, means and standard deviations for 
continuous variables and frequencies and percentages for categorical variables.  
Univariate analyses. Kolmogorov-Smirnov tests were used to assess the normality of 
variable distribution. Means were compared with independent t tests, paired t tests, ANOVA 
or ANCOVA and percentages were compared with χ2 tests. When data were not normally 
distributed, non-parametric tests (Mann-Whitney tests) are used instead and annotated 
accordingly). In addition, results reporting will replace (p <.001) with (p = 0+). 
Multivariate analyses. One-way Multiple Analysis of Variance (MANOVA) were used 
to determine the effect of the respective dimensions of psychological distress (i.e. Depressed 
vs. Non-Depressed, Anxious vs. Non-Anxious, Lonely vs. Non-Lonely & Hopeless vs. Non-
Hopeless) on the nine dimensions of Health Literacy as measured by the HLQ (nine 
continuous dependent variables). Key assumptions involving multicollinearity, univariate or 
multivariate outliers, having multivariate normality, homogeneity of variance-covariance 





In addition, hierarchical stepwise logistic regressions were used to identify important 
predictors of the 4 dimensions of psychological distress. In the context of the current study, 
the large amount of variables would increase the risk of Type 1 error and thus univariate tests 
of association would be used to identify the demographic, clinical and psychosocial variables 
associated with psychological distress.  p = .05 and p = .10 were used as entry and removal 
criteria. Forward stepwise procedure was deployed to select variables that were significant at 
.05 at univariate screening.  
Statistical significance level was set at .05 for all procedures. Bonferroni α-adjustment 
was applied for post-hoc comparisons. All analyses were performed using the Statistical 
Package for Social Sciences (SPSS) version 23.0 for Macintosh (IBM Corp, Armonk, NY, 
USA). 
Ethics 
The National University of Singapore Institutional Review Board approved this study, 
under the aegis of larger study called “Combined Diabetes and Renal Control Trial (C-



















Part I. Qualitative Component Results 
Part I presents results with respect to study aim 1. 
Qualitative Study Sample 
Out of 32 patients approached, 1 patient declined and the 31 others accepted the offer to 
participate in the study. The demographics of the participants for the qualitative component 
of the study are listed in Table 4. 
Thirty one (31) DM-ESRD patients participated in the qualitative component of the 
study. The mean age of the participants was 57.68 (SD = 7.48) and the median age was 57 
years, relatively close to the median age of 61 years for Singapore prevalent HD patients 
(Singapore Renal Registry, 2014).  Sixty five percent (65%) of the qualitative study sample 
are male. Fifty five percent (55%) of the sample are ethnic Malay and thirty nine percent 
(39%) are Chinese. Of note, the ethnic proportion in the present study sees a lower proportion 
of Chinese patients and a larger proportion of Malay patients compared to the prevalent HD 
patients (67% and 25% respectively) (SRR, 2014). Sixty five percent (65%) of the qualitative 
study sample are married, sixty eight percent (68%) are unable to be gainfully employed due 












Demographics of Qualitative Sample 
 Total Sample (n = 31) 
Age 57.68 ± 7.48 
Gender  
Male 20 (65) 
Female 11 (35) 
Ethnicity  
Chinese 12 (39) 
Malay 17 (55) 
Indian/Others 2 (6) 




Secondary 15 (48) 
Tertiary 4 (13) 
Marital Status  
Married 20 (65) 
Not Married 11 (35) 
Family Income  





Employed (Full or 
Part time) 
10 (32) 
Unemployed 21 (68) 
Housing  




Note. Data expressed as M ± SD or n (%) 
 
Key Themes 
The following themes were identified through appropriate coding schema and thematic 
analysis. The key themes voiced by the patients were mainly related to: 
i. Emotional Difficulties, 
ii. Dietary and Fluid Intake Issues, 
iii. Health Literacy and 








Theme (i): Emotional Difficulties  
In general, patients report experiencing general negative affect and/or mood 
changes often as a result of their kidney conditions. Most of the time, the patients 
are unable to articulate the reasons behind their negative affect and mood changes. 
In addition, feelings of negative affect are reported to influence motivation to 
adhere to treatment. 
 
“I feel sad…Everyday, I have all the illnesses – diabetes, the heart 
problems, there’s this and that…daily, there’s dialysis. If I want to go 
anywhere, I have to think, oh no, dialysis again tomorrow. I’ve been 
forced to…what else can I do.” -  P12. 
 
“They even they referred me to psychiatrist, just to give me a kind of 
motivation and inspiration…yah.. of course very sad.. a lot of things 
in my mind.. a bit mentally disturbed. And my mind, my emotion also a 
bit change. Because last time I was an active man..you know.. We 
used to work. Happy happy then suddenly like become like this la… 
now its already 4 years 4 months…but sometimes I feel down also lah 
but I try to control myself. - P13. 
 
In discussing their treatment goals, patients generally express depression and a kind of 





 “Patient: I’m so old…im just waiting to die. 
 Interviewer: No you’re not...you still have some time.  
Patient: I only have a few years left.” – P26. 
 
 “Nothing to achieve anymore because if no dialysis you will not be 
strong…the dialysis is forever until you close your eyes that’s all” – 
P8. 
 
Patients recounted a high perception of treatment burden and a high “workload” of 
health care that patients must perform, which is in turn associated with feelings of 
hopelessness. 
 
“What else do I have to say? That’s all I have to say. Diabetes…I 
have to look after my diet. Last time, without the kidney problems, I 
don't look after my diet, it’s still okay to eat a little bit because there’s 
medication. The kidneys can work the medication. Now, the kidneys 
can’t work the medication, although eating just a little bit, there will 
be a flare up. Eat a little bit and it will flare up, eat a little bit and it 
will flare up. I am always in and out of hospital”. – P4 
 
Patients also recounted how managing multiple coexisting conditions lead to a lack of 
confidence in managing their condition. Additionally, patients also report temper issues 
related to “frustration” and “anger” with their conditions. It is important to note that 
frustration and anger are qualitatively different constructs from the four psychological 




were also emotionally affected by the chronicity of their illness. These reasons have been 
linked to a decrease in motivation to adhere to treatment. 
 
“I feel very tired trying to manage both illnessess…I would put a 5/10 
in confidence in managing my illness. I actually don’t feel like I have 
to change the way I eat, except for the fact that I feel extremely 
tired…after dialysis. I have also felt my tempers soaring at times, I 
even feel lazy to come for dialysis. My temper flares about once a 
week, and my moodiness affects how willing I am to come for dialysis. 
At the end of the day however, I still come for dialysis” – P1 
 
“I feel…I do feel sad…I have to come for dialysis three times a week, 
so I feel like…sad because unitl when do I have to undergo dialysis? If 
possile, I would like to be cured from my illness”- P7. 
 
Patients also shared that they experienced an intensification of negative 
affect following the initial period of being diagnosed with ESRD. 
 
“That was beginning…in the year of 2008 when I got to know I’m 
(have)a kidney failure…so I really frustrated and I thought I want to 
give up my life”.- P15 
 
Not only are the requirements of dialysis rigid, but many patients also 




that financial aid may possibly be one of the more important types of assistance 
they can receive. 
 
“Now you cannot earn money whatever, you also control a bit la. Not 
necessary you don’t buy la, just buy some food, some every day want 
to pass on the thing. That’s a problem. Every time tell doctor, just 
money only, other thing okay, all perfect.” – P2 
 
“The most important help, finance...this is important. Finance right. 
Finance…other than that, I don’t think (there is anything else)” - P20.  
 
Theme (ii): Dietary and Fluid Intake Issues  
One of the key challenges was patients’ lack of restraint in following dietary 
recommendations. Challenges in lack of restraint may be related to the diabetic diet to control 
sugar intake and foods with high Glycemic Index (GI). In addition, patients also report have 
poorer restraint in social situations. 
 
“The sugar part is the hardest. Because, for example, when drinking 
beverages, some sugar makes it better. It has to become a habit. I find 
it also, very hard to abstain totally” – P27. 
 
“Interviewer: Why is that so? Why is that you think sometimes you 
can’t control the diet? 
Patient: Maybe the food is really nice? Tempting me so I… because 




to eat yellow noodle (a type of high GI food)s. But since I got this 
dialysis, I’m a kidney failure, so the dietician from Tan Tock Seng 
advised me to take beehoon (rice vermicelli) instead of yellow noodles. 
So I try my best, but actually bee hoon all I don’t like…I love the 
yellow mee.” P15.  
 
“Interviewer: When you go out to meet your friends, you know, 
gatherings…do you try to control what you eat? 
Patient: Sometimes I try…but the thing is that there are ten kinds of 
food. Foods ah, everything you (will) try some, add up…still the same 
what…correct or not?...How small portion still at the end you hit the 
target. Like that how ah…so it is very difficult to control”- P17. 
 
In similar veins as the reported lack of restraint in dietary intake, some patients report 
that coexisting conditions of DM and ESRD lead to conflicting dietary requirements. A 
commonly recounted situation where such a conflict might occur is that post-dialysis appetite 
may be greater (as patients feel weaker and require energy/carbohydrate rich foods), but this 
lies in conflict with the diabetic diet (that forbids quick energy, simple carbohydrates).   
 
“If I were to eat like what the dietician say (diabetic diet), I will faint. 
Not enough. Not enough and then nevermind ah. As a dialysis patient 





“I can’t eat too much after dialysis but I can’t help it. After dialysis, I 
kind of put my knowledge of diabetes(dietary adherence) aside and 
just go ahead to eat whatever I want”. – P1. 
 
Patients also reported a disturbance to their appetite. Most of the patients report that 
appetite and dietary patterns deteriorate when they experience negative affect (e.g. upset, 
troubled or distressed).  
 
“Sometimes, the lunch time…I don’t know. Sometimes when I eat the 
gravy, certain time I like it, certain time I don’t like it, I feel like throw 
out. And that’s where I don’t take anymore. I just stop it. Like 
yesterday the other time I know, they cook for me bean sprout, it was 
nice, I can eat. But yesterday I don’t know why, I just for moment I 
take one spoon of bean sprout, I cannot eat go in anymore. I just eat 
the rice with my fish, bean sprout left it alone. After that I go and 
throw out…it all depends on my body. Sometimes I can, sometimes I 
cannot. So I was telling to my maid, I say, it’s not your this one, 
sometimes it depends on me nowadays. I say this three months, I said 
it’s not good for me.” – P22. 
 
However, some patients conversely reported a general lack of appetite. 
 
“Sometimes…it’s not certain. Sometimes, I don’t have the appetite. 





Lastly, the lack of restraint also extends to fluid intake. Patients usually 
recount that living in a hot tropical weather increases their thirst. Although they 
do understand the need for fluid restriction, they commonly state that they are still 
unable to control their thirst. 
 
“Fluid…for me, I never follow…just ownself manage my cup…this 
(following strict fluid guidelines) creates suffering for me. You see, 
like a normal person drink one cup of water and feels happy, but I feel 
sad (that I cannot do the same)” – P2. 
  
Theme (iii): Health Literacy 
Patients recount having difficulties understanding health information (i.e. feeling like 
they do not have the information they need to manage their health concerns) and report that 
they may be unable to act on own behalf to use the healthcare system to address their health 
needs (e.g. navigate the healthcare system). Even when HCPs discuss aspects of their 
treatment with them, their understand of their conditions remain limited.  
 
“Doctors give me examples of what to eat and what not to eat. They 
teach me how to control my diet in that sense. They also tell me what 
effects dialysis has on my body but for the most part I forget about 
that easily. I don’t really know what dialysis does to my body except 





“I know briefly the kinds of food that I can or cannot eat. Beyond that, 
not really. I don’t know much else about what to eat or what not to eat. 
I also not sure if something is good for me or not” – P10 
 
The analysis also revealed that there may be a lack of explanation given to patients in 
addressing their misperception with regard to their treatment as well (e.g. not having to be on 
medication since they are already on dialysis). Patients also reported tensions in their 
engagement with HCPs (e.g. unable to ask questions to get information or to clarify what they 
do not understand), recounting unhappiness with the lack of explanation by HCPs with regard 
to providing sufficient information to their queries. In addition, patients also reported that they 
are not involved in the decision making process surrounding their treatment, and state some 
unhappiness with the lack of attention given to them by HCPs. 
 
“They put me (on) insulin…I told the doctor, if I put on insulin, I very 
weak. Sometimes I can get knocked down. Then he asked me to 
monitor myself. I said, you’re the doctor, you don’t know why you put 
me insulin then I find myself that I weak…after my dialysis ah…I say 
doctor, I got dialysis, no need medicine now is it? Still have to take 
medicine? Then what is the purpose of having dialysis? Doctor cannot 
answer me like that” – P3 
 
 “I learnt that I had diabetes... and then at first they ask me to go for 
my check-up, they say my blood creatinine is high, eh what protein. I 
was very scared, I said, why want to go? Because I didn’t want to go. 




what’s really happen to me? Why do I have to go for my blood test? 
What shows.. then I sitting there.. and they mentioned kidney. I get 
more worried when the doctor mention. So I went to the kidney centre. 
The doctor told me that you’re having a kidney problem, now we have 
to go give you a medication you go.. So he give me the urine 
medication. Don’t know what’s the name, forgot the name…then just 
recently, two years ago, doctor say your creatinine level all of a 
sudden is very high, you have to go for dialysis. I was very very sad 
when I went for my dialysis… So I said, why is it like that? She said it 
could be ‘cause sometimes you carry heavy thing? Or a infection? So 
I wonder what happened to me. How come got infection? So I 
wondering after how maybe I could have ask more details to the nurse, 
how to prevent it. – P22. 
 
“I think the doctors could be paying slightly more attention to us, 
especially those in the hospital. Service in the hospital is not great 
either.” – P6 
 
Conversely, some patients also report that health information is readily 
available, and that HCP support and advice are good.  
 
“I manage it…by the advice  of the nurses and doctors here. Good 





“My doctor…she will inform me what to do…the doctor is very 
supportive…so I already happy lah. When she have you know…what 
you got problem, what problem, then she will ask you. “how? 
Everything ok? Finance ok?”” – P20. 
 
Theme (iv): Interpersonal Relationships 
Patients also report having a lack of support as a result of their demanding chronic 
conditions. Considering that an individual’s social system provides them with support that 
they need for health, the possibility of poor social support can also impair their motivation for 
treatment.  
“I manage all of these (treatment aspects) by myself. My children do 
not care anymore about anything. If I want to be well and avoid 
frequent hospitalization, I have to watch what I eat and drink. That’s 
all on me. My children, they don’t care. All that they know is…waking 
up in the morning and going to work and back home again”. - P4. 
 
“Yeah. Angry sometimes…suddenly come. You cannot know 
why…suddenly…suddenly you get angry. So, I don’t know…I don’t… 
Sometimes I think I don’t understand why. Why? Maybe my wife do 
something wrong a little bit wrong also I can get angry.” – P20. 
 
Despite not receiving social support, some patients report bolstering their resiliency by 
aligning themselves with the cognition that  they should strive to adhere to their treatment 
regime as strictly as possible to reduce burden on their friends and family. This observation 





“I don't want to be a burden to others. I want to manage myself and 
then should be less problematic to others… Regular medication, 
regular diet and little exercise will make us live. I mean, lead a 
healthy life.” P12. 
 








1. General negative affect and/or mood changes as a result of 
kidney conditions. 
2. Managing coexisting conditions lead to lack of confidence 
and temper issues such as frustration. 
3. Intensification of negative affect following the initial 
period of ESRD diagnosis. 
4. Depression and hopelessness when discussing treatment 
goals and progress. 
5. Financial concerns are commonly explained to cause some 
distress. 




1. Lack of restraint in following dietary recommendations. 
2. Conflicting dietary requirements arising from coexisting 
conditions. 
3. Disturbances to appetite with deteriorating mood. 
4. Lack of appetite. 
5. Social settings may decrease restraint. 
6. Deviation from fluid guidelines. 
Health 
Literacy 
1. Difficulty understanding health information 
2. Lack of given health information and unhappiness and 
inability to actively engage with HCPs. 
3. Some evidence for good HCP support and advice 
Interpersonal 
Relationships 
1. Some evidence of strained social relationships and 
subsequent poor social support. 









Part II. Quantitative Component Results 
Aspects of Psychological Distress and Biopsychosocial Differences  
Part II presents results with respect to study aims 2a and 2b.  
Demographics/clinical characteristics of the study sample, documented rates of the 4 
dimensions of psychological distress (Depression, Anxiety, Loneliness and Hopelessness), 
followed by their respective subgroup (e.g. depressed vs non-depressed) comparison on 
dimensions of health literacy, nutritional QOL, illness perception and adherence will be 
presented. Following which, biopsychosocial determinants of psychological distress will be 
discussed. 
 
1. Demographics and Clinical Characteristics 
One hundred and seventy-one (171) DM-ESRD patients participated in the quantitative 
component of the study. Table 6 summarizes the patients’ demographic characteristics. The 
mean age of all participants was 58.84 years (SD = 9.43) and the median age was 58 years, 
relatively close to the median age of 61 years for Singapore prevalent HD patients (Singapore 
Renal Registry, 2014).  Sixty-two percent (62%) of the study sample are male. Fifty-one 
percent (51%) of the sample are ethnic Chinese and thirty-five percent (35%) are Malay. Of 
note, the present study population sees a slightly lower proportion of Chinese patients and a 
larger proportion of Malay patients compared to prevalent HD patients (67% and 25% 
respectively) (SRR, 2014). Sixty-three percent (63%) of the study sample are married, eighty 
percent (80%) of the sample are unable to be gainfully employed and eighty-eight percent 







Demographics of Total Sample (Quantitative) 
 Total Sample (n = 171) 
Age 57.97 ± 6.94 
Gender  
Male 65 (38) 
Female 106 (62) 
Ethnicity  
Chinese 87 (51) 
Malay 60 (35) 
Indian/Others 24 (14) 




Secondary 66 (39) 
Tertiary 24 (14) 
Marital Status  
Married 108 (63) 
Not Married 63 (37) 
Family Income  





Employed (Full or 
Part time) 
37 (20) 
Unemployed 134 (80) 
Housing  




Note. Data expressed as M ± SD or n (%). 
 
Table 7 displays the study samples’ clinical characteristics. Overall, the patients are 
observed to have high mean comorbidities, with sixty-three percent (63%) of the study 
sample scoring in the “high” category and sixteen percent (16%) scoring in the “very high” 
category in the Charlson Comorbidity Index. Seventy-four percent (74%) of the study sample 
















Clinical Characteristics of the Total Sample 
 Total Sample (n = 171) 
CCI 6.67 ± 2.15 
Low (<3) 0 (0) 
Moderate (4 to 5) 37 (21) 
High (6 to 8) 108 (63) 
Very High (>8) 26 (16) 
Time on Dialysis  
< 1 Year 24 (14) 
1 to 2 Years 20 (12) 
> 2 Years 127 (74) 
Biochemistry (n = 168)  
Potassium (mmol/I) 4.84 ± 0.66 
Creatinine (mmol/I) 8.68 ± 2.13 
Phosphate (mmol/I) 4.71 ± 1.22 
Hemoglobin (g/dl) 11.04 ± 1.19 
HbA1C (%) 8.05 ± 1.68 
Kt/V 1.55 ± 0.20 
Note. Data expressed as M ± SD or n (%). 
 
 
2. Psychological Distress 
 
 A broad summary of descriptive mental health results are first presented in the 
following table.  
 
Table 8 
Summary of Mental Health Results in Total Sample 
 Total 
(n = 171) 
HADS Depression 7.46 ± 4.17 
HADS Anxiety 8.23 ± 3.56 
Beck Hopelessness 
Inventory 
4.48 ± 3.27 
UCLA Loneliness 
Scale 
18.68 ± 3.98 
Note. Data expressed as M ± SD. Higher value indicates 
more anxiety, depression, hopelessness and/or loneliness. 
HADS = Hospital Anxiety and Depression Scale. 
 
Depression and Anxiety 
Distribution of HADS scores are illustrated in Figures 10 and 11. Mean depression 
score of 7.46 (SD = 4.17) was in the borderline range (8-10) and mean anxiety score of 8.23 




Based on clinical cut-offs (≥ 8; Bjelland et al., 2002), depression was documented in 
46% of the sample (n = 79). Anxiety was documented in 53% of the sample (n = 90). 
 
Figure 10 : Degree of Depression for All Patients (n = 171) 
 
 









Borderline + Abnormal (n = 79)
Normal  (n = 93)
90 81 
HADS Anxiety 
Borderline + Abnormal (n = 90)






Distribution of loneliness scores is illustrated in Table 8 and Figures 12 and 13. Mean 
loneliness score was 18.68 (SD = 3.98). There are currently no recommended loneliness 
clinical cutoffs for the ULS-8. For the purposes of this study, cutoff levels for the ULS-8 are 
mirrored and extrapolated from the scoring system of the Revised UCLA Loneliness Scale 
(ULS-20). The scores may be classified into low (8-14), moderate (15-21), moderately high 
(22-28) and high (29-36). Additionally, by classifying scores above the “moderate” threshold 
as recommended by Goossens et al., 2014, loneliness was documented in 79 % of the sample 
(n =135). 
 








































Distribution of hopelessness scores is illustrated in Table 8 and Figure 14. Mean 
hopelessness score of 4.48 (SD = 3.27) is slightly below the recommended clinical cutoff (>5; 














Moderate + Moderately High + High









2.1. Psychological Distress Subgroups – Demographics  
 
Between the depression subgroups, comparisons indicate that non-depressed patients 
were significantly more likely to be ethnically Malay and Indian, while depressed patients 
were significantly more likely to be Chinese, χ2 (2, N = 171) = 17.95, p < .01. No other 
differences were documented for other demographic variables between depressed and non-
depressed patients. 
Between the anxiety subgroups, comparisons indicate that non anxious patients were 
significantly more likely to be female than male, χ2 (1, N = 171) = 6.04, p = .01.  No other 
differences were documented for other demographic variables. 
Between the loneliness subgroups, comparisons indicate that lonely patients were 
significantly more likely to be Chinese, χ2 (2, N = 171) = 10.51, p = .02. No other differences 
were documented for other demographic variables.  
Between the hopelessness subgroups, comparisons indicate that hopeless patients were 
significantly more likely to be Chinese, χ2 (2, N = 171) = 11.12, p = .01. No other differences 
were documented for other demographic variables.  
Hopelessness 
Above Cutoff (>5)





All casemix differences were subsequently controlled for in further analyses between 
the respective Psychological Distress subgroups. Where applicable, Levene’s test of 
homogeneity of variances yielded equal variance (e.g. for “Age”, F= 2.80, p = .09).  
The following table provides a broad overview of the demographic differences between the 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.2. Psychological Distress Subgroups - Clinical Characteristics 
 
 
Mann-Whitney tests indicated that mean Kt/V levels were higher in non-anxious 
patients (Median = 1.60) patients than anxious patients (Median = 1.52), U = 4204.0, p = .03. 
This factor is controlled for in further analyses. 
There were no significant differences between the depression, hopelessness and 
loneliness subgroups in the clinical parameters. 
The following table provides a broad overview of the clinical characteristics difference 

























































































3. Health Literacy 
 
3.1. Depression and Health Literacy 
 
A one-way Multivariate Analysis of Variance (MANOVA) was run to determine the 
effect of depression on the nine dimensions of Health Literacy Questionnaire (HLQ) scores. 
Preliminary assumption checking revealed that there were no univariate outliers, as assessed 
by inspection of boxplots. All nine HLQ dimensions scores were normally distributed, as 
assessed by Shapiro-Wilks test (p < .05). There were no multicollinearity, as assessed by 
Pearson’s Correlation (lowest r = .19; highest r = .80, all p values <.05). Scatterplots suggest 
that there were linear relationships between the nine HLQ dimension scores. There were no 
multivariate outliers in the data, as determined by Mahalanobis distance (p > .001).  
There was homogeneity of variance-covariance matrices, as assessed by Box’s test of 
equality of covariance matrices (p < .01). There were homogeneity of variances, as assessed 
by Levene’s Test of Homogeneity of Variance (p > .05).  
There was a statistically significant difference between the depression subgroups on the 
combined dependent variables, F(9, 156) = 7.35, p = 0+; Wilks’ λ = .702; partial 2 = .298. 
Follow-up univariate ANOVAs showed that all but one (“Having Sufficient Information”) of 
the nine HLQ dimension scores were statistically significantly higher for non-depressed 
compared to depressed patients, using a Bonferroni adjusted α level of .025. These 


















Table 11: Health Literacy Scores of the Depression Subgroups, with Total Sample for Reference 
Health Literacy Dimension Total Sample Non-Depressed Depressed p 
 (N=171) (N=92) (N=79)  
Feeling Understood and 
Supported by Healthcare 
Providers 
 
3.02 ± 0.48 3.12 ± 0.42 2.87 ± 0.52 0+* 
Having Sufficient Information  
 
3.02 ± 0.44 3.06 ± 0.48 2.95 ± 0.38 .09 
Actively Managing My Health 
 
2.84 ± 0.45 2.91 ± 0.47 2.75 ± 0.41 .02* 
Social Support for Health 
 
2.98 ± 0.60 3.20 ± 0.55 2.71 ± 0.55 0+* 
Appraisal of Health Information 
 
2.66 ± 0.58 2.75 ± 0.63 2.53 ± 0.49 .02* 
Ability to Actively Engage with 
Healthcare Providers 
 
3.76 ± 0.77 4.05 ± 0.65 3.39 ± 0.74 0+* 
Navigating the Healthcare System 
 
3.66 ± 0.62 3.85 ± 0.62 3.41 ± 0.51 0+* 
Ability to Find Good Health 
Information 
 
3.53 ± 0.74 3.71 ± 0.77 3.28 ± 6.07 0+* 
Understanding Health 
Information Enough to Know 
what to Do 
3.57 ± 0.83 3.71 ± 0.89 3.35 ± 0.71 .02* 


















3.2. Anxiety and Health Literacy 
One-way MANOVA was run to determine the effect of anxiety on the nine dimensions 
of HLQ scores. There was homogeneity of variance-covariance matrices, as assessed by 
Box’s test of equality of covariance matrices (p = .01). There were homogeneity of variances, 
as assessed by Levene’s Test of Homogeneity of Variance (p > .05).  
There was a statistically significant difference between the anxiety subgroups on the 
combined dependent variables, F(9, 156) = 6.18, p = 0+; Wilks’ λ = .737; partial 2 = .263. 
Follow-up univariate ANOVAs showed that of the nine HLQ dimensions, five dimension 
scores (“Healthcare Provider Support”, “Social Support”, “Ability to Actively Engage with 
Healthcare Providers”, “Navigating Healthcare System” and “Ability to Find Good Health 
information”) were statistically significantly higher for non-anxious compared to anxious 
patients, using a Bonferroni adjusted α level of .025. These differences and their descriptives 
are displayed in Table 12. 
Table 12: Health Literacy Scores of the Anxiety Subgroups, with Total Sample for Reference 
Health Literacy Dimension Total Sample Non-Anxious Anxious p 
 (N=171) (N=81) (N=90)  
Feeling Understood and 
Supported by Healthcare 
Providers 
 
3.02 ± 0.48 3.08 ± 0.46 2.93 ± 0.48 0+* 
Having Sufficient Information  
 
3.02 ± 0.44 3.07 ± 0.40 2.97± 0.44 .16 
Actively Managing My Health 
 
2.84 ± 0.45 2.87 ± 0.47 2.82 ± 0.42 .44 
Social Support for Health 
 
2.98 ± 0.60 3.15 ± 0.62 2.81 ± 0.54 0+* 
Appraisal of Health Information 
 
2.66 ± 0.58 2.74 ± 0.59 2.60 ± 0.54 .11 
Ability to Actively Engage with 
Healthcare Providers 
 
3.76 ± 0.77 4.10 ± 0.69 3.43 ± 0.71 0+* 
Navigating the Healthcare System 
 
3.66 ± 0.62 3.90 ± 0.60 3.44 ± 0.56 0+* 
Ability to find Good Health 
Information 
 
3.53 ± 0.74 3.78 ± 0.73 3.33 ± 0.68 0+* 
Understanding Health information 
Enough to Know what to Do 
3.57 ± 0.83 3.69 ± 0.92 3.50 ± 0.71 .13 






3.3. Loneliness and Health Literacy 
One-way MANOVA was run to determine the effect of loneliness on the nine 
dimensions of HLQ scores. There was homogeneity of variance-covariance matrices, as 
assessed by Box’s test of equality of covariance matrices (p = .0+). There were homogeneity 
of variances, as assessed by Levene’s Test of Homogeneity of Variance (p > .05). However, 
the HLQ dimension of “Navigating the Healthcare System” did not test for homogeneity of 
variance, F (1, 164) = 10.99, (p = .01) even after transforming for the skewness. Hence, the 
level of statistical significance ( ) for “Navigating the Healthcare System” was set at p ≤.01 
instead of ≤.05 in univariate analysis. 
There was a statistically significant difference between the loneliness subgroups on the 
combined dependent variables, F(9, 156) = 2.19, p = 03; Wilks’ λ = .888; partial 2 = .112. 
Follow-up univariate ANOVAs showed that of the nine HLQ dimensions, all but one of the 
dimension scores (“Actively Managing My Health”) were significantly higher for non-lonely 
compared to lonely patients, using a Bonferroni adjusted α level of .025. These differences 
















Table 13: Health Literacy Scores of the Loneliness Subgroups, with Total Sample for Reference 
Health Literacy Dimension Total Sample Non-Lonely Lonely p 
 (N=171) (N=36) (N=135)  
Feeling Understood and 
Supported by Healthcare 
Providers 
 
3.02 ± 0.48 3.18 ± 0.44 2.96 ± 0.48 .02 
Having Sufficient Information  
 
3.02 ± 0.44 3.17 ± 0.38 2.98 ± 0.43 .02 
Actively Managing My Health 
 
2.84 ± 0.45 3.21 ± 0.55 2.91 ± 0.60 .30 
Social Support for Health 
 
2.98 ± 0.60 3.22 ± 0.62 2.91 ± 0.60 .01 
Appraisal of Health Information 
 
2.66 ± 0.58 2.90 ± 0.54 2.60 ± 0.56 .01 
Ability to Actively Engage with 
Healthcare Providers 
 
3.76 ± 0.77 4.14 ± 0.59 3.65 ± 0.79 0+ 
Navigating the Healthcare 
System* 
 
3.66 ± 0.62 4.01 ± 0.43 3.57 ± 0.63 0+ 
Ability to find Good Health 
Information 
 
3.53 ± 0.74 3.78 ± 0.73 3.33 ± 0.68 0+ 
Understanding Health 
Information Enough to Know 
what to Do 
3.57 ± 0.83 3.69 ± 0.92 3.50 ± 0.71 0+ 































3.4. Hopelessness and Health Literacy 
One-way MANOVA was run to determine the effect of hopelessness on the nine 
dimensions of HLQ scores. There was homogeneity of variance-covariance matrices, as 
assessed by Box’s test of equality of covariance matrices (p = .02). There were homogeneity 
of variances, as assessed by Levene’s Test of Homogeneity of Variance (p > .05).  
There was a statistically significant difference between the hopelessness subgroups on the 
combined dependent variables, F(9, 156) = 2.19, p = 0+; Wilks’ λ = .762; partial 2 = .238. 
Follow-up univariate ANOVAs showed that of the nine HLQ dimensions, all but three 
of the dimension scores (“Having Sufficient Information”, “Actively Managing My Health” 
and “Appraisal of Health Information”) were significantly higher for non-hopeless compared 
to hopeless patients, using a Bonferroni adjusted α level of .025. These differences are 


















Table 14: Health Literacy Scores of the Hopelessness Subgroup, with Total Sample for 
Reference 
Health Literacy Dimension Total Sample Non-Hopeless Hopeless p 
 (N=171) (N=104) (N=67)  
Feeling Understood and 
Supported by Healthcare 
Providers 
 
3.02 ± 0.48 3.04 ± 0.46 2.94 ± 0.48 .18 
Having Sufficient Information  
 
3.02 ± 0.44 3.03 ± 0.44 3.00 ± 0.40 .68 
Actively Managing My Health 
 
2.84 ± 0.45 2.88 ± 0.47 2.79 ± 0.41 .21 
Social Support for Health 
 
2.98 ± 0.60 3.13 ± 0.51 2.73 ± 0.64 0+ 
Appraisal of Health Information 
 
2.66 ± 0.58 2.75 ± 0.62 2.55 ± 0.47 .03 
Ability to Actively Engage with 
Healthcare Providers 
 
3.76 ± 0.77 3.98 ± 0.72 3.38 ± 0.73 0+ 
Navigating the Healthcare 
System* 
 
3.66 ± 0.62 3.81 ± 0.63 3.43 ± 0.53 0+ 
Ability to find Good Health 
Information 
 
3.53 ± 0.74 3.72 ± 0.77 3.328± 0.61 0+ 
Understanding Health 
Information Enough to Know 
What to Do 
3.57 ± 0.83 3.74 ± 0.85 3.35 ± 0.72 0+ 
Note. Data expressed as M ± SD 
 
3.5. Summary of Health Literacy vs. Psychological Distress 
For ease of reference, Table 15 illustrates all statistically significant differences 














































     
 






































































Enough to Know 
what to Do 
✓ 
 




Note. ✓ = Univariate statistically significant difference. All differences are uni-directional (i.e. distressed  







4. Nutritional Quality of Life 
 
The mean NSQOL score of the study sample was 9.52 (SD = 1.86). Population means 
are unavailable as the use of NSQOL has been used primarily in clinical populations. 
However, this mean NSQOL score in the present study is comparable to other studies 
performed on similar cohorts (e.g. Han et al., 2012). 
Table 16 illustrates the results of a one-way ANOVA indicated that NSQOL scores 
were statistically different for the depression subgroup, F (1,169) = 11.77, p < .01 and the 
anxiety subgroup, F (1,169) = 15.36, p < .01. ANCOVA tests controlling the influence of 
Kt/V levels (for Anxiety subgroup), gender and ethnicity yielded similar results. 
Table 17 illustrates the ANOVA results for Loneliness and Hopelessness subgroups. 
Results indicate that NSQOL scores were statistically different for the Loneliness subgroup, 
F (1,169) = 16.38, p < .01 and the hopeless subgroup F (1,169) = 8.63, p < .01. ANCOVA 
tests controlling the influence of gender and ethnicity yielded similar results. 
 
Table 16Health Beliefs Results in APD and CAPD Patients CAPD Patients 




(n = 92) 
Depressed 
(n = 79) 
p 
Non-Anxious 
(n – 81) 
Anxious 
(n = 90) 
p 
NSQOL 9.52 ± 1.86 10.19 ± 3.48 8.59 ±3.08 0+ 10.51 ±3.46 8.60 ±3.06 0+ 
Note. Data expressed as M ± SD. NSQOL = Nutrition-Specific Quality of Life. 
 
Table 17Health Beliefs Results in APD and CAPD Patients CAPD Patients 





(n = 36) 
Lonely 




(n – 104) 
Hopeless 
(n = 67) 
p 
NSQOL 9.52 ± 1.86 10.19 ± 3.48 8.59 ±3.08 0+ 10.12 ±3.42 8.59 ±3.13 0+ 







5. Illness Perception 
 
The mean score for BIPQ-Diabetes was 38.89 (out of a maximum score of 60) (SD = 
7.26) and the mean score for BIPQ-Dialysis is 41.23 (out of a maximum score of 60) (SD = 
7.74), indicating a degree of negative illness perception. One-way ANOVA comparison 
between scores on BIPQ-Diabetes and BIPQ-Dialysis revealed that patients had greater 
negative illness perception of dialysis, F (1, 339) = 7.83, p = .01 (see superscript “1” in table 
18). 
 The mean MULTIPleS – Prioritization score was 12.46 (out of a maximum score of 
24) (SD = 7.09) and mean MULTIPleS-Treatment Burden Score was 12.19 (out of a 
maximum score of 36) (SD = 5.62). No cutoff or categorizations are available. The item with 
the highest mean score, out of 6 in the prioritization scale was “One of my conditions has 
more of an impact on my life” (M = 3.76). The item with the highest mean score, out of 6, in 
the treatment burden scale was “I feel so overwhelmed by the treatment for one condition that 
it is hard to manage any others”(M = 3.88). 
 
Anxiety and Depression 
Table 18 illustrates the results of a one-way ANOVA indicated that BIPQ-Dialysis 
scores were significantly higher for the depressed subgroup compared to the non-depressed 
subgroup, F (1,169) = 6.37, p = .01. No other differences are documented in other BIPQ 
scores within the depression and anxiety subgroups.  
One-way ANOVA results indicate that MULTIPleS-Treatment Burden scores were 
significantly higher for the depressed subgroup, F (1, 169) = 13.57, p = 0+. Both 
MULTIPleS-Treatment Burden, F (1,169) = 11.48, p = 0+, and MULTIPleS-Prioritization 
scores F (1,169) = 4.10, p = 05 are significantly higher for the anxious subgroup. ANCOVA 




Table 18 Health Beliefs Results in APD and CAPD Patients CAPD Patients 




(n = 92) 
Depressed 
(n = 79) 
p 
Non-Anxious 
(n = 81) 
Anxious 
(n = 90) 
p 








39.64 ± 7.01 42.61 ± 7.98 .01* 40.44 ± 7.32 42.29 ± 8.03 .12 





11.59 ± 6.29 12.87 ± 4.79 0.14 
11.28 ± 5.95 13.01 ± 5.25 .05* 




10.93 ± 7.78 14.54 ± 5.57 0+* 10.63 ± 7.78 14.15 ± 6.01 0+* 
Note. Data expressed as M ± SD. Higher value indicates greater negative illness perception and/or treatment 
burden. 1Significant difference found for BIPQ-Diabetes and BIPQ-Dialysis. 
 
Loneliness and Hopelessness 
Table 19 illustrates the ANOVA results for Loneliness and Hopelessness subgroups. 
Results indicate that BIPQ scores were significantly higher in the Hopeless subgroup, F 
(1,169) = 4.39, p = .04. In addition, one-way ANOVA results indicate that MULTIPleS-
Treatment Burden scores were significantly higher in the lonely subgroup, F (1,169) = 12.74, 
p = 0+ and for the hopeless subgroup, F (1,169) = 8.74, p = 0+.  ANCOVA tests controlling 
the influence of ethnicity and gender yielded similar results. No other differences are 
documented in other Illness perception scores within the lonely and hopeless subgroups. 
 
Table 19 Health Beliefs Results in APD and CAPD Patients CAPD Patients 





(n = 36) 
Lonely 




(n = 104) 
Hopeless 
(n = 67) 
p 








38.62 ± 6.92 39.88 ± 8.42 .08 38.46 ± 6.42 39.70 ± 7.34 .55 





11.38 ± 6.56 12.40 ± 5.35 0.34 
11.86 ± 6.06 12.70 ± 4.88 .34 




8.83 ± 7.72 13.42 ± 6.62 0+* 11.20 ± 7.44 14.41 ± 6.08 0+* 










A summary of the patients’ self-reported adherence results is included in Table 20. 
Forty-seven percent (47%), twenty-six percent (26%) and twenty-seven percent (27%) of the 
study sample reported high, medium and low adherence to medication in the MMAS 
respectively. 
Thirty-eight percent (38%) reported some difficulty in following their prescribed diet in 
the ADAT. 
In SDSCA, study participants reported that out of the last seven days, a mean of 5.08 
(SD=2.01) days was spent following their diet plans and a mean of 6.99 (SD = 0.58) days 
was spent following their recommended diabetic medication.  
In DDFQ-diet, participants reported that the frequency of deviation from their dietary 
guidelines within the recent 2 weeks to be M = 3.48 (SD = 1.48) days, median = 2 days, with 
the mean degree of deviation from dietary guidelines to be 1.09 (SD = 0.96) days out of a 
maximum possible of 14 days. In DDFQ-fluid, participants reported that the frequency of 
deviation from their fluid guidelines within the recent 2 weeks to be M = 3.56  (SD = 1.09) 
days, median = 2 days, with the mean reported degree of deviation from fluid guidelines to be 
1.13 (SD = 1.09) days out of a maximum possible of 14 days. 
 
Anxiety and Depression  
Table 20 illustrates the self-reported adherence outcomes in the Depression and 
Anxiety subgroups. Between the depression subgroups, comparisons indicate that non-
depressed patients were significantly more likely to report no difficulty in following their diet 
on the ADAT, χ2 (2, N = 171) = 13.95, p = .01. No other differences were documented for 
other adherence variables between depressed and non-depressed patients. ANCOVA tests 




Between the anxiety subgroups, comparisons indicate that non-anxious patients were 
significantly more likely to report no difficulty in following their diet on the ADAT, χ2 (2, N 
= 171) = 15.22, p = .0. No other differences were documented for other adherence variables 
between anxious and non-anxious patients. ANCOVA tests controlling the influence of 
gender yielded a similar result. 
 
Table 20Health Beliefs Results in APD and CAPD Patients CAPD Patients 






(n = 92) 
Depressed 
(n = 79) 
p 
Non-Anxious 
(n = 81) 
Anxious 
(n = 90) 
p 
MMAS    .69   .06 
High (0) 80 (47) 45 (49) 35 (45)  44 (54) 37 (41)  
Medium (1,2) 45 (26) 21 (23) 24 (30)  15 (19) 30 (33)  
Low (>2) 46 (27) 25 (28) 20 (25)  22 (27) 23 (26)  
ADAT    .01*   0+* 
Difficulty 
Following Diet 




106 (62) 65 (71) 41 (52)  59 (73) 47 (52) 
 









6.87 ± 0.03 6.88 ± 0.01 .91 6.90 ± 0.01 6.86 ± 0.03 .70 












1.01 ± 0.91 1.18 ± 0.90 .23 0.93 ± 0.82 1.23 ± 0.96 .03* 












1.18 ± 1.05 1.06 ± 1.08 .46 0.92 ± 0.10 1.17 ± 0.12 .17 
Note. Data expressed as M ± SD. Scores of reversed items are recorded. 
MMAS = Morisky Medication Adherence Scale. SDSCA = Summary of Diabetes Self-Care Activities revised 




Loneliness and Hopelessness 
Table 21 illustrates the self-reported adherence outcomes in the loneliness and 




documented for any of the adherence variables in the loneliness subgroup. ANCOVA tests 
controlling the influence of ethnicity yielded similar results. 
Between the hopelessness subgroups, comparisons indicate that hopeless patients were 
significantly more likely to report difficulty in following their diet on the ADAT, χ2 (2, N = 
171) = 13.12, p = .0+. No other differences were documented for other adherence variables. 
ANCOVA tests controlling the influence of ethnicity yielded similar results. 
Table 21Health Beliefs Results in APD and CAPD Patients CAPD Patients 






(n = 36) 
Lonely 




(n = 104) 
Hopeless 
(n = 67) 
p 
MMAS1    .55   .21 
High (0) 80 (47) 19 (53) 61 (45)  47 (45) 27 (40)  
Medium (1,2) 45 (26) 10 (27) 35 (36)  28 (27) 26 (38)  
Low (>2) 4627) 7 (20) 38 (19)  29 (28) 14 (22)  
ADAT    .12   0+* 
Difficulty 
Following Diet 




106 (62) 9 (25) 33 (24)  71 (68)  28 (42) 
 
SDSCA        
General Diet 5.08 ± 0.41 5.16 ± 0.39 5.05 ± 0.43 .78 5.14 ± 0.35 4.98 ± 0.46 .34 
Diabetic 
Medication 
6.99 ± 0.01 6.99 ± 0.01 6.97 ± 0.01 .93 6.97 ± 0.01 6.99 ± 0.01 .32 
DDFQ- Diet        
Frequency of 
Deviations 
3.48 ± 1.48 
(Median = 2) 
3.52 ± 4.13 3.42 ± 3.82 .71 3.33 ± 0.41 3.64 ± 0.44 .44 
Degree of 
Deviation 
1.09 ± 0.96 1.04 ± 0.95 1.19 ± 0.92 .14 1.03 ± 0.82 1.14 ± 0.96 .24 
DDFQ-Fluid        
Frequency of 
Deviations 
3.56 ± 4.39 
(Median = 2) 
3.59 ± 4.38 3.52 ± 4.31 .43 3.45 ± 0.29 3.62 ± 0.39 .43 
Degree of 
Deviation 
1.13 ± 1.09 1.14 ± 1.15 1.10 ± 1.02 .55 0.92 ± 0.10 1.17 ± 0.12 .17 
Note. Data expressed as M ± SD. Scores of reversed items are recorded.1Mann-Whitney U test 
MMAS = Morisky Medication Adherence Scale. SDSCA = Summary of Diabetes Self-Care Activities revised 
















Biopsychosocial Determinants of Psychological Distress 
Part III presents results with respect to study aim 3. Hierarchical stepwise logistic 
regression models for (1) Depression, (2) Anxiety, (3) Loneliness and (4) Hopelessness will 




Univariate analyses. Results indicating univariate association between demographics, 
clinical and psychosocial variables with depression that were performed in Part II of the 
present study are summarized in Table 22A. Significant associations were mainly found for 
demographic and psychological variables. In consideration of results from previous 
univariate comparisons, Malays and Indians/Others have been combined into an independent 


































Table 22AFactors  
Factors Affecting Depression Based on Biopsychosocial factors in Univariate Analyses 
 Non-Depressed (n = 79) Depressed (n = 92)       p 
Ethnicity    0+ 
Chinese 33 (51) 54 (69)  
Non-Chinese 59 (49) 24 (31)  
HLQ    
Feeling Understood and Supported by 
Healthcare Providers 
 
3.12 ± 0.42 2.87 ± 0.52 0+ 
Actively Managing My Health 
 
2.91 ± 0.47 2.75 ± 0.41 .02  
Social Support for Health 
 
3.20 ± 0.55 2.71 ± 0.55 0+  
Appraisal of Health Information 
 
2.75 ± 0.63 2.53 ± 0.49 .02  
Ability to Actively Engage with Healthcare 
Providers 
 
4.05 ± 0.65 3.39 ± 0.74 0+  
Navigating the Healthcare System 
 
3.85 ± 0.62 3.41 ± 0.51 0+  
Ability to find Good Health Information 
 
3.71 ± 0.77 3.28 ± 6.07 0+  
Understanding Health Information Enough 
to Know what to Do 
3.71 ± 0.89 3.35 ± 0.71 .02  
NSQOL 10.19 ± 3.48 8.59 ±3.08 0+ 
BIPQ - Dialysis 39.64 ± 7.01 42.61 ± 7.98 .01 
MULTIPLES – Treatment Burden 10.93 ± 7.78 14.54 ± 5.57 0+ 
ADAT   .01 
Difficulty following diet 27 (29) 38 (48)  
No difficulty following diet 65 (71) 41 (52)  
Note. Data expressed as M ± SD or n (%). HLQ = Health Literacy Questionnaire. NSQOL = Nutrition-Specific 
Quality of Life. BIPQ = Brief Illness Perception Questionnaire. MULTIPLES = Multimorbidity Illness 
Perception Scale. ADAT = Appetite and Diet Assessment Tool. 
 
Multivariate Analysis. Depression (as a binary variable) was regressed to ethnicity and 
psychosocial variables in two separate logistic regression models. Only variables associated 
with depression were entered as potential predictors (See Table 22A). Demographic variables 
were entered on the first step, followed by psychosocial variables on the second step. 
Nagelkerke’s R2 was used to assess how much variance in depression could be explained by 
the regression models. Forward: Likelihood Ratio was used to select each variable. Table 22B 
presents the final regression models for depression.  
The final logistic regression model included four variables: ethnicity, HLQ-Ability to 
Actively Engage with HCP, HLQ Social Support and NSQOL (Omnibus χ2 = (4, n = 171) = 
63.64, p = 0+, Nagelkerke R
2
 = .43. Chinese had 2.48 times more likelihood to exhibit 




2.48, CI [2.33, 2.54], p = 0+). An increase in one point of score on “HLQ-Ability to actively 
engage with HCP” was associated with 1.47 times (or 47%) less likelihood of exhibiting 
depression (β = -1.09, OR = 0.68, CI [0.21, 0.42] p = 0+.). An increase in one point of score 
on “HLQ – Social Support” was associated with a 1.49 times (or 49%) less likelihood of 
exhibiting depression (β  = -1.21, OR = 0.67, CI [0.28, 0.36], p = .05). Additionally, an 
increase in one point of score on NSQOL was associated with 1.07 times 7% less likelihood 
of exhibiting depression (β  = -0.50, OR = 0.93, CI [0.87,0.98], p = .05). The final model was 
able to explain 43% (Nagelkerke R
2
) of the variance in depression and correctly classified 
78% of the cases. 
Table 22B 
Predictors of Depression in Stepwise Logistic Regression 
 
Dependent variable: HADS-Depression (0 = Non-depressed, 1 = Depressed) 
 
Step Predictor      β OR Nagelkerke R
2   χ2 p 
1 Chinese (vs Non-Chinese) −0.91** 2.48 .27 38.02 0+** 
2 HLQ – Actively Engage with HCP  −1.09** 1.47 .43 63.64 0+** 
 HLQ – Social Support  - 1.21* 1.49    
 NSQOL −- 0.50* 1.07    
Note. Hierarchical stepwise logistic regressions were used. OR = Odds Ratio. HLQ = Health Literacy 
Questionnaire. NSQOL = Nutrition Specific Quality of Life. 



























Univariate Analyses. Results examining the demographical, clinical and psychosocial 
associated with anxiety with observed significant results are summarized in Table 23A. 
 
Table 23A Factors Affecting 
Factors Affecting Anxiety Based on Biopsychosocial factors in Univariate Analyses 
 Non-Anxious (n = 81) Anxious (n = 90) p 
Gender   .01 
Male 58 (71) 48 (53)  
Female 23 (29) 42 (47)  
Kt/V 1.53  ± 0.21 1.59  ± 0.19 .01 
HLQ    
Feeling Understood and Supported by 
Healthcare Providers 
 
3.08 ± 0.46 2.93 ± 0.48 0+ 
Social Support for Health 
 
3.15 ± 0.62 2.81 ± 0.54 0+  
Ability to Actively Engage with Healthcare 
Providers 
 
4.10 ± 0.69 3.43 ± 0.71 0+  
Navigating the Healthcare System 
 
3.90 ± 0.60 3.44 ± 0.56 0+  
Ability to Find Good Health Information 
 
3.78 ± 0.73 3.33 ± 0.68 0+  
NSQOL 10.51 ±3.46 8.60 ±3.06 0+ 
MULTIPLES - Prioritization 11.28 ± 5.95 13.01 ± 5.25 .05 
MULTIPLES – Treatment Burden 10.63 ± 7.78 14.15 ± 6.01 0+ 
ADAT   0+ 
Difficulty following diet 22 (27) 43 (48)  
No difficulty following diet 59 (73) 47 (52)  
DDFQ – Degree of Deviation 0.93 ± 0.82 1.23 ± 0.96 .03 
Note. Data expressed as M ± SD or n (%). HLQ = Health Literacy Questionnaire. NSQOL = Nutrition-Specific 
Quality of Life. BIPQ = Brief Illness Perception Questionnaire. MULTIPLES = Multimorbidity Illness 
Perception Scale. ADAT = Appetite and Diet Assessment Tool. DDFQ = Diabetic Diet and Fluid Non-
adherence Questionnaire.  
 
Multivariate Analysis. Anxiety (as a binary variable) was regressed to gender, Kt/V 
levels and psychosocial variables in three separate logistic regression models. Only variables 
associated with anxiety were entered as potential predictors. Demographic variables (gender) 
were entered on the first step; clinical variables (Kt/V levels) were entered on the second 
step, followed by psychosocial variables on the third step. Nagelkerke’s R2 was used to assess 
how much variance in anxiety could be explained by the regression models. Forward: 
Likelihood Ratio was used to select each variable. Table 23B presents the final regression 




The final logistic regression model included four variables: gender, Kt/V, HLQ-
Actively Managing my Health, and NSQOL (Omnibus χ2 = (4, n = 171) = 38.67, p = 0+, 
Nagelkerke R
2
 = .28. Males had 1.11 times (or 11%) less likelihood to report anxiety (scoring 
≥ 8 on the HADS-Anxiety) than females (β = -0.11, OR = 1.11, CI [0.92, 1.18], p = .02).  
A decrease in 0.1 mL of Kt/V was associated with a 4.46 times more likelihood of reporting 
Anxiety (β  = -1.82, OR = 4.46, CI [4.13, 4.66], p = .04). An increase in one point of score on 
“HLQ-Actively Managing my Health” was associated with 1.75 (or 75%) times less 
likelihood of reporting anxiety (β  = -1.11, OR = 1.75, CI [1.43, 2.03] p = 0+.). Additionally, 
an increase in one point of score on NSQOL was associated with 4.94 times less likelihood of 
reporting anxiety (β  = -0.12, OR = 4.94, CI [4.35, 5.44], p = .0+). The final model was able 
to explain 28% (Nagelkerke R
2
) of the variance in anxiety and correctly classified 79% of the 
cases. 
 
Table 23B  
Predictors of Anxiety in Stepwise Logistic Regression 
 
Dependent variable: HADS-Anxiety (0 = Non-Anxious, 1 = Anxious) 
 
Step Predictor     β OR Nagelkerke R2   χ2 p 
1 Male (vs Female) -0.11* 1.11 .21 28.59 .02 
2 Kt/V -1.82* 4.46 .25 34.08 .04 
3 HLQ – Actively Managing my Health - 1.11** 1.75 .28 38.67 0+ 
 NSQOL - 0.12** 4.93    
Note. Hierarchical stepwise logistic regressions were used. OR = Odds Ratio. HLQ = Health Literacy 
Questionnaire. NSQOL = Nutrition Specific Quality of Life. 

















Univariate Analyses. Results examining the demographical, clinical and psychosocial 
associated with loneliness with observed significant results are summarized in Table 24A. 
Table 24A 
Factors Affecting Loneliness Based on Biopsychosocial factors in Univariate Analyses 
 Non-Lonely (n = 36) Lonely (n = 135) p 
Gender   .02 
Chinese 11 (31) 76 (56)  
Non-Chinese 25 (69) 59 (44)  
HLQ    
Feeling Understood and Supported by 
Healthcare Providers 
3.18 ± 0.44 2.96 ± 0.48 .02 
Having Sufficient Information 3.17 ± 0.38 2.98 ± 0.43 .02  
Social Support for Health 3.22 ± 0.62 2.91 ± 0.60 .01  
Appraisal of Health Information 2.90 ± 0.54 2.60 ± 0.56 .01  
Ability to Actively Engage with Healthcare 
Providers 
 
4.14 ± 0.59 3.65 ± 0.79 0+  
Navigating the Healthcare System 
 
4.01 ± 0.43 3.57 ± 0.63 0+  
Ability to find Good Health Information 
 
3.78 ± 0.73 3.33 ± 0.68 0+  
Understanding Health Information Enough 
to Know what to Do 
3.69 ± 0.92 3.50 ± 0.71 0+  
NSQOL 10.19 ± 3.48 8.59 ±3.08 0+ 
MULTIPLES – Treatment Burden 8.83 ± 7.72 13.42 ± 6.62 0+ 
Note. Data expressed as M ± SD or n (%). HLQ = Health Literacy Questionnaire. NSQOL = Nutrition-Specific 
Quality of Life. BIPQ = Brief Illness Perception Questionnaire. MULTIPLES = Multimorbidity Illness 
Perception Scale.  
 
Multivariate Analysis. Loneliness (as a binary variable) was regressed to ethnicity and 
psychosocial variables in two separate logistic regression models. Only variables associated 
with loneliness were entered as potential predictors. Ethnicity was entered on the first step 
followed by psychosocial variables on the second step. Nagelkerke’s R2 was used to assess 
how much variance in loneliness could be explained by the regression models. Forward: 
Likelihood Ratio was used to select each variable. Table 24B presents the final regression 
models for loneliness.  
The final logistic regression model included four variables: HLQ - Social Support, 
HLQ – Navigating Healthcare, MULTIPleS Treatment Burden and NSQOL (Omnibus χ2 = 
(4, n = 171) = 26.74, p = 0+, Nagelkerke R
2




An increase in one point of score on HLQ – Social Support was associated with a 1.07 
times (or 7%) less likelihood of reporting loneliness (β = -1.23, OR = 0.93, CI [0.81, 1.02], p 
= .0+). An increase in one point of score on “HLQ-Navigating Healthcare” was associated 
with a 1.02 times (or 2%) less likelihood of reporting loneliness (β = -0.81, OR = 0.98, CI 
[0.96, 0.99] p = .04.). An increase in one point of score on MULTIPleS-Treatment Burden 
was associated with 1.06 (or 6%) times more likelihood of reporting loneliness (β = 0.67, OR 
= 1.06, CI [1.03, 1.11], p = .03). Additionally, an increase in one point of score on the 
NSQOL was associated with 1.21 times (or 21%) less likelihood of reporting loneliness (β = -
0.20, OR = 0.82, CI [0.69, 0.93] p = 0+). The final model was able to explain 23% 
(Nagelkerke R
2
) of the variance in loneliness and correctly classified 64% of the cases. 
 
Table 24B  
Predictors of Loneliness in Stepwise Logistic Regression 
 
Dependent variable: ULS-8 (0 = Non-Lonely, 1 = Lonely) 
 
Step Predictor      β OR Nagelkerke R2   χ2 p 
2 HLQ - Social Support - 1.23** 1.07 .23 26.74 0+ 
 HLQ – Navigating Healthcare - 0.81* 1.02    
 MULTIPleS - Treatment Burden 0.67* 1.06    
 NSQOL -0.20* 1.21    
Note. Hierarchical stepwise logistic regressions were used. OR = Odds Ratio. HLQ = Health Literacy 
Questionnaire. NSQOL = Nutrition Specific Quality of Life. MULTIPleS = Multimorbidity Illness Perception 
Scale. 






















Univariate analyses. Results examining the demographical, clinical and psychosocial 
associated with hopelessness with observed significant results are summarized in Table 25A. 
 
Table 25A  
Factors Affecting Hopelessness Based on Biopsychosocial factors in Univariate Analyses 
 Non-Hopeless (n = 104) Hopeless (n = 67) p 
Gender   .01 
Chinese 43 (41) 44 (65)  
Non-Chinese 61 (59) 23 (35)  
HLQ    
Social Support for Health 3.13 ± 0.51 2.73 ± 0.64 0+  
Appraisal of Health Information 2.75 ± 0.62 2.55 ± 0.47 .03  
Ability to Actively Engage with Healthcare 
Providers 
 
3.98 ± 0.72 3.38 ± 0.73 0+  
Navigating the Healthcare System 
 
3.81 ± 0.63 3.43 ± 0.53 0+  
Ability to Find Good Health Information 
 
3.72 ± 0.77 3.328± 0.61 0+  
Understanding Health information enough 
to Know What to Do 
3.74 ± 0.85 3.35 ± 0.72 0+  
NSQOL 10.12 ±3.42 8.59 ±3.13 0+ 
BIPQ - Diabetes 42.322 ± 7.91 39.70 ± 7.34 .04 
MULTIPLES – Treatment Burden 11.20 ± 7.44 14.41 ± 6.08 0+ 
ADAT   0+ 
Difficulty Following Diet 33 (32) 39 (58)  
  No Difficulty Following Diet 71 (68) 28 (42)  
Note. Data expressed as M ± SD or n (%). HLQ = Health Literacy Questionnaire. NSQOL = Nutrition-Specific 
Quality of Life. BIPQ = Brief Illness Perception Questionnaire. MULTIPLES = Multimorbidity Illness 
Perception Scale.  
 
Multivariate Analysis. Hopelessness (as a binary variable) was regressed to ethnicity 
and psychosocial variables in two separate logistic regression models. Only variables 
associated with loneliness were entered as potential predictors. Ethnicity was entered on the 
first step followed by psychosocial variables on the second step. Nagelkerke’s R2 was used to 
assess how much variance in hopelessness could be explained by the regression models. 
Forward: Likelihood Ratio was used to select each variable. Table 25B presents the final 
regression models for hopelessness.  
The final logistic regression model included four variables: ethnicity, HLQ – Ability to 
actively engage with HCP, HLQ - Social Support and NSQOL (Omnibus χ2 = (4, n = 171) = 
44.39, p = 0+, Nagelkerke R
2




Chinese had 1.04 (or 4%) times more likelihood to report hopelessness than other races 
(β = 0.47, OR = 1.04, CI [1.01, 1.10], p = .03). An increase in one point of score on HLQ – 
Social Support was associated with a 1.13 times (or 13%) less likelihood of reporting 
hopelessness (β  = -0.75, OR = 0.88, CI [0.81, 0.92], p = .0+). An increase in one point of 
score on “HLQ-Ability to Actively Engage with HCP” was associated with a 1.11 times (or 
11%) less likelihood of reporting hopelessness (β = -0.66, OR = 0.90, CI [0.83, 0.96] p = 0+). 
Additionally, an increase in one point of score on the NSQOL was associated with a 1.13 
times (or 13%) less likelihood of reporting loneliness (β = -1.24, OR = 0.88, CI [0.77, 0.91] p 
= 0+). The final model was able to explain 32% (Nagelkerke R
2
) of the variance in 
hopelessness and correctly classified 78% of the cases. 
Table 25B  
Predictors of Hopelessness in Stepwise Logistic Regression 
 
Dependent variable: BHI (0 = Non-Hopeless, 1 = Hopeless) 
 
Step Predictor      β OR Nagelkerke R2   χ2 p 
1 Chinese (vs Non-Chinese) 0.47* 1.04 .04 4.85 .03 
2 HLQ - Social Support - 0.75* 1.13 .32 44.39 0+ 
 HLQ – Actively Engage with HCP - 0.66** 1.11    
 NSQOL -1.24** 1.13    
Note. Hierarchical stepwise logistic regressions were used. OR = Odds Ratio. HLQ = Health Literacy 
Questionnaire. NSQOL = Nutrition Specific Quality of Life. MULTIPleS = Multimorbidity Illness Perception 
Scale. 















The present study is a pioneering effort in describing and examining the prevalence and 
predictors of psychological distress (Depression, Anxiety, Loneliness and Hopelessness) in 
DM-ESRD patients, as well as examining select psychosocial dimensions (Health Literacy, 
Illness Perception, Nutritional QOL and Adherence to Treatment) in the context of DM-
ESRD.   
There are several important findings in this study. Firstly, DM-ESRD patients 
experience a broad range of psychological distress symptoms. Secondly, psychologically 
distressed subgroups report poorer outcomes in each of the 4 psychosocial dimensions. 
Finally, the present study was able to identify several biopsychosocial factors that were 
predictive of the 4 different subgroups of psychological distress dimensions. 
This chapter presents key findings and will be presented in the following sequential 
sections. Qualitative findings will be jointly discussed with quantitative results in each 
section. 
1. Section one discusses the documented prevalence of psychological distress 
(Research aims 1 and 2a.i). 
2. Section two discusses findings on the 4 psychosocial dimensions measured (Health 
Literacy, Illness Perception, Nutritional Quality of Life and Adherence) (Research 
aims 1 and 2a.ii). 
3. Section three discusses the differences between psychological distress subgroups on 
the 4 psychosocial dimensions (Research aims 1 and 2b). 
4. Section four discusses biopsychosocial determinants of psychological distress 




5. Section five states the study strengths/limitations and future directions.  
 
Section 1: Psychological Distress (Research Aims 1 and 2a.i) 
Psychological distress is a common comorbidity following a chronic disease diagnosis, 
and the severity of psychological distress may increase with time (Jim et al., 2006). The 
present study was able to document rates of psychological distress in the DM-ESRD 
population. 
At 46%, the prevalence rate of depression (HADS depression ≥ 8) in the study 
population was substantial. The prevalence rates were slightly higher compared to the rate of 
depression in the general ESRD population in other studies using the HADS (34% in Martin 
et al., 2004; 38% for Murtagh et al., 2007). With regard to DM-ESRD, little data is available 
on the prevalence of any form of psychological distress. It is pertinent to note that depression 
rates measured with different instruments may vary widely, with studies examining 
depression rates varying from 24% to 46% in HD patients (Brown et al., 2010; Conde et al., 
2010; Hung et al., 2011). Qualitative analyses revealed that patients generally report negative 
affect and that having a chronic condition may possibly lead to a more depressed outlook of 
life and of their treatment goals. Through the study interviews, the presence of coexisting 
conditions has also been reported to have a negative influence on the wellbeing of patients.  
The prevalence rate of anxiety (HADS anxiety ≥ 8) was also found to be substantial at 
53%, a number slightly higher compared to other studies examining the general ESRD 
population using the HADS   (45.6% in Martin et al., 2004; 27% in Murtagh et al., 2007). 
Qualitative findings suggest that patients report feeling anxious and worried about their 
health status, with several stating that coexisting conditions may make coping more difficult 




The documented depression and anxiety rates in the present study were comparable to 
that of other Asian populations (Kim et al., 2002; Ko et al., 2010). Some suggested reasons 
for this phenomenon are that Asian patients perceive their chronic disease as a burden not just 
to themselves, but to their families as well (Chen et al., 2010). This resonates with the 
documented qualitative subtheme of patients not wanting to be a burden to their families. 
Perceived burden has not only been postulated to be related to depression and anxiety, but 
suicide ideation as well (Brown et al., 2009). 
The rates of depression and anxiety in the present study are generally comparable to 
other ESRD populations, but the rates are markedly high in comparison to studies examining 
depression and anxiety in a population with no chronic conditions (7.9% for depression and 
2.6% for anxiety) (Broekman et al., 2008). A Singaporean study examining the prevalence of 
depression and anxiety in patients with chronic obstructive pulmonary disease using the 
HADS (with similar cutoff scores) reported the rates to be only 42% and 10% for depression 
and anxiety respectively (Cao, Ong, Eng, Tan & Ng, 2006). It is thus important to note that 
prevalence of depression and anxiety are high, even when compared to other chronic disease 
populations in Singapore.  
A significant portion of the study population (79%) reported loneliness. These rates are 
comparatively higher compared to other studies examining loneliness in the HD population 
(e.g. 42.7% in Koc & Saglam, 2013). Qualitative analyses revealed that many patients report 
either feeling socially isolated or having a lack of social support. In examining individual 
item scores in the ULS-8, the item “No one really knows me well” is reported to be the top 
concern (highest mean score) reported by patients, which suggests that the patients do not 
feel like they are understood and supported from those around them. Moreover, social 
support has been reported to be an inverse correlate of loneliness (Kara & Mirici, 2004). 




underlying reasons or directionality (i.e. whether the individuals close to the patient are 
unwilling to provide support or if the patients themselves are the barriers to poor social 
support), as a study reported that dialysis patients themselves may be embarrassed by the 
discussion of their treatment experiences with others and as a result, exhibit social withdrawal 
behaviour to avoid talking about their conditions (Herlin & Wann-Hannson, 2010).  
Hopelessness was documented in 39% of the study sample. Studies examining 
hopelessness in the ESRD patient population are limited. A study using the parent version of 
the BHI (i.e. Beck Hopelessness Scale (BHS)) in PD patients found similar rates of 
hopelessness. Qualitative findings suggest that the chronicity of DM-ESRD, as well as their 
coexistence/comorbidity contributes to feelings of hopelessness about their conditions, which 
led to patients expressing bleak views about their future. In particular, the BHI item “My 
future seems dark to me” appears to be the top concern reported by patients. Of note, some 
studies have reported that hopelessness leads patients to feel that “enough is enough” and that 
remaining on dialysis represents a hopeless situation that may not improve (e.g. Ganzini et al., 
1994). However, none of the patients interviewed in the qualitative component of the present 
study report any intention to withdraw from dialysis. In a previously listed example by P1, 
the quote “at the end of the day however, I still come for dialysis” suggests that hope and 
hopelessness are a dialectically interacting construct. Oncology research examining hope and 
hopelessness in patients with terminal cancer suggests that the relationship between hope and 
hopelessness might be balanced on the subjective acceptance of their diagnosis (Sachs et al., 
2013). However, while hopelessness may not be a strong indicator of treatment withdrawal in 
the present study, it remains important to highlight the documented prevalence of 
hopelessness in the DM-ESRD population as it has been found to affect overall well-being 




Depression, anxiety, loneliness and hopelessness, while measured as separate 
dimensions in this study, are nonetheless under the overarching construct of psychological 
distress. These four dimensions may all be responses to the demanding treatment 
requirements arising from coexisting conditions such as DM-ESRD (Abramson, Metalsky & 
Alloy, 1989).  
It is also important to consider the sociocultural factors embedded within the present 
population that may contribute to the rates of psychological distress.  
Firstly, qualitative analyses reveal that finances and the cost of treatment is a common 
problem that patients report to be a burden. Tan and colleagues (2005) reported that financial 
burden was the biggest stressor in Singaporean ESRD patients. In the Singapore healthcare 
framework, dialysis costs are not fully subsidized by the government (vis-à-vis the United 
Kingdom and the Netherlands) (Lai et al., 1999; Vanholder et al., 2012). In 2014, the average 
medical bill for HD per month in Voluntary Welfare Organizations (VWO) (which is also the 
cheapest option that HD patients have) amounted to S$2048.00 (Chowdhury, 2006). This 
problem may also be compounded with reported findings that ESRD patients are unable to be 
gainfully employed which in turn increases the financial burden on their family and/or 
caregivers (e.g. Tan et al., 2005). A study examining the annual cost for DM treatment in 
Singapore reported the number to be around S$700.00 per annum, but the actual cost may 
differ between individual needs and the medical facilities they attend (Ng et al., 2015). 
Beyond medication costs, the proper management of DM may require a strict adherence to a 
diabetic diet, which may require patients to deviate from cheaper, easier but less healthy 
alternatives from the plethora of food establishments in Singapore (Hankin et al., 2001). It 
may also be useful to compare the cost of treatment with the median monthly household 




Statistics Singapore, 2015), suggesting that DM-ESRD is likely to pose significant financial 
burden on most households in Singapore.  
Relatedly, another sociocultural context that may act as a backdrop for the documented 
rates of psychological distress is that rising trends of dual-income households (which sees 
working children leaving their retired elderly parents at home during the day) may further 
contribute to feelings of depression, anxiety and loneliness in the typically elderly ESRD 
population (Ministry of Social and Family Development Singapore, 2011; Long & Martin, 
2000). With dual-income households, it is common to hire domestic workers (commonly 
called maids in Singapore) to assist in household chores. However, it is also common for 
these domestic workers to also provide primary lay-caregiving to debilitated/chronically ill 
members present in the household (Yeoh et al., 2009). Several issues may surface with 
domestic workers providing caregiving. Firstly, considering that most of these domestic 
workers are not professionally trained to holistically manage patients (as compared to social 
workers or nurses), the low and/or poor level of care provided my them may instead lead to 
adverse mental health consequences, as reported by studies examining the effect of domestic 
workers’ caregiving (Philips & Rempusheski, 1986). Secondly, turnover rates of domestic 
workers may be high, as employers are known to frequently re-hire new domestic workers 
whenever they feel dissatisfied with their domestic worker (Yeoh & Huang, 2000). This may 
create a barrier to forming a long-term, effective caregiving relationship. 
Lastly, ESRD carries with it a stigma that patients have to manage (Bakewell et al., 
2001). To exacerbate the situation for DM-ESRD patients, the diagnosis of DM has also been 
found to lead to guilt and shame (Nash, 2013). Considering that Asian cultures tend to 
embody the concept of face, defined as “the positive social value that a person effectively 
claims for himself…face is an image of self-delineated in terms of approved social attributes” 




from their friends and neighbours (thus further contributing to feelings of loneliness). DM-
ESRD patients may hence experience an extra burden in this respect, even when compared to 
other ESRD subgroups.  
 
Section 2: Rates of Health Literacy, Illness Perception, Nutritional QOL and 
Adherence (Research Aims 1 and 2a.ii) 
Health Literacy 
The present study is the first to utilize the HLQ to examine health literacy in the ESRD 
population. Comparisons with other studies examining health literacy in ESRD populations 
may not be meaningful because of the difference in health literacy instruments used, although 
reports suggest that ESRD populations generally have some health literacy deficiencies (Lai 
et al., 2013). Currently, only one other study has utilized the HLQ in examining health 
literacy, with the study sample examining the general population in Australia (Beauchamp et 
al., 2015). In comparison to the present study population, the overall trends in the nine health 
literacy dimensions on the HLQ are somewhat comparatively similar, although it can be 
observed that the current study sample scored poorer on most of these dimensions (except for 
“Having Sufficient Information”). Future studies examining the HLQ on general populations 
would be useful for population norms comparison. For ease of reference, the Beauchamp et al 
















(Beauchamp et al., 2015) 
 (N=171) (N= 813) 
Feeling Understood and 
Supported by Healthcare 
Providers 
 




3.02 ± 0.44 2.98 ± 0.54 
Actively Managing My 
Health 
 
2.84 ± 0.45 3.02 ± 0.50 
Social Support for Health 
 
2.98 ± 0.60 3.03 ± 0.55 
Appraisal of Health 
Information 
 
2.66 ± 0.58 2.78 ± 0.54 
Ability to Actively 
Engage with Healthcare 
Providers 
 
3.76 ± 0.77 3.97 ± 0.69 
Navigating the Healthcare 
System 
 
3.66 ± 0.62 3.82 ± 0.67 
Ability to Find Good 
Health Information 
 
3.53 ± 0.74 3.65 ± 0.75 
Understanding Health 
Information Enough to 
Know What to Do 
3.57 ± 0.83 3.85 ± 0.74 
Note. Data expressed as M ± SD.  
 
 In addition, Beauchamp et al (2015) in their study also reported that sub-populations 
with chronic conditions report (1) more difficulties navigating the healthcare system, (2) have 
insufficient information for health, and (3) having less social support for health.  These three 
HLQ themes also resonate with the identified themes in the qualitative analysis results of the 
present study.  Patients recount being unable to use the healthcare system to address their 
needs and have a limited understanding of what health services are available (Corresponding 
to “Navigating the Healthcare System”). In addition, patients also report having difficulties 
and gaps in their knowledge, and that they don’t have the necessary information they need to 
live with and manage their health concerns (Corresponding to “Having Sufficient Information 




unsupported for health (Corresponding to “Social Support for Health”). Some proposed 
reasons for chronic disease patients having difficulties in navigating the healthcare system 
and/or having enough information to manage health may be that patients with multimorbidity 
have been reported to be overwhelmed by the complexity of information and the number of 
different service providers to their health care (Manderson et al., 2012). This may be 
plausible in the context of DM-ESRD, as a typical patient in Singapore would be required to 
have monthly appointments with nephrologists, dieticians, resident physicians in dialysis 
centers as well as other medical specialists, subject to individual needs. Social support and 
loneliness are intimately related constructs (Jones & Moore, 1987), and thus it is expected 
that the observation of lack of social support follows the discussion of documented loneliness 
in the current study. The lack of social support has been associated with increased risk of 
mortality in several cohort studies among the general population, as individuals perceiving a 
non-supportive environment are more likely to be emotionally distressed, which in turn 
increases the likelihood of noncompliance with treatment (McClellan et al., 1993). Reasons 
for poor social support in the ESRD population has been suggested to be because ESRD 
patients require a broad range of forms of support, including anywhere from financial to 
emotional support. The long-term burden placed on patients’ closed ones may increase 
interpersonal stress, which may have adverse consequences for a healthy, supportive 
relationship (Eitel et al., 1995).  A systematic review of social support in diabetic patients 
suggests that the lack of social support is related to poorer overall psychosocial functioning, 
but underlying mechanisms for this relationship remain unclear (van Dam et al., 2005). 








The present study utilized a subset of items from the Brief Illness Perception 
Questionnaire (B-IPQ) to measure ESRD and DM separately as two conditions. Quantitative 
results revealed that patients have greater negative illness perception of ESRD compared to 
DM. This is also supported by the Multimorbidity Illness Perceptions Scale (MULTIPleS) 
findings that the highest mean score belonged to the prioritization subscale item, “One of my 
conditions has more of an impact on my life”.  While no current studies in the literature have 
compared differences in illness perception between DM and ESRD, several reasons may 
explain this finding. Firstly, studies examining the relationship between illness perceptions 
and quality of life in dialysis patients found that ESRD patients consistently report strong 
illness identity (an aspect of BIPQ measurement) which is associated with poorer outcomes 
such as quality of life (Timmers et al., 2008), while similar studies on DM patients found that 
illness identity varies significantly between individuals (Luyckx et al., 2008). Secondly, the 
impact of dialysis on ESRD patients includes a range of side effects, including pain in the 
area of the arteriovenous fistula graft that patients re-experience each time they undergo 
dialysis (Bhatia et al., 1996). While DM presents many complications and side effects to a 
patient as well, the negative experience may not be as frequent or severe compared to 
undergoing dialysis. This is also supported by the qualitative analyses results highlighting 
that more attention to bodily needs are required by the patient after dialysis of kidney failure 
compared to before (see P4). 
In general, the BIPQ scores for both DM and ESRD indicate a degree of negative 
illness perception, and scores are comparable to studies on similar populations (e.g. in 
dialysis, Chilcot, 2012; in diabetes, Broadbent, Donkin & Strorh, 2011). 
Overall, MULTIPleS results supplement the findings on BIPQ and suggest that patients 




reporting that one of their conditions is more overwhelming (note that the questionnaire does 
not inquire on the specific conditions). The number of studies utilizing MULTIPleS is limited, 
considering that the conception of the instrument is relatively recent (Gibbons et al., 2013). A 
cohort study using MULTIPleS to examine the effect of multimorbidity on health outcomes 
in a primary care population did not provide descriptive statistics, but reported that the 
experience of burden associated with multimorbidity was related to poorer self-reported 
health status (e.g. self-help behaviors). Future research utilizing MULTIPles on general 
populations would be useful for population norms comparison. 
 
Nutritional Quality of Life and Adherence 
To present a more congruent discussion, nutritional QOL and adherence will be jointly 
discussed, as qualitative analyses suggest the existence of a relationship between nutritional 
QOL and adherence (mainly dietary adherence). 
The NSQOL was developed specifically to assess appetite-related QOL in HD patients. 
Overall, NSQOL scores indicate comparable outcomes with other studies using the NSQOL 
on the HD population (Han et al., 2012), suggesting that the present patient population may 
face moderate malnutrition. In clinical populations, malnutrition is closely related to dietary 
nonadherence (Klahr, 1989). SDSCA-General Diet and DDFQ-Diet results concur that 
patients do not consistently follow their dietary recommendations. Qualitative interviews also 
highlight that patients report problems with dietary adherence. Sub-themes from the 
interviews also suggest that conflicting dietary requirements from different conditions and 
fluctuations in appetite after dialysis. Research examining dietary adherence is lacking, but 
one study identified knowledge of diet, language, socioeconomic status and attitudes toward 
the renal diet as important factors related to dietary adherence (Lopez, Burrowes, Gizis & 




adherence in HD patients suggest that factors such as poor knowledge and/or understanding 
of treatment requirements potentially hinder adherence to diet, fluid and medication 
requirements (Griva et al., 2013). Overall, it makes sense that nutritional QOL deficiencies 
also reflect difficulties in dietary adherence. 
However, results highlighting dietary nonadherence was incongruent with majority of 
patients (62%) reporting that they do not face difficulties following their diet on the ADAT 
scales. This suggests that while patients may not perceive that following their dietary 
guidelines are difficult, they make conscious decisions not to adhere to their recommended 
guidelines. This is supported by qualitative interviews revealing that patients consciously 
deviate from dietary guidelines during social and festive occasions. Further research is 
needed to explore the relationship between perceived difficulty of adherence and actual 
adherence behavior. 
Medication adherence did not emerge as a theme in qualitative analysis, but a 
substantial portion of the quantitative sample reported  medium and low levels of medication 
adherence on the MMAS (26% and 27% respectively, with a combined total of 53%). This 
finding is comparable to similar studies examining the Singaporean ESRD population. For 
example, a study examining adherence rates in PD patients found overall deviations from 
medication regimen to be around 47% (Griva et al., 2013). However, the medication 
nonadherence rates were slightly higher than those reported in studies on western populations 
(e.g. DeOreo, 1997; Holley & Devore, 2006; Russo et al., 2006). In addition, an examination 
of PD patients in Hong Kong found nonadherence rates for medication to be only 17%, 
although the operational definition in their study was less stringent (Lam et al., 2010). 
Research on understanding the causes of medication nonadherence is unclear, but associated 
factors with medication nonadherence usually include patient factors such as a lower 




medication nonadherence (Kutner et al., 2002), interventions are needed to address these 
needs.  
Interestingly SDSCA-diabetic medication suggests that patients rarely deviate from 
their diabetic medication regimen. This is supported by Balkrishnan and colleagues (2003) 
findings that adherence rates to diabetic medications were higher than other concurrent 
medications that a geriatric population may be prescribed. Medication adherence in the DM-
ESRD population is not widely examined, but it may be possible that patients regard dialysis 
as more important than medication in terms of life sustenance (DeOreo, 1997), and thus may 
downplay the importance of ESRD medications. 
Lastly, study results also indicate that some degree of deviation of fluid guidelines are 
present in the quantitative sample (DDFQ-Fluid deviation mean = 3.56 out of 14 days), 
which was also an emerging theme reported in qualitative analyses. In general, fluid 
nonadherence is consistently documented in studies examining the ESRD population. For 
example, a large cohort study examining fluid adherence in HD patients reported that as 
many as 74.6% of the HD population reported difficulty in following fluid guidelines (Kugler, 
Vlaminck, Haverish & Maes, 2005). However, correlates of fluid nonadherence in the HD 
population remain unexplored. No relationship between diabetes and thirst has been reported. 
 
Section 3: Psychological Distress Subgroup Difference on Psychosocial Dimensions 
(Research Aims 1 and 2b) 
 
The following section discusses all univariate results found in comparing psychological 
distress subgroups on the four psychosocial dimensions. While all statistically significant 
relationships in univariate results are eventually used as predictors in multivariate modelling 




studies have examined the relationship between psychological distress and the four 
psychosocial dimensions in DM-ESRD patients. 
 
Health Literacy Subgroup Differences 
Across the board for all psychological distress subgroups, distressed subgroups scored 
worse on each respective health literacy dimension. Significant differences in each of the 
health literacy dimensions are briefly discussed below. All significant differences are uni-
directional (i.e. distressed subgroups score lower on all health literacy dimensions): 
1. Health literacy dimension 1 – “Feeling Understood and Supported by Healthcare 
Providers”: Significant differences were found for depression, anxiety and loneliness 
subgroups. Briefly, this dimension requires patients to have an established relationship 
with at least one healthcare provider (Osborne et al., 2013). A suggested explanation 
for this may be that depression, anxiety and loneliness have all reported to impair the 
ability to form established relationships with others, which can in turn be extended to 
healthcare providers as well (Jones, 1982; Friedmann et al., 2006).  
2. Health literacy dimension 2 – “Having Sufficient Information to Manage My Health”: 
Significant differences were found for the loneliness subgroup. This was also an 
emerging theme in the qualitative component. A study reviewing loneliness 
consequences in a geriatric population suggests that feelings of loneliness can adversely 
affect cognitive ability and in turn, impair confidence with managing information 
(Hawkley & Cacioppo, 2010). This explanation may be applicable to the present study 
as the mean age was relatively high (mean age = 58.84, SD = 9.43). 
3. Health literacy dimension 3 – “Actively Managing my Health”: Significant 
differences were reported for the depression subgroup. Briefly, the description of this 




proactively engage in their own health care (Osborne et al., 2013). Depressive 
symptoms have been reported to be inversely related to proactive behavior (Ironson et 
al., 2005), which may help explain this particular finding.  
4. Health literacy dimension 4 – “Social Support for Health”: All subgroups reported 
significant differences in this dimension. In addition, this dimension was also identified 
as a theme in the qualitative component. In terms of social support, current literature is 
rich in documented an existing relationship between poor social support and 
depression/anxiety/loneliness (e.g. Griva et al., 2014) and hopelessness (e.g. Kimmel et 
al., 1993) in the ESRD population. One of the mechanisms underlying poor social 
support and general psychological distress is suggested to be because poor social 
support leads to deficiencies in cognitive and behavioral strategies for coping with 
stress, which in turn increases the risk of psychological distress (Holahan & Moos, 
1981). 
5. Health literacy dimension 5 – “Appraisal of Health Information”: Depression, 
loneliness and hopelessness subgroups reported significant differences in this 
dimension. Qualitative analyses also supplement this finding. As defined by Osborne et 
al (2013), “Appraisal of Health Information requires an ability to identify good 
information and reliable sources of information, including a resolution of conflicting 
information by themselves or with help from others”. A meta-analysis examining the 
relationship between depressed/anxious mood and cognitive bias modification suggest 
that depressed and anxious moods may negatively impact cognitive appraisal of 
information (Hallion & Ruscio, 2011). Similarly, another review examining the impact 
of loneliness on cognitive appraisal also suggested that loneliness led to an impaired 
ability to process information (Omdahl, 2014). However, the mechanisms behind the 




6. Health literacy dimension 6 – “Ability to Actively Engage with Healthcare 
Providers”: All subgroups reported significant differences in this dimension. This also 
concurs with results from qualitative analyses. The description of this dimension by 
Osborne et al (2013) includes the ability of the patient to have a sense of agency in 
interactions with healthcare providers and be able to seek advice from healthcare 
providers when necessary. Studies examining the relationship between these two 
constructs are limited, but some findings examining the chronic disease population 
indicate that patient engagement (by healthcare providers) is dependent on patients’ 
emotional state, such that a poor emotional state can function as a barrier to effective 
patient engagement (Barello, Graffigna & Vegni, 2012). The relationship between 
psychological distress and health literacy may be explained by some findings that poor 
mental health may lead to a stigmatizing attitude that hinders help-seeking behavior 
(Jorm, 2000). Stigmatizing attitudes can also be extended to approaching medical 
professionals as well, which may further worsen health literacy behaviors such as in 
this particular health literacy dimension (Raguram et al, 1996). 
7. Health literacy dimension 7 – “ Navigating the healthcare system”: All subgroups 
reported significant differences in this dimension. Qualitative analyses also identify this 
dimension as a theme. Broadly, patients’ ability to find out about health services and 
supports in order to get their needs met (Osborne et al., 2013) may require proactive 
behavior (as discussed in dimension 3). Extrapolating part of the description from this 
health literacy dimension suggests that some desire for independence is required from 
patients to be able to advocate on their own behalf to address their health needs. 
Relatedly, some studies report that psychological distress (specifically, depression, 




(e.g. Sharp et al., 2002). The psychological constructs of hopelessness remains to be 
further explored.  
8. Health literacy dimension 8 – “Ability to find good health information”: All 
subgroups reported significant differences in this dimension. The authors of the HLQ 
instrument suggest that an individual scoring high on this construct is an “information 
explorer” and actively uses a diverse range of sources to find information and is up to 
date with information (Osborne et al., 2013). Macfarlane et al (1999) found that the 
influence of psychological distress (in general) can negatively impact health-seeking 
behavior, which in the current study’s context, affect how much of an “information 
explorer” the patient can be. 
9. Health literacy dimension 9 – “Understanding health information well enough to 
know what to do”: Depression, loneliness and hopelessness subgroups reported 
significant differences in this dimension. The description of this dimension requires 
patients to be “able to understand all written information…in relation to their health and 
be able to write appropriately on forms where required” (Osborne et al., 2013). This 
construct is in part dependent on the literacy. Thus, relatedly, the education level of the 
individual can also influence this dimension (take note that about 47% of the 
quantitative sample received only primary education or below). This finding supports 
the advocacy for literacy interventions, which has been found to have a degree of effect 
on improving psychological distress (e.g. Sorensen, 2012).  
 
Taken together, it is clear that psychologically distressed subgroups report poorer 
health literacy outcomes compared to non-distressed subgroups. However, the mechanisms 





Illness Perception Subgroup Differences 
The depression subgroup reported poorer illness perception of dialysis/ESRD compared 
to non-depressed subgroups on the BIPQ. This finding is consistent with many existing 
studies examining the relationship between dialysis and depression (e.g. Chilcot et al., 2008), 
with the finding that depression is the most common psychopathology reported by ESRD 
patients. Some of the explanations for depression in ESRD patients include poor locus of 
control and the invasive routine of dialysis being the greatest cause of associated stress, poor 
coping strategies, which in turn amplifies risk of depression (Chilcot et al., 2008). In addition, 
considering that 74% of the quantitative sample in the present study have been on dialysis for 
more than 2 years, temporal factors may increase the negativity of ESRD illness perception.  
Findings indicate that the hopeless subgroup reported poorer illness perception of DM 
compared to non-hopeless subgroups on the BIPQ. No studies have yet examined the 
relationship between hopelessness and DM, but some evidence suggests that hopelessness has 
an impact on the prognosis of diabetes, although more research into the potential mechanisms 
is needed (Pedersen et al., 2009). 
The anxiety subgroup reported prioritizing one condition over another. A review 
examining self-management of multiple chronic diseases and illness prioritization suggested 
that because prioritizing an illness was often linked with feelings of uncertainty, patients 
usually report feeling being out of control which in turn promotes feelings of anxiety 
(Lindsay, 2009). 
Across all psychological distress subgroups, the quantitative sample reported 
significant differences in the treatment burden subscale of MULTIPleS, suggesting that 
depression, anxiety, loneliness and hopeless patients are more likely to form perceptions that 
consider multimorbidity to cause additional burden. Qualitative analyses also suggest that 




been referred to as “self-care practices that patients with chronic illness must perform…as 
well as the impact that these practices have on patient well-being” (Gallacher et al., 2013). 
The relationship between treatment burden and depression/anxiety has been found in a 
number of other chronic illnesses, including DM (Kaptein et al., 2006; Ponzo et al., 2006). 
However, there is a dearth of research examining the relationship between treatment burden 
and loneliness/hopelessness. In terms of the related mechanisms, it is suggested that treatment 
burden impacts the overall well-being and reduces patients’ capacity to follow treatment 
management plans, which in turn leads to poorer physical health and increases the risk of 
patients developing psychological distress (Gallacher et al., 2013). However, a complete 
understanding of the phenomena is yet to be achieved.  
 
Nutritional Quality of Life Subgroup Differences 
All psychologically distressed (i.e. depressed, anxious, lonely and hopeless) subgroups 
reported poorer scores on the NSQOL. As discussed earlier, the NSQOL is a measure of 
appetite-related QOL and is also based on tools examining nutritional status (Han et al., 
2012), and although the use of NSQOL in empirical studies is gaining traction, available 
studies utilizing the NSQOL are not widely available. Thus, the discussion will use studies 
examining nutritional status instead. 
 Literature generally documents a relationship between depression and poor nutrition. A 
study reported that DM-ESRD patients reported poorer depression and nutrition scores 
compared to subsets of ESRD patients without DM, along with an overall high correlation 
between the severity of depression and degree of malnutrition in HD patients (Koo et al., 
2005). However, the reasons for the relationship between depression and malnutrition remain 
unclear, but some suggested reasons include findings that depression is associated with a loss 




Furthermore, these studies have usually examined under-nutrition instead of over-nutrition in 
examining depression. 
The relationship between anxiety and poor nutritional QOL has not been thoroughly 
examined, but anxiety has been reported to be a symptom of malnutrition, along with other 
behavioral changes (Miranda et al., 2007). In addition, anxiety disorders are common in both 
anorexics and obese populations (Pollice et al., 1997; Strine et al., 2008). 
Loneliness and poor nutrition is commonly studied in the context of the geriatric 
population, as the elderly demographic has been described to be at most risk of loneliness 
(Chen, Schilling & Lyder, 2001). The relationship between loneliness and poor nutrition is 
highlighted by findings that loneliness is associated with reduced number of daily meal intake 
(especially of protein, fruits and vegetables) (Ramin et al., 2011). The authors further propose 
that physiological decrease in appetite is related to loneliness, but further studies are required.  
Lastly, existing studies examining hopelessness and nutritional status are very limited. 
Studies usually examine the relationship between nutritional status and psychological 
distress/poor mental health in general, and hopelessness is often part of instruments used to 
assess psychological distress and not a separate construct on its own (e.g. Galler et al., 2010; 
Kvamme et al., 2011). 
Overall, further research is required to uncover the mechanisms linking psychological 
distress to poor nutrition/nutritional QOL. 
 
Adherence Subgroup Differences 
Depressed patients reported difficulty in following their diet regimen, compared to non-
depressed patients on the 1-item ADAT (i.e. yes/no answer to “Do you have difficulty 
following your diet?”). In the context of multimorbidity, depressed patients with coexisting 




2013). A suggested mechanism underlying this relationship is that depression is often 
associated with reductions in cognitive functioning that governs memory and following 
through with treatment recommendations (e.g. diet) (DiMatteo, 2000). 
Anxious patients reported difficulty in following their diet compared to non-anxious 
patients on the ADAT. Anxious patients also reported a greater degree of deviation from their 
diet in DDFQ-Diet. Current literature is mixed on identifying the relationship between 
anxiety and adherence. A recent cohort study examining the association between anxiety 
symptoms and adherence in a clinical population reported that anxiety was associated with 
self-efficacy, which may in turn function as a mediator adherence as low self-efficacy 
reduces motivation and perseverance required in adherence behavior (Bautista, Vera-Cala, 
Colombo & Smith, 2012). In addition, because the concept of anxiety is not heterogeneous, it 
may be noteworthy to mention that paradoxically, some forms of anxiety (i.e. generalized 
anxiety about health) might actually improve adherence to treatment, as patients are over-
concerned about their health (Mineka, Watson & Clark (1998) 
Hopeless patients reported difficulty in following their diet, compared to non-hopeless 
patients on the ADAT. In terms of underlying mechanisms, current literature suggests that 
hopeless patients, with little optimism that any action they take will be worthwhile, would 
have little interest in complying to the strict dietary guidelines that DM and ESRD both 
demand (DiMatteo et al., 1993). 
Interestingly, while loneliness has been documented to influence adherence (because 
social isolation is associated with lack of emotional support and assistance, in turn 
influencing the likelihood of adherence) (DiMatteo, 2000), differences between loneliness 




Overall, future research is suggested to rigorously test the proposed mechanisms, 
ideally in a multidimensional model to discern the exact explanations to the significantly 
disconcerting relationship between psychological distress and adherence. 
 
Section 4: Biopsychosocial Determinants of Psychological Distress (Research Aim 1 
and 3) 
Overview 
Results in the present study suggest that psychological distress is determined by a 
combination of biopsychosocial factors. The most consistent predictor of psychological 
distress (across all subgroups) was Nutritional QOL. Some of the predictors have been 
discussed briefly in the previous section, but the discussion in this section aims to explore 
significant predictors in-depth. 
An interesting finding in the present study emerged: that is, the significant predictors 
identified using stepwise logistic regression models for both depression and hopelessness 
were identical (i.e. being Chinese, HLQ-Social Support, HLQ – Ability to Actively Engage 
with Healthcare Providers, and NSQOL). To present a more congruent discussion, depression 
and hopelessness will be discussed under the same subsection, but the differences these two 
constructs will be highlighted accordingly. 
 
Depression and Hopelessness 
Earlier in the introduction chapter, the paper has presented a review of the literature and 
argued for the cause for examining depression and hopelessness as separate constructs. While 
multivariate modeling revealed the identical variables in predicting depression and 
hopelessness, different underpinning mechanisms and theoretical implications may be applied 





Ethnicity was found to be a significant predictor of both depression and hopelessness. 
More specifically, the Chinese were more likely to exhibit depression and hopelessness than 
the non-Chinese. This finding rallies the need for further research into ethnic differences on 
depression/hopelessness in the DM-ESRD population specifically, particularly so because 
previous studies examining mental health in both general and clinical populations did not find 
any differences between different ethnic groups (Ko & Kua, 1995; Lim et al., 2005; Stahl et 
al., 2008). Studies examining depression in the Singaporean ESRD population also did not 
report similar findings (e.g. Griva et al., 2014). In addition, results in the present study were 
contrary to findings from a cross-sectional epidemiology study of Singaporean DM patients 
in that Indians were more likely to exhibit depression (Chong et al., 2009).  
Few studies have documented ethnic differences in hopelessness in Singapore. 
However, noting that hopelessness is predictive of suicide ideation, studies on ethnic 
differences in suicide behavior in Singapore have similarly not reported significant 
differences between ethnic groups (Mak, Ho, Chua & Ho, 2015). However, the study did 
mention that Indians were more likely to have more protective factors than the Chinese 
(which runs contrary to findings for depression). Therefore, while ethnicity is found to be a 
common predictor in two separate multivariate models for depression and hopelessness, 
further research is required to tease out the different impact ethnicity has for these two 
psychological constructs.  
 
Nutritional QOL.  
Poor nutritional QOL was found to be a significant predictor of both depression and 
hopelessness. As discussed earlier, a review of the literature on DM or ESRD populations 




In general, several studies have reported that individuals who have poor quality diet are 
more likely to report symptoms of depression (Jacka et al., 2010). Underlying mechanisms 
proposed by neurology studies on rats suggest that poor diet and nutritional status may alter 
biological processes underpinning depression, such as negatively affecting brain plasticity 
and function (Molteni et al., 2002) and a maladaptive stress response system stemming fron 
the hypothalamus (Tannenbaum et al., 1997). The loss of appetite as a result of depression 
was briefly mentioned in the last section. An in-depth review of literature examining 
depression and appetite in other clinical populations suggests that depression is accompanied 
by both a reduction and increment of appetite, and the amount of change in either direction is 
a function of the severity of depression (Paykel, 1977). Suggested mechanisms underlying 
appetite and depression include disruption of patterns of sleep typical of depressed 
individuals that lead to fluctuations in appetite (Silverstein, 1999), fluctuations in food 
cravings that are reportedly related to exhibiting symptoms of depression (Weingarten & 
Elston, 1991) and in addition, reductions in food intake that are reported to be related to 
associated symptoms of depression, such as self-doubt and pessimism (Capuron et al., 2002).  
Studies examining feelings of hopelessness and nutritional QOL suggest that the 
underlying biological processes may be different from depression. Hopelessness, 
characterized as a pessimistic cognitive style, is associated with a feeling that it is most 
improbable that any plans made will achieve goals (Melges & Bowlby, 1969). Plans of goals 
and actions primarily involve the prefrontal cortex, which is found to exhibit neural pattern 
impairments in several neurology studies examining effects of poor nutrition (e.g. Soto-
Moyanoet al., 1987; De Bellis et al., 2005). In addition, while explanations for the 
relationship between depression and poor nutrition primarily involve patients’ subjective 
experiences (e.g. food cravings, sleep disruptions), explanations for hopelessness involve 




diet quality and the likelihood of making healthy food choices were related to optimism 
(Hingle et al., 2014). An emerging theme in qualitative analyses was that patients report not 
following their dietary recommendations. Considering that dietary adherence is reported by 
the overall study sample to be one of the more challenging aspects of treatment, it then makes 
sense to suggest that because hopelessness is associated with loss of hope for improvement or 
recovery (Jones et al., 2003), poor nutritional QOL (representing dietary nonadherence) will 
be predictive of hopelessness as well.   
Overall, more research is required to examine the connection between depression, 
hopelessness and nutritional QOL.  
 
HLQ – Ability to actively engage with HCP 
Higher scores in the HLQ Item “Ability to actively engage with HCP” were found to be 
predictive of a less likelihood of exhibiting depression and hopelessness. The ability to 
actively engage with healthcare providers is briefly described as the extent to which patients 
are “proactive about their health and feels in control in relationships with HCPs and is able to 
seek advice from additions HCPs when necessary” (Osborne et al., 2013).  It is necessary to 
note that research examining HCP engagement and depression/hopelessness in the context of 
DM-ESRD is unavailable. 
Chronic disease patients with documented rates of depression have been known to 
report a loss of interest in engagements with resident physicians and nurses in an inpatient 
setting (Miranda et al., 2003). In the context of ESRD, the fact that patients go for dialysis 
thrice weekly can lead to a sense of independence and at the same time, desensitize them to 
the HCPs in the DCs, thus promoting the lack of a sense of agency with HCPs (Hunkeler et 
al., 2006; Tamura, Goldstein & Perez-Stable, 2009). An experimental study targeting the 




educational intervention reported that depression rates were significantly improved after the 
intervention (Clever et al., 2006). Some patients have expressed the desire for greater HCP 
engagement, as described in the qualitative analyses.  
Hopelessness is associated with the lack of proactive behavior, which makes good 
sense explaining why hopelessness would be associated with the lack of proactive behavior in 
engagement with HCPs. This is supported by psychotherapy research highlighting a strong 
relationship between being hopeful about the future and good client engagement in patients 
suffering from debilitating conditions (Quinlivan et al., 2013). Overall, the evidence 
describing good HCP engagement in improving feelings of hopelessness are available 
(Collins & Cutcliffe, 2003) 
In psychotherapy research, concepts such as having a therapeutic relationship have 
been found to improve both depression and hopelessness rates (Lambert & Barley, 2001). 
Therefore, this supports the need for cross-disciplinary education to increase HCP awareness 
of effective methods discussed in psychotherapy research, especially in the present study’s 
context community DCs and hospitals. 
 
HLQ - Social Support 
Higher scores in the HLQ Item “Social Support” were found to be predictive of a less 
likelihood of exhibiting depression and hopelessness. Social support is found to consistently 
predict survival in ESRD patients (Thong et al., 2007). 
The negative correlation between depression and social support in ESRD patients has 
been documented in several studies (Watnick et al., 2003; Asti et al., 2006; Thong et al., 
2007). For ESRD patients, the strict requirements in the treatment regimen severely restricts 
patients’ social activities and causes disruptions in family and social life. As described in the 




frequency of attending dialysis sessions per week severely limits their capacity for social 
activities. With decreased social engagements and/or support, patients may be cut off from 
important relationships that help mitigate feelings of depression that accompanies ESRD 
treatment (Littlefield et al., 1990). 
Fewer studies examine the relationship between hopelessness and social support in 
ESRD patients. In studies examining other chronic disease populations (e.g. cancer), social 
support is not only documented to act as a buffer to harmful events, but is also found to 
decrease thoughts of hopelessness (Tan & Karabulutlu, 2005). In addition, social support has 
been found to be key factor in increasing the subjective feeling of treatment efficacy (Brent et 
al., 1998).  
It is clear that depression and hopelessness may be examined as two distinct 
constructs (in that depression may be related to feelings and/or mood, and hopelessness with 
cognition), but further research is needed to identify the exact relationship between 
depression, hopelessness and the four psychosocial dimensions. 
 
Anxiety 
Study results indicate that the significant predictors identified using stepwise logistic 




Results suggest that females have more likelihood of reporting anxiety as compared to 
males. Examination of anxiety in the ESRD population in general state that either females 
report higher rates of anxiety (e.g. Cukor et al., 2008) or that they do not report any 




prevalence of trait anxiety (Kendler et al., 1995). Gender differences in psychological 
outcomes have been well studied, and neurological explanations suggest that these 
differences may be due to a “flight-or-fight” response activated more readily in women (and 
also stays activated for a longer period) compared to men due to high contents of estrogen 
and progesterone (Almeida et al., 2009). In addition, the neurotransmitter serotonin 
(regulating stress response and anxiety responsiveness) has also been reported to be 
processed less quickly in the female brain (Almeida et al., 2009). In addition, women are also 
found to be more sensitive to low levels of Corticotropin-Releasing Factor (CRF) (a hormone 
organizing stress response), potentially making them more vulnerable to stress-related 
disorders compared to men (Valentino et al., 2013).  
 
Kt/V 
As a number used to quantify hemodialysis treatment adequacy, Kt/V indicates how 
well the dialysis treatment is working for a patient. Kt/V has been found to correlate with 
survival rates (Horigan, 2012). The recommended rate of Kt/V is 1.2mL. A study found that a 
3-month average Kt/V that is consistently below 1.2mL is associated with increased mortality 
(Held et al., 1996). 
The present study reports that a decrease in 0.1mL of Kt/V was associated with 
greater likelihood of reporting anxiety. This finding is previously undocumented in studies 
examining anxiety in ESRD populations (e.g. Bossola et al., 2012; Ng et al., 2015). A 
possible explanation for this is that dialysis inadequacy may have somatic feedback to the 
patient, which in turn increases worries and concerns about their general health. However, 






HLQ – Actively Managing my Health 
Results suggest that an increase in scores on HLQ – Actively Managing my Health 
was associated with less likelihood of reporting anxiety. Osborne et al (2013) suggest that 
individuals who score highly on this HLQ dimension recognize the importance and are able 
to take responsibility for their own health, in addition to proactively engaging in their own 
health care. Although this dimension has yet to be examined in the ESRD population, 
findings suggest that improving self-care management behaviors leads to greater confidence 
in managing a patient’s illness (Fredericks et al., 2012). Feelings of confidence have 
consistently been reported to be negatively correlated with anxiety (e.g. Lent & Brown, 2013). 
Thus, it makes sense that patients who take control and responsibility for their own health 
experience a better health locus of control, which acts as a buffer against feelings of anxiety 
(Cheng et al., 2013). 
 
Nutritional QOL 
Lower nutritional QOL is reported to be a predictor of anxiety. As discussed in the 
previous section, the relationship between anxiety and poor nutritional QOL has not been 
examined in the literature. However, it is interesting to note that anxiety disorders are 
common in both anorexics and obese populations (Pollice et al.,1997; Strine et al., 2008). The 
suggested mechanism primarily involves a obsessive-compulsive trait typical of persons 
suffering from anxiety disorders that leads to compulsive rituals connected to food (e.g. 
weighing every bit of food or binge eating). However, these findings relate to the official 
DSM-V diagnosis of eating disorders and may not be applicable to the present study. 
Nonetheless, future research on DM-ESRD should focus on examining the anxiety-nutritional 






Study findings indicate that the significant predictors identified using stepwise logistic 
regression models for loneliness were HLQ – Social Support, HLQ – Navigating Healthcare 
System, MULTIPles – Treatment Burden and Nutritional QOL. 
 
HLQ – Social Support 
Social support was associated with the less likelihood of reporting loneliness in the 
present study. As discussed in the previous section, current literature is rich in documenting 
an existing relationship between social support and feelings of loneliness (e.g. Griva et al., 
2014). Poor social support is documented to lead to feelings of isolation and loneliness, and 
in particular to the context of chronic diseases, it has been found to contribute to poor coping 
strategies (Lazarus & Folkman, 1991). The documentation of the link between social support 
and loneliness rallies for future interventional efforts to target this area. 
 
HLQ – Navigating the Healthcare System 
A higher score on the HLQ – Navigating the Healthcare System was associated with 
the less likelihood of reporting loneliness. Osborne et al (2013) describes this HLQ 
dimension to involve patients’ ability to advocate on their own behalf, or at least, find 
someone who can help them use the healthcare system to address their health needs if they 
are unable to do so. Hence, if patients are unable to make decisions on their own or find 
someone else to assist them in doing so, we may reasonably infer that these patients have a 
poor support network in the first place. However, it remains unclear how exactly a person’s 
ability to navigate the healthcare system affects their levels of loneliness. Hence, further 





MULTIPles – Treatment Burden 
Treatment burden was associated with a greater likelihood of reporting loneliness. As 
chronic conditions, DM and ESRD are expected to cause feelings of burden on the population. 
Qualitative results suggest that patients experience treatment burden as a result of the high 
demands of dialysis, and that they often have to face the management of their conditions 
alone. Research examining the relationship between treatment burden and loneliness suggests 
that treatment burden is related to feelings of a loss of freedom with engaging in social 
activities, as well as feeling isolated and inadequately supported (and experiencing 
relationship strain) (Demain et al., 2015). Relationship strain is also documented in the 
qualitative results, where some elderly patients state that their children do not spend enough 
time with them and instead work too much. 
 
Nutritional QOL 
Poor nutritional QOL is found to be predictive of loneliness in the present study. In 
current literature, research is lacking in explaining the link between these two constructs. In 
the context of debilitating illnesses, the lack of social support is found to be related to poor 
nutrition, although the study did not examine the concept of loneliness per se (Gibbons et al., 
2013). Proposed reasons include that patients with debilitating chronic conditions often rely 
on their caregivers and/or family members to look after aspects of their treatment (e.g. diet), 
and thus a poor network of such support may lead to the patient not receiving adequate 
nutrition. It is suggested that further research examine the biopsychosocial contexts 





Section 5: Study Strengths/Limitations and Future Directions. 
 
Strengths and Limitations 
The strengths of this study include a sample that is highly representative of the 
Singapore HD population. Selection bias was minimized as participants were not limited to 
patients who could read and complete the questionnaires by themselves.  
Additionally this is the first systematic study to examine the prevalence and predictors 
of psychological distress in DM ESRD patients. A number of predictors were identified 
which offers future research some options for targeting psychological distress. 
Although the qualitative component of the study is able to provide a rich description 
of patients’ experience with multimorbidity, it is important to note that typical of qualitative 
studies, results may be more easily influenced by research bias. 
The quantitative component of the study was cross-sectional, which disallows the 
conclusion of causality in the significant relationships documented. In addition, the present 
study extrapolated cut-off/classification categories from the original ULS-20, as there are no 
recommended guidelines for the proper cut-off/classification of ULS-8 score. While the 
reliability of the ULS-8 in the present study is accounted for, further validation of the ULS-8 
would nonetheless be beneficial to determine the exact cut-off scores required for 
classification of lonely vs non-lonely. 
 
Future Directions 
The present study was able to successfully document the effect of psychological 
distress on the four measured psychosocial dimensions. However, current literature is lacking 




distress and the four psychosocial dimensions should be explored as a way to guide further 
research into the phenomena and inform intervention efforts.  
The present population also reports poor health literacy, particularly so with 
psychologically distressed patients. Potential strategies to address health literacy in patients 
with chronic conditions include the increased use of patient navigators in supporting patients 
through the system (Manderson et al., 2012) such as the use of online methods of information 
delivery, which could be a viable option considering the increasing uptake of technology in 
the general population. 
Illness perception is associated with a myriad of patient-reported outcomes. This 
study documents the presence of treatment burden perceptions and that the DM-ESRD 
population may face coping problems in prioritizing one illness over another. In addition, the 
study also found less-than ideal rates for nutritional QOL and problems with adherence. 
These psychosocial dimensions are important in improving the overall patient well-being and 
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A. INTRO BY FACILITATOR 
Interviewer to introduce him/herself and outline purpose of interview - 
(emphasis on confidentiality) 
 
B. INTERVIEW QUESTIONS 
 
Diabetes & Dialysis 
1. Could you give me a brief history of your diabetes and kidney 
problem(s) from when it started to you beginning dialysis? 
 
2. Are there any aspects of the HD or diabetes that you find 
particularly difficult to manage? Why? 
 
3. How do you feel about having to be on dialysis as well as 
managing diabetes? Have you ever felt that being on dialysis 
affects your diabetes or the opposite that diabetes affects how 
well you do on dialysis? In what ways and why? 
 
Prompt: Has there ever been a time when you have felt 
frustrated with having to manage both diabetes and dialysis? 
Please describe/give an example 
4. What is the physician’s role/responsibility for the management of 
diabetes and kidney condition? 
 
5. What is the role/responsibility of your family for the management 
of diabetes and kidney condition? 
 
6. What are your treatment goals for your conditions? 
 
Prompt: Who set your treatment goals; Are you involved and if so 
is this effective? 
 
7. What are the main reasons for failing to achieve treatment goals 
(diabetes/kidney conditions)? Any other reasons? 
 
Prompt: What are the most important reasons for achieving 
treatment goals? 
 






Prompt: Do you have particular strategies for helping you with…? 
Diet 
9. What are the main challenges for people who have to follow diet for both 
diabetes and dialysis and why? 
 
10. How do you manage your diet for diabetes and dialysis on day-to-day 
basis? 
 
Prompt: Has there been a time when you had to prioritise one condition 
over other and when or why? Please describe or give an example. 
 
11. Can you think of any problems you have with following your diet or 
situations that make it more difficult? 
 
Prompt: Mood, special/social events, family outings 
 
12. Are there some aspects of your diet for either diabetes and/or kidney 
condition) that harder to follow than others/ that you find particularly (more) 
troublesome than others? Why? 
 
13.  Are there any aspects of your diet for either diabetes and/or kidney 
condition) that you find hard to understand or remember? Why? 
 
14. Do you have any concerns regarding your dietary recommendations? 
 
Prompt: Is this more in relation to diabetes, kidney condition or both? 
 
Fluid Intake 
15. How do you manage with fluid intake? 
 
16. Can you think any problems you have with following your fluid 
intake recommendations? 
 
17. To what extent diabetes may affect or interfere with your fluid 
control? Why? (Give an example) 
 
18. Are there any things that you do that make it easier for you to 
regulate fluid intake? 
 
Medication 
19. What medication are you currently on as part of your treatment 
for diabetes and kidney condition? 
 






Prompt: Side effects; addictive; costs 
 
Support/Information Needs 
21. Thinking of your health condition and all aspects of your 
treatment for both diabetes and kidney condition which do you 
think you could use the most help with? 
In what way you could use help?  
 
22. What do patients and their families need to know to manage 
better diabetes and dialysis? 
 
23. What more can be done to support patients and their families? 
What do you really think may be missing that could useful/helpful 
for patients with diabetes and on dialysis?  
 
24. What are some of the difficulties you foresee for running a 
program for people with diabetes and on dialysis? How to best 
work round or overcome these? 
 
25. When would be the best time to deliver any intervention, why and 
who would you like to deliver it? 
 
26. To what degree would you like your caregiver / family members 
to be involved in the intervention/program? 
 
27. Would you be interested in to engage with technology as part of 
intervention if at no extra costs for you but provided free (e.g. 
interactive applications, or mobile technology etc.) Why and why 
not? 
 
28. What program would be interested to participate? Why? 
 
29.  Is there anything else on these topics or anything else that you 












Information Sheet and Consent Form 
Project Title: IMPROVING OUTCOMES IN PATIENTS WITH DIABETES 
AND ON DIALYSIS – GAINING INSIGHT TO DESIGN A PROGRAM OF 
SUPPORT 
 
Principal Investigator: National University of Singapore 
A/Professor Griva Konstadina  
[tel: 65163156; 81861423] 
 
Co – Investigators:  National Kidney Foundation  
Dr Nandakumar Mooppil [tel: 95735564] 
National University Hospital 
Dr Eric Khoo [tel: 97220379] 
You are invited to participate in a research project. This information sheet provides 
you with information about the research. The Principal Investigator or her 
representative will also describe this research to you and answer all of your 
questions. Read the information below and ask questions bout anything you don’t 
understand before deciding whether or not to take part. 
After you are satisfied that you understand this study and that you wish to take part 
in the study you must sign the consent form. You will be given a copy of this 
consent form to take home with you. 
 
(1) What is the purpose of this research? 
Managing diabetes and dialysis at the same time can be a particularly diffcult. 
Accomodating treatment in everyday life and following recommendations 
regarding self-care, diet and medication for both conditions can be quite 
overwhelming.  
The purpose of this study is to develop a support intervention for patients with 
diabetes and on dialysis. To do so first we wish to understand better patients’ and 
family members’ experience with diabetes and dialysis, how they manage their 
treatments, the difficulties they are facing and the aspects with which they can use 
most help with.  
By focusing on their perspectives we hope to be able to develop a service that 
would be better suited to meet patients’ needs for support and improve on the 
health care they receive. 
  
(2) Who can participate in the research? What is the expected duration of my 




You were selected as a possible subject in this study because we are 
approaching all patients with diabetes who receive hemodialysis in the 
participating NKF centres as long as they have been on hemodialysis for 
more than 3 months, are over the age of 21 years, and are willing to 
participate in the study. 
Individuals who only speak dialects (for example Teochew, Hokkien), or those 
with health concerns such as severely impaired hearing or vision or speech, or a 
comorbid diagnosis of dementia or severe cognitive impairment will not be eligible 
to take part in this research. Also, those who do not agree to the audio-recording of 
the interview will not be eligible to participate.  
 
The research study will be running for 12 months but your actual participation will 
be no more than 40-60 minutes as it only involves one interview. 
 
(3) What is the approximate number of participants involved? 
 
Overall, we hope to invite approximately 20 patients, 20 family members and 10 
health care professionals to take part in this study. 
 
(4) What will be done if I take part in this research? 
You will be asked to take part in one interview on your experience with 
managing diabetes and dialysis and your resources and preference for 
support. The interview will take place at a time and place convenient for 
you. This can be at one of your routine dialysis clinic visits or at different 
place and time if you so wish. The interview will take about 40-60 minutes 
depending on your sharing and wish to discuss your experience. 
Should you feel too tired to complete the interview in a single session, you 
can ask the researcher to return for another session, if necessary. Please 
note that your interview session will be audio-recorded to facilitate 
transcriptions and analysis. The transcription will bear no personal 
information, i.e., it will be anonymized.  Once transcribed the recordings will 
be destroyed.   
 
Medical data will also be retrieved from your medical records only if you 
consent to this. These will include recent laboratory test results and 
interdialytic weight gains, information on treatment such as prescribed 
medications, how long you have been diagnosed with diabetes, how long 
you have been on dialysis and any other additional medical conditions and 
hospitalisation rates. 
 





All information collected during the course of the research will be kept strictly 
confidential. The National University of Singapore will overview the collection, 
storage, handling and processing of the data and Associate Professor Griva 
Konstadina, in her capacity as the principal investigator, will be responsible for 
security and access to the data. The information collected, except your name and 
NRIC number, will be stored and analysed confidentially in a computer. No 
personal information on the data held in the computer will enable a third party to 
link the data to you. 
All your research data will be coded (i.e. only identified with a code number) at the 
earliest possible stage of the research. Only the principal investigator will know 
that the information is related to you and will have access to your identifiable 
information (i.e., your name, NRIC and contact information). This will not be 
released to any other person, including members of the research team. Your 
research data (including anonymized interview transcripts and medical information 
bearing only your study ID number) will be archived for 10 years after the 
completion of the research – after which time they will be deleted.  
Personal identifiers such as name and NRIC number are required to 
facilitate retrieval of medical information from your medical records. This 
personal information will only be kept for 3 years after completion of study, 
after which it will be safely destroyed. We will be adhering to local and 
national data protection laws. We therefore need your permission to allow 
access to the parts of your medical records that are related to this study.  
The results of the study may be published in the medical literature, but any 
identifiable information (e.g. name) will not be revealed. Quotes from your 
interview may be used in publications/presentations of this research without 
identifying you. 
 
(6) What are the possible discomforts and risks for participants? 
We do not expect there to be any discomfort or distress arising from this study. 
You are welcome to share and discuss as much or little as they like. You are in 
control of how much you want to share or which questions you like to answer or 
not. You do not have to answer a question that makes you uncomfortable or a 
question you do not wish to answer.  
 
(7) What is the compensation for any injury? 
 
The study procedures have been carefully designed to be completely non-invasive 
– none of the procedures is likely to pose any risk of harm or injury to you. As 






You will receive $20 as a token of appreciation for study participation. This will be 
handed over after the completion of the interview. 
 
(9) What are the possible benefits to me and to others?  
There is no direct benefit to you from participating in this research. Most 
patients however enjoy the opportunity to express their views and report on 
their illness and treatment experience. 
The knowledge gained will benefit the public and other patients in the future. We 
hope that the information produced by this study will help us to better understand 
patients’ experiences with diabetes and dialysis and hence develop an intervention 
program that will be better meeting their needs and supporting them in making 
lifestyle changes related to medication, diet and fluid intake. 
 
(10) Can I refuse to participate in this research? 
You are entitled to refuse to participate or discontinue participation at any time in 
this research without giving any reason, by informing the Principal Investigator, 
and all research data relating to you will be destroyed. Refusal to participate or 
withdrawal from participation will not affect your medical management at or cause 
loss of benefits to which you are otherwise entitled either now or in the future. 
 
(11) Whom should I call if I have any questions or problems? 
Please contact the Principal Investigator, A/Professor Griva Konstadina at 
telephone 65163561 and email psygk@nus.edu.sg for all research-
related matters and in the event of research-related injuries. 
 
For an independent opinion regarding the research and the rights of 
research participants, you may contact a staff member of the National 
University of Singapore Institutional Review Board (Attn: Mr Chan Tuck Wai, 






Project Title: IMPROVING OUTCOMES IN PATIENTS WITH DIABETES AND ON DIALYSIS 
– GAINING INSIGHT TO DESIGN A PROGRAM OF SUPPORT 
 
Principal Investigator: Associate Professor Griva Konstadina (Tel: 65163156) National 
University of Singapore 
I hereby acknowledge that: 
1. My signature is my acknowledgement that I have agreed to take part in the above research.  
2. I have received an information sheet that explains study aims and procedures and the use of 
my data in this research. I understand its contents and agree to take part in this research. 
3. I can withdraw from the research at any point of time by informing the Principal Investigator 
and all my data will be discarded. 
4. I will not have any financial benefits that result from the commercial development of this 
research. 
5. I agree/ do not agree* to the use of my medical records for this research. 
6. I agree to the audio-recording of the interview. 
* This research has been explained to me in _________________ (state language), which I 
understand, by ____________ (name of translator) on _______ (date) 
 
_______________________________    ___________ 
Name and Signature (Participant) Date 
 
_______________________________    ___________ 
Name and Signature (Consent Taker) *    
 Date 
 
_______________________________    ___________ 
















Quantitative Study Questionnaires (Without HLQ) 
 
IMPROVING OUTCOMES IN PATIENTS WITH DIABETES AND ON DIALYSIS – 
GAINING INSIGHT TO DESIGN A PROGRAM OF SUPPORT  
Your response to the following questions about yourself (e.g. age, employment 
status)  would be very helpful. Please circle one number for each question or write 
in the answer on the lines provided.  
   
[A1]  
  
What is your gender? (please tick): MALE ______  FEMALE _____  
[A2]  
  
What is your age and date of birth? __________  _____________  
[A3]  
  
What is your first language? (please write in) _________________  
[A4]  What is your ethnic group? (according to NRIC)  
      
 Chinese          1  
    Malay           2  
    Indian           3  
    Others: please specify ________________ 4   
  
[A5]     How many years of full-time education have you received? _____  years  
  
[A6]     What is your highest educational qualification? _____________________  
  
[A7]   What approximately is the current estimated monthly income of your            
overall family? (Please remember your answers are confidential)  
  
1    $ 0 - $ 2,000               4        $ 6,001 – above  
2   $ 2,001 - $ 4,000              5        don’t know  
3    $ 4,001 - $ 6,000              6        don't wish to answer  
  
[A8]     How would you describe your relationship status?  
            (please circle one number)  
  
1    Married               4        Single  
2   Divorced              5        Living with partner  
3    Widowed              6        Others ________________  
  
[A9]     Are you now able to work for pay full-time, part-time or not at all?   
            (please circle one number)  
  
1 I am able to work for pay full-time  
2 I am able to work for pay part-time  
3 I am unable to work for pay  
  
[A10]    Which of the following responses best characterises your current work               





1 employed full-time               5     retired  
2 employed part-time               6     looking after home and family  
3 self-employed                 7     student  
4 unemployed, laid off looking for work    8     other/none of the above   
  
[A11] Which of the following best describes your living arrangements:  
            (please circle one number)   
  
1 rent from private landlord  
2 own home  
3 live with parents/children  
4 other  
  
[A12] Which of the following best describes your housing:   
            (please circle one number)   
  
1 1-2 HDB flat  
2 3-4 HDB flat  
3 HDB 5 room/executive/maisonette  
4 Condominium, including executive condominium or private apartment  
5 Terrace / Semi – Detached / Bungalow  
6 Other (please specify_____________________)  
  
[A13]   What is your current living arrangement? (please choose that apply)  
  
  1     staying alone      6     extended family members  
  2     with spouse      7     landlord and/or flatmate  
  3     with children      8     friend  
4 with parents  
5 with siblings  
               9     nursing home  
  
[A14]   Do you have any long-standing illness, disability or infirmity other than 






[A15]   How old were you when you have been diagnosed with diabetes?   




[A16] When did the doctor first tell you that you had kidney problems caused by 





 Age when told    ___________  
    (or) Year when told  │___│___│___│___  
    (or) _________ years ago  
    Not sure     999  
  
[A17]   How long have you been on hemodialysis?  
  
1 6 to 12 months  
2 13 to 24 months  
3 More than 24 months (2 years) __________  
     
[B1]     Have you been told by a physician (Western-trained) that you have              
diabetic eye disease? (please circle one number)  
  
    Yes      1    
    No      2 (Go to B2)  
    Refuse to answer  888 (Go to B2)   
    Do not know   999 (Go to B2)  
  
[B1.1] When did the doctor first tell you you had diabetic eye disease?  
  
    Age when told    ___________  
    (or) Year when told  │___│___│___│___  
    (or) _________ years ago  
    Not sure     999  
  
[B1.2]  Did you have eye surgery or laser procedure for your diabetic eye disease?  
           (please circle one number)  
      
                       Yes      1    
    No      2   
    Refuse to answer  888   
    Do not know   999   
  
[B2]    Have you ever been told by a physician (Western-trained) that you have 
nerve             problems in your arms or legs caused by your diabetes?             
(please circle one number)  
  
    Yes      1    
    No      2 (Go to question B3)  
    Refuse to answer  888 (Go to question B3)   
    Do not know   999 (Go to question B3)  
  
[B2.1]  When did the doctor first tell you that you had nerve problems in your arms 
and              legs caused by your diabetes?  
  
  




    (or) Year when told  │___│___│___│___  
    (or) _________ years ago  
    Not sure     999  
  
[B3]     Has a doctor, a nurse, or healthcare professional told you that you have             
high blood pressure? (please circle one number)  
  
                       Yes      1    
                       No      5  (Go to next questionnaire; turn page)  
                       Do not know    999  (Go to next questionnaire; turn page)  
  
[B3.1] How many years have you had high blood pressure? ______ no. of years  
    
[B3.2]  Are you currently on regular medications from your physician for high             
blood pressure? (please circle one number)  
  
 Yes      1   





























THE BRIEF ILLNESS PERCEPTION QUESTIONNAIRE   
For the following questions, please circle the number that best corresponds to your 
views:  
DIABETES  
1. How much does your diabetes affect your life?   
0           1           2           3           4           5           6           7           8           9           10   
no affect                                                                                                             
severely at all                                                                                                           
affects my life   
2. How much control do you feel you have over your diabetes?   
0           1           2           3           4           5           6           7           8           9           10  
absolutely                                                                                                           extreme 
no control                                                                                             amount of control  
  
3. How much do you think your treatment can help your diabetes?   
0           1           2           3           4           5           6           7           8           9           10  
not at all                                                                                                           extremely  
                                                                                                                             helpful  
4. How much do you experience symptoms from your diabetes?  
0           1           2           3           4           5           6           7           8           9           10  
no symptoms                         many severe  
at all                                                                                                               
symptoms   
5. How concerned are you about your diabetes?  
0           1           2           3           4           5           6           7           8           9           10  
not at all                                 extremely  
concerned                                                                                           concerned                           
6. How well do you feel you understand your diabetes?  
0           1           2           3           4           5           6           7           8           9           10  
don’t understand                                    understand  
















KIDNEY DISEASE  
7. How much does your kidney disease affect your life?   
0           1           2           3           4           5           6           7           8           9           10   
no affect                       severely  
at all                                                                                                          affects my life  
  
8. How much control do you feel you have over your kidney disease?   
0           1           2           3           4           5           6           7           8           9           10  
absolutely                                                                                                           extreme 
no control                                                                                             amount of control  
  
9. How much do you think your treatment can help your kidney disease?   
0           1           2           3           4           5           6           7           8           9           10  
not at all                                                                                                           extremely  
                                                                                                                             helpful  
10. How much do you experience symptoms from your kidney disease?  
0           1           2           3           4           5           6           7           8           9           10  
no symptoms                         many severe  
at all                                                                                                               
symptoms   
11. How concerned are you about your kidney disease?  
0           1           2           3           4           5           6           7           8           9           10  
not at all                                 extremely  
concerned                                                                                          concerned                           
12. How well do you feel you understand your kidney disease?  
0           1           2           3           4           5           6           7           8           9           10  
don’t understand                                   understand  
at all                                                                                                             very clearly  
 




Thinking about your diabetes and kidney disease, for the following questions, 
please circle the number that best corresponds to your views:  
Treatment Burden Scale  
1. Taking different medications for each of my conditions has caused me problems   
  
0 1    2    3   
 4    5  
Strongly Disagree                                            Strongly Agree  
  
2. Having more than one condition makes my treatments less effective   
  
0 1    2    3   
 4    5  
Strongly Disagree                         Strongly Agree  
  
3. It is difficult to take all my medications the way I am supposed to   
  
0 1    2    3   
 4    5  
Strongly Disagree                         Strongly Agree  
  
4. Having more than one condition makes it difficult to get the best available treatment   
  
0 1    2    3   
 4    5  
Strongly Disagree                         Strongly Agree  
  
5. I don’t like mixing medications for different conditions   
  
0 1    2    3   
 4    5  
Strongly Disagree                         Strongly Agree  
  
6. I feel so overwhelmed by the treatment for one condition that it is hard to manage any     
others  
  
0 1    2    3   
 4    5  
Strongly Disagree                         
Strongly Agree Prioritisation Scale  
1. One of my conditions is more serious than the others   
  




Strongly Disagree                
  
2. One of my conditions has more of an impact on my life   
  
         Strongly Agree  
  0    1    2    3    4    5  
Strongly Disagree                
  
3. One of my conditions dominates the others   
  
         Strongly Agree  
  0    1    2    3    4    5  
Strongly Disagree                
  
4. One of my conditions is more worrying than the others  
         Strongly Agree  
  0    1    2    3    4    5  
Strongly Disagree                         Strongly Agree  
       
HOSPITAL ANXIETY AND DEPRESSION SCALE (HADS)   
Please circle your answer to indicate whether you have been feeling this way the  
last 14 days.  
  
    0  1  2  3  
1  I feel tense or ‘wound up’  Most of the 
time  
A lot of the time  
  
Time to time,  
occasionally  
Not at all  
  




Not quite so 
much  
Only a little  Not at all  
  
3  I get a sort of frightened feeling   
like something awful is about to   
happen  




A little, but it 
doesn’t  
worry me  
  
Yes but not 






4  I can laugh and see the funny  
side of things  
As much as  
I always 
could  
Not quite so 




Not at all  
5  Worrying thoughts go through  




From time to 
time but not too 
often  
A lot of the 
time  
A great deal 
of the time  
6  I feel cheerful  Most of the 
time  
Sometimes  Not often  Not at all  
  
7  I can sit at ease and feel relaxed  Definitely  Usually  Not often  Not at all  
8  I feel as if I am slowed down  Not at all  
  
Sometimes  Very often  Nearly all the 
time  
9  I get a sort of frightened feeling  
like ‘butterflies in the stomach’  
Not at all  
  




10  I have lost interest in my  
appearance  
I take just as 
much  
care as ever  
I may not take 
quite as much 
care  
I don’t take 
as much 
care as I 
should  
Definitely  
11  I feel restless as if I have to be 
on the move  
Not at all  
  
Not very much  Quite a lot  Very much 
indeed  
12  I look forward with enjoyment to  
things  
As much as  
I ever did  
  
Rather less 
than I used to  
Definitely 
less than I 
used to  
Hardly at all  
  
13  I get sudden feelings of panic  Not at all  Not very often  Quite often  Very often 
indeed  
14  I can enjoy a good book or radio  
or TV programme  
























SHORT-FORM UCLA LONELINESS SCALE (ULS-8)  
Please circle your answer.  
(a) I lack companionship  
  
     Never        Rarely        Sometimes        Always  
  
(b) There is no one I can turn to  
  
     Never        Rarely        Sometimes        Always  
  
(c) I am an outgoing person  
  
     Never        Rarely        Sometimes        Always  
  
(d) I feel left out  
  
     Never        Rarely        Sometimes        Always  
  
(e) I feel isolation from others  
  
     Never        Rarely        Sometimes        Always  
  
(f) I can find companionship when I want it  
  
    Never        Rarely        Sometimes        Always  
  
(g) I am unhappy being so withdrawn  
       
     Never        Rarely        Sometimes        Always  
  
(h) People are around me but not with me  
       














 BECK HOPELESSNESS INVENTORY – Short Version  
Please circle your answer for the statements below. Based on the past week:  
1. I feel that the future is hopeless and that things cannot improve.   
0 – Not typical  1 – Rarely typical  2 – Typical  3 –Very typical  
  
2. My future seems dark to me.   
 
0 – Not typical  1 – Rarely typical  2 – Typical  3 –Very typical  
 
3. Things just won’t work out the way I want them to.   
 
0 – Not typical  1 – Rarely typical  2 – Typical  3 –Very typical  
  
4. There’s no use in really trying to get something I want becaus     
get it.   
  
e I probably won’t  
0 – Not typical  1 – Rarely typical  2 – Typical  3 –Very typical  
            
   
DIET AND FLUID INTAKE QUESTIONNAIRE  
A. Nutrition-Specific Quality of Life (NSQOL)  
Please circle your answer.  
 
1. Since I started dialysis treatment food smells worse than before  
(1) Never  
(2) Rarely  
(3) Sometimes  
(4) Usually  
(5) Always  
 
2. Since I started dialysis treatment I like different foods than I used to  
(1) Never  
(2) Rarely  
(3) Sometimes  
(4) Usually  





3. Since I started dialysis treatment I enjoy mealtimes  
(1) Never  
(2) Rarely  
(3) Sometimes  
(4) Usually  
(5) Always  
 
4. Since I started dialysis treatment I do not feel like eating  
(1) Never  
(2) Rarely  
(3) Sometimes  
(4) Usually  
(5) Always  
 
5. During the past 4 weeks how often have you had difficulty following your diet?  
(1) Never  
(2) Rarely  
(3) Sometimes  
(4) Usually  
(5) Always  
 
 
6. During the past 4 weeks how often have you not felt like eating?  
(1) Never  
(2) Rarely  
(3) Sometimes  
(4) Usually 
(5) Always  
 
7. Overall how do you rate your appetite over the past 4 weeks?  
(1) Very good  
(2) Good  
(3) Fair  




(5) Very poor 
 
8. During the past week (7 days), how would you rate your usual appetite?  
(1) Very good  
(2) Good  
(3) Fair  
(4) Poor  
(5) Very poor 
 
9. Please select the appropriate statement  
(1) Over the past 7 days my appetite has remained good  
(2) Over the past 7 days my appetite has changed from good to poor  
(3) Over the past 7 days my appetite has changed from poor to good  
(4) Over the past 7 days my appetite has remained poor     
 
10. How would you rate your appetite on days that you have dialysis?  
(1) Very good  
(2) Good  
(3) Fair  
(4) Poor  
(5) Very poor 
 
11. Describe how you usually eat on days that you have dialysis?  
(1) I usually don't eat enough food  
(2) I usually eat the right amount of food  






12. How often do you enjoying eating on days that you have dialysis?  
(1) Never  
(2) Rarely  
(3) Sometimes  
(4) Usually  
(5) Always 
 
13. How would you rate your appetite on days that you do not have dialysis?  
(1) Very good  
(2) Good  
(3) Fair  
(4) Poor  
(5) Very poor 
 
14. Describe how you usually eat on days that you do not have dialysis?  
(1) I usually don't eat enough food.  
(2) I usually eat the right amount of food.  
(3) I usually eat too much food  
 
15. How often do you enjoying eating on days that you do not have dialysis?  
(1) Never  
(2) Rarely  
(3) Sometimes  
(4) Usually  
(5) Always  
  
B. Appetite and Diet Assessment Tool (ADAT) + Additional diet and fluid intake         
questions  
  







1. Do you have difficulty following your diet? Please tick your answer.  
   
 0 = No (Proceed to question number 2)  
 1 = Yes  
  
  
        If you answered “yes,” which of the following (1.1 – 1.6) describes why you are          
having difficulty. Please circle YES or NO.  
 
        
        1.1 I do not feel like eating.   





C. Thirst/Dry Mouth  
  




1. On a scale of 0 – 10, how much of a problem is thirst for you on an everyday     
basis?   
  
    0          1          2           3          4          5          6          7          8          9          10      
Not a                                                                                                         Very much     
problem                                                                                                     a problem  
  
  
2. On a scale of 0 – 10, how much of a problem is dry mouth for you on an everyday     
basis?   
  
    0          1          2           3          4          5          6          7          8          9          10      
Not a                                                                                                         Very much     




DIALYSIS DIET AND FLUID NON-ADHERENCE QUESTIONNAIRE (DDFQ)  




1. How many times in the last 14 days did you not follow your diet 
guidelines? Your       response can range from 0 to 14 days.  
    _____  
2. To what degree did you deviate from your diet guidelines? Please circle 
your     answer.  
      No deviation      Mild     Moderate     Severe     Very severe  
                0________1_______2________3________4  
3. How many times in the last 14 days did you not follow your fluid 
guidelines? Your       response can range from 0 to 14 days.  
     _____  
4. To what degree did you deviate from your fluid guidelines? Please circle 
your     answer.  
      No deviation      Mild     Moderate     Severe     Very severe  
                0________1_______2________3________4  
THE SUMMARY OF DIABETES SELF-CARE ACTIVITIES (SDSCA)  
The questions below ask you about your diabetes self-care activities for the 
past 7 days. If you were sick during the past 7 days, please think back to the 
last 7 days that you were not sick.  
DIET  
  
1.1   How many of the last SEVEN days have you followed a healthful eating plan?   
  0    1    2    3    4    5    6    7  
    
1.2   On average, over the past month, how many DAYS PER WEEK have you followed your eating 
plan?   
  0    1    2    3    4    5    6    7  
  











Which of the following medications for your diabetes has your doctor prescribed? Please 
tick all that apply.  
_ a. An insulin shot 1 or 2 times a day.  
_ b. An insulin shot 3 or more times a day.  
_ c. Diabetes pills to control my blood sugar level.  
_ d. Other (specify): _____________________  
_ e. I have not been prescribed either insulin or pills for my diabetes.  
  
  
5.2     
On how many of the last SEVEN DAYS, did you take your recommended diabetes medication?  
  
  0    1    2    3    4    5    6    7  
  
  
   
             
    
ADHERENCE TO MEDICATIONS (MORISKY)  
You indicated that you are taking medications for your diabetes and kidney disease.  
Individuals have identified several issues regarding their medication-taking 
behaviour and we are interested in your experiences.  There is no right or wrong 
answer.  Please answer each question based on your personal experience with your 
diabetes and kidney disease medications.   
Please put an “X” in the box that best indicates your response to each item.  
    NO   YES   
M1  
Do you sometimes forget to take your diabetes and kidney 
disease medication(s)?                
          0  
      
          1  
M2  
People sometimes miss taking their medications for reasons other 
than forgetting.  Thinking over the past two (2) weeks, were there 
any days when you did not take your diabetes and kidney disease 
medication(s)?  
     
           0  
     





Have you ever cut back or stopped taking your medication(s) 
without telling your doctor, because you felt worse when you 
took it?  
     
           0  
     
          1  
M4  
When you travel or leave home, do you sometimes forget to bring 
along your diabetes and kidney disease medication(s)?  
     
           0  
     
          1  
M5  
Did you take your diabetes and kidney disease medication(s) 
yesterday?      
           0  
     
          1  
M6  
When you feel like your diabetes and kidney disease is under 
control, do you sometimes stop taking your medication(s)?  
     
           0  
     
          1  
M7  
Taking medication everyday is a real inconvenience for some 
people. Do you ever feel hassled about sticking to your diabetes 
and kidney disease treatment plan?  
     
           0  
    
          1  
M8  
  
How often do you have difficulty remembering to take all your medication(s)?  
 
            0           1           2            3          4  






















Health Literacy Questionnaire 
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